Sentence,class,file
http://dx.doi.org/10.1128/ IAI.00059-09 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/ 10.1128/IAI.01386-07 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.2741/Corﬁeld .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Cell Host Microbe 4:447– 457. http://dx.doi.org/10.1016/ j.chom.2008.09.007 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1093/glycob/cwt040 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Glycobiology 10:669 – 689. http://dx.doi.org/ 10.1093/glycob/10.7.669 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1016/j.cocis.2005.11.001 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/ 10.1099/mic.0.27621-0 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.00279-09 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1099/mic.0.059659-0 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.01925.x .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1099/ mic.0.2007/009480-0 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
"BMC Evol Biol 9:118. http://dx.doi.org/ 10.1186/1471-2148-9-118 .27.Fischer M, Zhang QY, Hubbard RE, Thomas GH .",OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Trends Micro-biol 18:471– 478. http://dx.doi.org/10.1016/j.tim.2010.06.009 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/microbiolspec.MBP-0005-2014 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/ 10.1073/pnas.95.20.11751 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/ AEM.07395-11 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1111/1574-6968.12213 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/ IAI.01197-08 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
J Infect Dis 113: 59 – 66. http://dx.doi.org/ 10.1093/infdis/113.1.59 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.71.5.2839 -2858.2003 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Infect Immun 76:4726 – 4736. http://dx.doi.org/10.1128/IAI.00319-08 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Infect Immun 75:4891– 4899. http://dx.doi.org/10.1128/IAI.00484-07 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.06193-11 .V.cholerae Sialic Acid Utilization In Vivo Fitness March/April 2016 Volume 7 Issue 2 e02237-15 ®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1371/ journal.pone.0053957 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/mBio.00430-13 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.01435-13 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.02943-14 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
BMC Struct Biol7:11. http://dx.doi.org/10.1186/1472-6807-7-11 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1074/jbc.M111.281030 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Infect Immun73:6727– 6735. http://dx.doi.org/10.1128/IAI.73.10.6727-6735.2005 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.73.3.1284 -1294.2005 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/IAI.73.9.5291-5300.2005 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2005.04901.x .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1111/j.1574 -6968.2009.01881.x .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Microb Inform Exp 3:3.http://dx.doi.org/10.1186/ 2042-5783-3-3 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
J Bacteriol 187:6119 – 6127. http://dx.doi.org/10.1128/ JB.187.17.6119-6127.2005 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1111/j.1462-2920.2009.02001.x .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/JB.00079-10 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/ JB.00811-08 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Appl Envi- ron Microbiol 80:4414 – 4426. http://dx.doi.org/10.1128/AEM.01114-14 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1371/journal.pone.0059539 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1074/jbc.M113.453654 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1038/ nature12503 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/ IAI.01210-13 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1128/ IAI.06284-11 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
Nucleic Acids Res 22:4673– 4680. http://dx.doi.org/10.1093/nar/ 22.22.4673 .,OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1093/molbev/mst197 .,Non-OADS,/arxiv_data1/oa_pdf/f8/8e/mBio.02237-15.PMC4959520.pdf
http://dx.doi.org/10.1086/595011 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Nature 477:457– 461. http://dx.doi.org/10.1038/nature10388 .Resistance and Mobile Gene Cooccurrence in Pig Farms March/April 2016 Volume 7 Issue 2 e02214-15 ®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1016/j.tim.2012.01.002 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1126/ science.1120800 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1038/ nrmicro2312 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Microbiol Mol Biol Rev 74:417– 433. http://dx.doi.org/10.1128/ MMBR.00016-10 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1021/ es901221x .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Nat Rev Microbiol 12:465– 478. http://dx.doi.org/10.1038/ nrmicro3270 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001540 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
ACS Infect Dis 1(2):80 – 84. http://dx.doi.org/10.1021/id500052s .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.3382/ps.2007-00249 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.2460/ajvr.71.7.726 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1073/ pnas.1120238109 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1111/ j.1574-6941.2008.00526.x .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1128/AEM.02577-10 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1128/CMR.00002-11 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1016/ j.tim.2012.11.001 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1016/j.mib.2014.05.020 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1016/ j.tree.2012.02.006 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1016/ j.cell.2007.03.004 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1126/science.1220761 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Front Microbiol4:138. http://dx.doi.org/10.3389/fmicb.2013.00138 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
IncP-1 /H9255 plasmids are important vectors of antibiotic resistance genes in agricul-tural systems: diversiﬁcation driven by class 1 integron gene cassettes.Front Microbiol 3:2. http://dx.doi.org/10.3389/fmicb.2012.00002 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1038/ ismej.2014.226 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Front Microbiol 5:52. http://dx.doi.org/10.3389/ fmicb.2014.00052 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1128/ JB.00152-08 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
FEMS Microbiol Rev 38:865– 891. http://dx.doi.org/10.1111/1574-6976.12067 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1128/AEM.00688 -11.,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1371/journal.pgen.0020007 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1016/S0147-619X(02)00120-8 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1111/j.1574-6976.2009.00175.x .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1093/ bioinformatics/btp105 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1099/mic.0.033639-0 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Front Microbiol 5:394. http://dx.doi.org/10.3389/fmicb.2014.00394 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1089/mdr.2004.10.231 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1089/mdr.1999.5.53 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
BMC Genomics 16:964. http://dx.doi.org/10.1186/s12864-015-2153-5 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1016/S1001-0742(11)60890-5 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1128/mBio.00305-11 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1038/ nature10571 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Nature 509:612– 616. http://dx.doi.org/10.1038/nature13377 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Res Microbiol160:427– 433. http://dx.doi.org/10.1016/j.resmic.2009.06.005 .,OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1021/es501098g .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1021/es060413l .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1289/ehp.1408555 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1021/es302657r .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1056/ NEJM197609092951103 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1093/jac/dkq167 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1371/ journal.pone.0017424 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1093/nar/gkt1244 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/10.1093/bioinformatics/btr381 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
http://dx.doi.org/ 10.1128/AEM.01043-13 .,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
Front Mi-crobiol 5:358. http://dx.doi.org/10.3389/fmicb.2014.00358 .Resistance and Mobile Gene Cooccurrence in Pig Farms March/April 2016 Volume 7 Issue 2 e02214-15 ®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/2a/2b/mBio.02214-15.PMC4959523.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ott-9-4351.PMC4959577.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4351–4355OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4351Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10793 0 Nab-paclitaxel and trastuzumab combination:  a promising approach for neoadjuvant treatment  in Her2-positive breast cancer Giuseppina rosaria rita  ricciardi Tindara Franchina alessandro russo silvia schifano Giuseppa Ferraro Vincenzo adamo Human pathology University  Department & Medical Oncology Unit  aO papardo, Messina, ItalyAbstract:  Neoadjuvant therapy is a well-established approach for the treatment of locally  advanced or inflammatory breast cancer (BC) and has been increasingly used in recent years  not only as a management strategy but also as a research tool.",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ott-9-4351.PMC4959577.pdf
"In the neoadjuvant setting, large clinical trials were  conducted to evaluate the association of trastuzumab with different cytotoxic chemo - therapeutic agents.5–7 Taxanes are a standard component of adjuvant chemotherapy  regimens for patients with both node-positive or high-risk node-negative BC,8–10 and Correspondence: Vincenzo adamo Medical Oncology Unit, aO papardo,  Contrada papardo, 98158, Messina, Italy email vadamo@unime.i t Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Ricciardi et al Running head recto: Nab-paclitaxel and trastuzumab combination DOI: http://dx.doi.org/10.2147/OTT.S107930",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ott-9-4351.PMC4959577.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ott-9-4351.PMC4959577.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ott-9-4351.PMC4959577.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3265–3276International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3265OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10673 6 Preclinical systemic toxicity evaluation of  chitosan-solid lipid nanoparticle-encapsulated  aspirin and curcumin in combination with free  sulforaphane in B alB/c mice arvind Thakkar1 sushma chenreddy1 astrid Thio1 Wael Khamas2 Jeffrey Wang1 sunil Prabhu1 1Department of Pharmaceutical  sciences, college of Pharmacy,   2college of Veterinary Medicine,   Western University of health  sciences, Pomona, ca, UsaAbstract:  Our previous studies have established the efficacy of chemopreventive regimens of  aspirin and curcumin (CUR) encapsulated within solid lipid nanoparticles (SLNs) in combination  with free sulforaphane (ACS combination) to prevent or delay the initiation and progression of  pancreatic cancer, classified as one of the deadliest diseases with very low chances of survival  upon diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
"Some DDI events have fatal life-threatening concerns due to toxicity and may prompt  the removal of approved medications from the marketplace.4–8 The reasons for toxicity  vary depending on the mixture of drugs, for example, when digoxin and clarithromycin correspondence: sunil Prabhu Department of Pharmaceutical sciences,  college of Pharmacy, Western University  of health sciences, 309 e second street,  Pomona, ca 91766, Usa Tel +1 909 469 5550 email sprabhu@westernu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Thakkar et al Running head recto: In vivo toxicity of nanoparticulate ACS chemopreventive regimens DOI: http://dx.doi.org/10.2147/IJN.S106736",Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
"The poster’s abstract was published in  “Supplements section” in Cancer Research Journal: Cancer  Res August 1, 2015 75;2621 ; http://cancerres.aacrjournals.",Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/11/ijn-11-3265.PMC4959578.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 295–298International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  295Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJWH.S10435 4 Combined uterine and urinary bladder rupture:  an unusual complication of obstructed labor in a  primigravida Idris Usman takai1 abdulkadir abubakar2 1Department of obstetrics and  Gynaecology, 2Department of surgery,   Bayero University/ aminu Kano  teaching Hospital, Kano, Kano state,   NigeriaBackground:  Combined uterine and urinary bladder rupture following prolonged obstructed  labor is indeed a momentous uro-obstetric emergency.",Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"We obtained approval from the Jigawa State Ministry of Health Ethics  Committee to report these unusual complications of labor in a primigravida.Correspondence: abdulkadir abubakar Department of surgery, Bayero  University/aminu Kano teaching  Hospital, Zaria road, Kano, pMB 3452,  Kano state, Nigeria tel +234 64 803 678 1418 email aabdulkadir21@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Case report Y ear: 2016 Volume: 8 Running head verso: Takai and Abubakar Running head recto: Combined uterine and urinary bladder rupture in a primigravida DOI: http://dx.doi.org/10.2147/IJWH.S104354",Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"Available from: http://www.unicef.org/nigeria/ children_1926.htm l. Accessed December 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"Available from: http://www.msf.org/sites/msf.org/files/msf_interna - tional_activity_report_2014_en.pd f. Accessed December 27, 2015.",OADS,/arxiv_data1/oa_pdf/c3/cd/ijwh-8-295.PMC4959579.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/a3/ott-9-4465.PMC4959580.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4465–4471OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4465Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10536 8 Mast cells positive to tryptase, endothelial  cells positive to protease-activated receptor-2,  and microvascular density correlate among  themselves in hepatocellular carcinoma patients  who have undergone surgery Michele ammendola,1 rosario  sacco,1 giuseppe sammarco,1  T ullio Piardi,2 Valeria Zuccalà,3  rosa Patruno,4 alessandra  Zullo,1 nicola Zizzo,4 Bruno  nardo,5 ilaria Marech,6 alberto  crovace,7 cosmo Damiano  gadaleta,6 Patrick Pessaux,8  girolamo ranieri6 1Department of Medical and surgical  sciences, general surgery Unit, University  of catanzaro “Magna graecia” Medical  school, catanzaro, italy; 2Department of  general, Digestive and endocrine surgery,  hopital robert Debre, centre hospitalier  Universitaire de reims, Universite de  reims champagne-ardenne, reims, France;  3Department of health science, Pathology  Unit, University of catanzaro “Magna  graecia” Medical school, catanzaro, 4chair  of Pathology, Veterinary Medical school,  University “ aldo Moro”, Bari, 5Department  of Medical and surgery sciences, s Orsola  hospital, University of Bologna, Bologna,  6interventional radiology Unit with  integrated section of Translational Medical  Oncology, national cancer research  centre, “ giovanni Paolo ii”, 7Department  of emergency and Organ Transplantation  (DeTO), Veterinary Medical school,  University “ aldo Moro”, Bari, italy; 8hepato- Biliary and Pancreatic surgical Unit, general,  Digestive and endocrine surgery, ircaD,  ihU Mix- surg, institute for Minimally  invasive image-guided surgery, University  of strasbourg, strasbourg, FranceBackground:  Mast cells (MCs) can stimulate angiogenesis, releasing several proangiogenic  cytokines stored in their cytoplasm.",Non-OADS,/arxiv_data1/oa_pdf/21/a3/ott-9-4465.PMC4959580.pdf
"Keywords:  tumour angiogenesis, stromal cells, translational research Introduction Mast cells (MCs) can play a role in tumor angiogenesis, and their involvement has  been demonstrated in several animal and human malignancies.1,2 MCs can secrete  several classical proangiogenic factors, including vascular endothelial growth factor,  fibroblast growth factor-2, thymidine phosphorylase, and interestingly a nonclassical  proangiogenic factor named tryptase, stored in their secretory granules.3–7 With special  reference to tryptase, it induces in vitro  microvascular endothelial cells (EC) prolifera - tion in the matrigel assay and displays in vivo  capillary growth on the chick embryo  chorioallantoic membrane, which is conversely suppressed by tryptase inhibitors.8  This proangiogenic stimulus induced by tryptase is mainly mediated via protease- activated receptor-2 (PAR-2), which belongs to the G-protein-coupled receptor correspondence: girolamo ranieri interventional radiology Unit with integrated  section of Translational Medical Oncology,  national cancer research centre, “giovanni  Paolo ii”, Viale Orazio Flacco, 70124, Bari, italy Tel +39 080 555 5561 Fax +39 080 555 5563 email giroran@tiscalinet.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ammendola et al Running head recto: Tryptase, PAR-2, and angiogenesis in HCC DOI: http://dx.doi.org/10.2147/OTT.S105368",Non-OADS,/arxiv_data1/oa_pdf/21/a3/ott-9-4465.PMC4959580.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/21/a3/ott-9-4465.PMC4959580.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/a3/ott-9-4465.PMC4959580.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 159–166Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 159 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S91263 Stigmatization and self-perception in children with  atopic dermatitis Pavel V Chernyshov Department of Dermatology and  Venereology, National Medical University, Kiev, UkraineAbstract:  Atopic dermatitis (AD) is one of the most common skin diseases.",Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
"1–7 Majority of AD patients have a positive family history of atopic  diseases.8 AD is a common condition in first years of life but disappears in almost a  half of children by 3 years of age.9Correspondence: Pavel V Chernyshov Department of Dermatology and Venereology, National Medical University, Bulvar Shevchenko, 13, Kiev 01601, UkraineTel +380 44 234 8660Fax +380 44 234 8660Email chernyshovpavel@ukr.netJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: ChernyshovRunning head recto: Stigmatization and self-perception in children with atopic dermatitisDOI: http://dx.doi.org/10.2147/CCID.S91263",Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
Available from: http://cirrie.buffalo.edu/encyclopedia/en/article/152/.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 166 Chernyshov  64.,Non-OADS,/arxiv_data1/oa_pdf/6c/db/ccid-9-159.PMC4959581.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/8b/ott-9-4425.PMC4959582.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4425–4433OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4425Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9794 1 JaK2 inhibitor combined with Dc-activated aFP- specific T -cells enhances antitumor function in a  Fas/Fasl signal-independent pathway Yang liu1 Yue-ru Wang2 guang-hui Ding1 Ting-song Yang1 le Yao1 Jie hua1 Zhi-gang he1 Ming-ping Qian1 1Department of Hepatobiliary Surgery,   Shanghai 10th People’s Hospital,   School of Medicine, T ongji University,   Shanghai, People’s Republic of China;   2Department of Infection, Shanghai  First People’s Hospital Affiliated to  Jiaotong University, Shanghai, People’s  Republic of ChinaObjective:  Combination therapy for cancer is more effective than using only standard chemo- or  radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/7a/8b/ott-9-4425.PMC4959582.pdf
"Its expression level is very correspondence: Yang liu Department of Hepatobiliary Surgery,  Shanghai 10th People’s Hospital, School  of Medicine, Tongji University, 301  Middle Yanchang Road, Shanghai 200072,  People’s Republic of China email liuyangdtwz@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: DC-activated AFP-specific T-cells DOI: http://dx.doi.org/10.2147/OTT.S97941",Non-OADS,/arxiv_data1/oa_pdf/7a/8b/ott-9-4425.PMC4959582.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/8b/ott-9-4425.PMC4959582.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/8b/ott-9-4425.PMC4959582.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/d1/opth-10-1323.PMC4959583.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1323–1327Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1323Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11071 7 axial length, refraction, and retinal vascularization  1 year after ranibizumab or bevacizumab  treatment for retinopathy of prematurity Chun-Ju lin1,2 Yi-Yu Tsai1,2 1school of Medicine, College of  Medicine, China Medical University,   Taichung, Taiwan; 2Department of  Ophthalmology, China Medical  University hospital, China Medical  University, Taichung, TaiwanPurpose:  The purpose of this study was to report on the axial length, refraction, and retinal  vascularization 1 year after ranibizumab or bevacizumab treatment for threshold retinopathy  of prematurity.",Non-OADS,/arxiv_data1/oa_pdf/f4/d1/opth-10-1323.PMC4959583.pdf
"Patients with  threshold ROP were identified and evaluated retrospectively from August 2011 to Correspondence: Chun-Ju lin Department of Ophthalmology, China  Medical University hospital, no 2,  Yuh-Der road, Taichung, Taiwan 40447,  republic of China Tel +886 4 2205 2121 ext 1141 Fax +886 4 2205 9265 email doctoraga@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lin and Tsai Running head recto: Axial length, refraction, and retinal vascularization after anti-VEGF for ROP DOI: http://dx.doi.org/10.2147/OPTH.S110717",Non-OADS,/arxiv_data1/oa_pdf/f4/d1/opth-10-1323.PMC4959583.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f4/d1/opth-10-1323.PMC4959583.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/d1/opth-10-1323.PMC4959583.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 977–984Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  977OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10443 3 legislative and ethical aspects of introducing new  technologies in medical care for senior citizens in  developed countries Jaroslav Kacetl1 Petra Maresova2 1Department of Applied linguistics,   2Department of economics, Faculty  of Informatics and Management,   University of hradec Kralove, hradec  Kralove, Czech republicIntroduction:  The majority of developed countries are currently experiencing demographic  aging.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Positive effects of medical devices are discussed Correspondence: Petra Maresova Department of economics, Faculty of  Informatics and Management, University  of hradec Kralove, rokitanskeho 62,  hradec Kralove 3, 50003, Czech republic Tel +420 737 927 745 email petra.maresova@uhk.c z Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kacetl and Maresova Running head recto: Challenges of introducing new technologies in medical care DOI: http://dx.doi.org/10.2147/CIA.S104433",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
Available from: http://www.registrarcorp.com/fda- medical-device/registration/?lang =en.,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available  from: http://www.fda.gov/MedicalDevices/default.ht m. Accessed   December 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from: http://www.hhs.gov/about/ index.htm l. Accessed December 14, 2015.",OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID =9 97ee953cbebe663b8b9cc29,87c67076&mc =true&tpl=/ecfrbrowse/ Title21/21chapterI.tp l. Accessed December 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from:  http://www.fda.gov/downloads/ MedicalDevices / ScienceandResearch/UCM467552.pd f. Accessed July 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from: http://ec.europa.eu/growth/sectors/ medica l- devices/index_en.ht m. Accessed December 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from: http://obelismedical.net/ europe-moves-forward-on-new-and-emerging-technologie s. Accessed  December 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Available from: http://www.imdrf.org/docs/ imdrf/final/technical/imdrf-tech-131209-udi-guidance-140901.pd f.  Accessed November 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
Available from: http://www.dicardiology.com/content/ fda-forecasts-medical-device-technology-trends-next-decade#sthash.,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
Available  from: http://www.un.org/en/universal-declaration-human-rights/index.,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/cia-11-977.PMC4959584.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/e8/ijn-11-3287.PMC4959585.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3287–3303International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3287RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10719 4 Nanobody-derived nanobiotechnology tool  kits for diverse biomedical and biotechnology  applications Y ongzhong wang1 Zhen Fan2 Lei Shao3 Xiaowei Kong1 Xianjuan Hou1 Dongrui Tian1 Ying Sun1 Yazhong Xiao1 Li Yu4 1School of Life Sciences, Collaborative  Innovation Center of Modern Bio- manufacture, Anhui University,   Hefei, People’s Republic of China;   2Department of Biomedical  engineering, The Ohio State  University, Columbus, OH, USA;   3State Key Laboratory of New  Drugs and Pharmaceutical Process,   Shanghai Institute of Pharmaceutical  Industry, Shanghai, 4Department  of Microbiology and Parasitology,   Anhui Provincial Laboratory of  Microbiology and Parasitology, Anhui  Key Laboratory of Zoonoses, Anhui  Medical University, Hefei, People’s  Republic of ChinaAbstract:  Owing to peculiar properties of nanobody, including nanoscale size, robust  structure, stable and soluble behaviors in aqueous solution, reversible refolding, high affinity  and specificity for only one cognate target, superior cryptic cleft accessibility, and deep tissue  penetration, as well as a sustainable source, it has been an ideal research tool for the development  of sophisticated nanobiotechnologies.",Non-OADS,/arxiv_data1/oa_pdf/ef/e8/ijn-11-3287.PMC4959585.pdf
"Keywords:  nanobody, VHH, V -NAR, HCAbs, IgNAR, nanobiotechnology Introduction Over the decades, single-domain antibodies (sdAbs) have received a progressive interest  from pharmaceutical and biotechnology industries owing to their peculiar properties,  including small size, robust structure, high affinity and specificity, superior cryptic  cleft accessibility, and deep tissue penetration.1–3 The sdAbs could be categorized into  man-made sdAbs and naturally occurring counterparts,4 the latter including variable  domain of heavy-chain-only antibodies in camelids (VHH), a naturally occurring  antigen-binding variable domain of heavy chain from heavy-chain-only antibodies  (HCAbs),1 and variable domain of immunoglobulin new antigen receptors in sharks  (V -NAR), a variable domain from immunoglobulin new antigen receptors (IgNARs).5  Totally different from the man-made sdAbs, which have been pursued for the ideal ones  by scientists for half a century, several naturally occurring sdAbs, including VHHs and  V -NARs, already exist in nature in camelids or cartilaginous fish, sharing a surprising  structural convergent evolution and performing similar biological functions.1–5Correspondence: Yongzhong wang School of Life Sciences, Anhui University,  Hefei 230601, People’s Republic of China Tel +86 551 6386 1298 email yongzhong00@126.co m Li Yu Department of Microbiology and  Parasitology, Anhui Provincial Laboratory  of Microbiology and Parasitology, Anhui  Key Laboratory of Zoonoses, Anhui  Medical University, Hefei 230032,  People’s Republic of China Tel +86 551 6516 1136 email lilyyu33@126.co m Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Nanobody-derived nanobiotechnology tool kits DOI: http://dx.doi.org/10.2147/IJN.S107194",Non-OADS,/arxiv_data1/oa_pdf/ef/e8/ijn-11-3287.PMC4959585.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ef/e8/ijn-11-3287.PMC4959585.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/e8/ijn-11-3287.PMC4959585.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1329–1334Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1329Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10697 3 Characterization of the serological biomarkers  associated with sjögren’s syndrome in patients  with recalcitrant dry eye disease Cynthia Matossian1,2 Joan Micucci1 1Matossian eye associates,   Doylestown, P a, Usa; 2Department  of Ophthalmology, Temple University  school of Medicine, Philadelphia,   Pa, UsaPurpose:  The purpose was to characterize the biomarkers associated with Sjögren’s syndrome  (SS) identified in the serological samples of patients with recalcitrant dry eye disease;  additionally, the modalities utilized in the treatment of dry eye disease were evaluated for  subsets of patients with and without SS.",Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
"Correspondence: Cynthia Matossian Matossian eye associates, 501 hyde Park,  Doylestown, Pa 18902, Usa Tel +1 215 230 9200 Fax +1 215 230 9292 email cmatossian@matossianeye.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Matossian and Micucci Running head recto: Sjögren’s syndrome biomarker analysis DOI: http://dx.doi.org/10.2147/OPTH.S106973 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
Or use: http://youtu.be/c8u-zjD7Ce wVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
"Available from: http://www.sjogrens.org/home/about- sjogrens-syndrome/diagnosi s. Accessed September 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/94/3b/opth-10-1329.PMC4959586.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1639–1646International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1639OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11211 0 a year in the life of german patients with COPD:  the D aCCOrD observational study roland Buhl1 Carl-Peter Criée2 Peter Kardos3 Claus Vogelmeier4,5 nadine lossi6 Claudia Mailänder6 heinrich Worth7 1Pulmonary Department, Mainz  University hospital, Mainz,   2Department of sleep and respiratory  Medicine, evangelical hospital  göttingen-Weende, Bovenden, 3group  Practice and Centre for allergy,   respiratory and sleep Medicine,   red Cross Maingau hospital,   Frankfurt am Main, 4Department of  Medicine, Pulmonary, and Critical  Care Medicine, University Medical  Center giessen and Marburg,   Philipps-University Marburg, 5german  Center for lung research, Marburg,   6Clinical research Primary Care,   novartis Pharma gmbh, nürnberg,   7Facharztforum Fürth, Fürth, germanyIntroduction:  Randomized interventional trials generally recruit highly selected patients.",Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
"Data from their placebo arms are  often described as representing “natural” disease progression, but they reflect neither  a general COPD population nor the “real world” treatment of COPD, since patients  are both highly selected and generally washed out of their maintenance medication on Correspondence: roland Buhl Pulmonary Department, Mainz University  hospital, langenbeckstrasse 1, 55131  Mainz, germany Tel +49 6131 17 7270 email r oland.buhl@unimedizin-mainz.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Buhl et al Running head recto: DACCORD 1-year analysis DOI: http://dx.doi.org/10.2147/COPD.S112110",Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
The study is regis - tered in the European Network of Centers for Pharmacoepide - miology and Pharmacovigilance ( http://www.encepp.eu/encepp/ viewResource.htm?id=631 6).,Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/47/copd-11-1639.PMC4959587.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/e1/ott-9-4435.PMC4959588.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4435–4440OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4435Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10829 0 Congenital anomalies of the genitourinary  system can help in diagnosis of the primary site  of metastatic cancer: a case report and a review  of the literature andrzej Deptala1,2 agnieszka romanowicz2 aleksandra Czerw3 Jerzy Walecki4 Wojciech rogowski5 anna Nasierowska- Guttmejer6 1Department of Oncology and  Hematology, Central Clinical  Hospital of the Ministry of Interior,   2Department of Cancer prevention,   3Department of p ublic Health, Faculty  of Health sciences, Medical University  of Warsaw, 4Department of radiology,   postgraduate Medical school,   5Department of Urology, 6Department  of pathology, Central Clinical Hospital  of the Ministry of Interior, Warsaw,   polandObjective:  To analyze whether the presence of congenital anomalies of the genitourinary system  that are accompanied by specific types of cancer and predispose patients to many complications,  including infection, obstruction, stasis, calculus formation, and impaired renal function, could  help in the diagnosis of the primary site of a metastatic tumor.",Non-OADS,/arxiv_data1/oa_pdf/51/e1/ott-9-4435.PMC4959588.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/51/e1/ott-9-4435.PMC4959588.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/e1/ott-9-4435.PMC4959588.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/32/opth-10-1335.PMC4959589.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1335–1342Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1335Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10645 1 Frequency and risk factors associated with dry eye  in patients attending a tertiary care ophthalmology  center in Mexico City Jaime D Martinez1 anat galor2,3 nallely ramos-Betancourt1 andrés lisker-Cervantes1 Francisco Beltrán1 Jorge Ozorno-Zárate1 Valeria sánchez-huerta1 Marco-antonio T orres- Vera1 everardo hernández- Quintela1 1Cornea and external Diseases  service, asociación Para evitar  la Ceguera en Mexico (association  to prevent blindness in Mexico),   Universidad nacional autónoma  de México, Mexico City, Mexico;   2Department of Ophthalmology,   Miami Veterans affairs Medical Center,   3Cornea and external Diseases  Division, Bascom Palmer eye institute,   University of Miami, Miami, Fl, UsaPurpose:  The purpose of this study was to ascertain the frequency and risk factors of dry eye  (DE) among patients attending a tertiary care ophthalmology center in Mexico.",Non-OADS,/arxiv_data1/oa_pdf/10/32/opth-10-1335.PMC4959589.pdf
"The epidemiology of DE has been  evaluated in several large population-based studies both in the US and abroad with a  wide range of frequencies reported for DE symptoms (6%–50%), signs (16%–85%), Correspondence: everardo hernández- Quintela Cornea and external Diseases services,  asociacion para evitar la Ceguera en  Mexico (association to prevent blindness  in Mexico), #46 Vicente garcía Torres,  Delegación Coyoacán, México City  04030, Mexico Tel +52 55 1084 1400 email evehq@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Martinez et al Running head recto: Frequency and risk factors associated with dry eye DOI: http://dx.doi.org/10.2147/OPTH.S106451",Non-OADS,/arxiv_data1/oa_pdf/10/32/opth-10-1335.PMC4959589.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/10/32/opth-10-1335.PMC4959589.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/32/opth-10-1335.PMC4959589.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/d5/ott-9-4453.PMC4959590.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4453–4464OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4453Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10566 4 lapatinib induces autophagic cell death and  differentiation in acute myeloblastic leukemia Yu-Jen chen1–4 li-Wen Fang5 Wen-chi su6,7 Wen-Yi hsu1 Kai-chien Yang1 huey-lan huang8 1Department of Medical research,   2Department of radiation Oncology,   Mackay Memorial hospital, 3institute  of Traditional Medicine, school  of Medicine, national Yang-Ming  University, 4institute of Pharmacology,   Taipei Medical University, Taipei,   5Department of nutrition, i-shou  University, Kaohsiung, 6research  center for emerging Viruses,   china Medical University hospital,   7graduate institute of clinical Medical  science, china Medical University,   Taichung, 8Department of Bioscience  T echnology, college of health science,   chang Jung christian University,   Tainan, Taiwan, republic of chinaAbstract:  Lapatinib is an oral-form dual tyrosine kinase inhibitor of epidermal growth factor  receptor (EGFR or ErbB/Her) superfamily members with anticancer activity.",Non-OADS,/arxiv_data1/oa_pdf/c8/d5/ott-9-4453.PMC4959590.pdf
"Keywords:  lapatinib, autophagic cell death, leukemia, differentiation, AML Introduction Acute myeloid leukemia (AML) is a group of heterogeneous diseases with abnor - mally active proliferation of hematopoietic precursors, which block patients’ normal  hematopoiesis, causing neutropenia and anemia.1 Although more than 50% of adult  AML patients show complete remission with conventional chemotherapeutic drugs,  only 20%–30% of patients show long-term disease-free survival.2 Despite being  associated with complicated genetic mutations, ~50% of AML cases correlate with  mutations caused by the aberrant activation of receptor tyrosine kinases (eg, FLT3 and  c-KIT) or downstream effectors (eg, Ras).1–3 Thus, in recent years, some small-molecule  inhibitors, for example, sorafenib, gefitinib, erlotinib, and quizartinib (AC220) have  been tested in preclinical studies as targeted therapies for AML.1,4,5 Lapatinib (GlaxoSmithKline plc, London, UK) is a small-molecule inhibitor  against the receptor tyrosine kinase of epidermal growth factor receptor (EGFR)  or ErbB/Her family members.6–8 EGFR/ErbB/Her superfamily members, including  EGFR/ErbB1/Her1, ErbB2/Her2/Neu, ErbB3/Her3, and ErbB4/Her4, are common  targets for anticancer drugs because their functions are commonly dysregulated in  many cancers.9–11 Lapatinib, which is taken orally, was originally approved by the correspondence: huey-lan huang Department of Bioscience Technology,  college of health science, chang Jung  christian University, 1 changda rd,  Tainan 71101, Taiwan, republic of china Tel +886 6278 5123 ext 3204 Fax +886 6278 5010 email hueylanhuang@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Lapatinib-induced autophagy in AML DOI: http://dx.doi.org/10.2147/OTT.S105664",Non-OADS,/arxiv_data1/oa_pdf/c8/d5/ott-9-4453.PMC4959590.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c8/d5/ott-9-4453.PMC4959590.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/d5/ott-9-4453.PMC4959590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/00/copd-11-1623.PMC4959591.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1623–1638International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1623OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10633 7 The differential effects of inspiratory, expiratory,  and combined resistive breathing on healthy lung Konstantinos loverdos1 Dimitrios T oumpanakis1 eleni litsiou1 Vassiliki Karavana1 Constantinos glynos1 Christina Magkou2 stamatios Theocharis3 Theodoros Vassilakopoulos1 1Department of Critical Care,   Pulmonary Unit and Marianthi simou  applied Biomedical research and  Training Center, evangelismos general  hospital, University of athens Medical  school, 2Department of Pathology,   evangelismos general hospital,   31st Department of Pathology,   University of athens Medical school,   athens, greeceAbstract:  Combined resistive breathing (CRB) is the hallmark of obstructive airway disease  pathophysiology.",Non-OADS,/arxiv_data1/oa_pdf/16/00/copd-11-1623.PMC4959591.pdf
"The first aim of our study was to identify the lowest level of  inspiratory pressure generated by inspiratory resistive loading that can induce lung  injury and inflammation.Correspondence: Theodoros  Vassilakopoulos 1st Department of Critical Care,  Pulmonary Unit, evangelismos general  hospital, University of athens Medical  school, 45-47 Ispilandou street,  10676 athens, greece Tel +30 21 3204 1952 Fax +30 21 0724 4941 email tvassil@med.uoa.g r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Loverdos et al Running head recto: Effect of resistive breathing on the lung DOI: http://dx.doi.org/10.2147/COPD.S106337",Non-OADS,/arxiv_data1/oa_pdf/16/00/copd-11-1623.PMC4959591.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/16/00/copd-11-1623.PMC4959591.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/00/copd-11-1623.PMC4959591.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3277–3286International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3277OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11174 8 Proretinal nanoparticles: stability, release, efficacy,  and irritation Pimolphan Pisetpackdeekul,1  Piyapan supmuang,2 Porntip  Pan-In,3 Wijit Banlunara,4,*  Benchaphorn limcharoen,4  chayada Kokpol,5,* supason  Wanichwecharungruang3,6,* 1Program in Technopreneurship and  Innovation Management, graduate school,   2Program in Biotechnology, 3Department of  chemistry, Faculty of science, 4Department  of Pathology, Faculty of Veterinary science,   chulalongkorn University, 5Division of  Dermatology, Department of Medicine,   Faculty of Medicine, ramathibodi hospital,   6Nanotec-chulalongkorn University center  of excellence on Food and agriculture,   chulalongkorn University, Bangkok, Thailand *These authors contributed equally to  this  workAbstract:  Despite many potent biological activities, retinoids such as retinoic acid (RA) and  retinal possess dose-related broad side effects.",Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
"It is believed that any physiological effects caused by other retinoids on skin are the  result of their conversion into RA.4 The interconversion of retinoids in cells occurs  through a variety of metabolic processes, eg, retinol can be  sequentially oxidized to  retinal and RA in vivo.6,7 Nevertheless, it has been shown that retinol and retinal are  capable of modulating gene expression in keratinocyte cell line HaCaT through two  nuclear receptors directly with no need to be converted to the RA.8 Retinyl esters are  regarded as a storage form of vitamin A, since they are precursors of all biologically  active forms of vitamin A.9 The limitations on the enzymatic hydrolysis of the esters correspondence: supason  Wanichwecharungruang Department of chemistry, Faculty of science,  chulalongkorn University, Phayathai road,  Bangkok 10330, Thailand Tel +66 2 218 7634 Fax +66 2 254 1309 email psupason@chula.ac.t hJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pisetpackdeekul et al Running head recto: Proretinal nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S111748 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
Or use: http://youtu.be/EoDWfmOtjB 0Video abstract,Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/c2/ijn-11-3277.PMC4959592.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/74/ijwh-8-299.PMC4959593.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 299–310International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  299OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10038 5 The experiences of women with polycystic ovary  syndrome on a very low-calorie diet John g love1 John s McKenzie2 efsevia a nikokavoura3 John Broom3 catherine rolland3 Kelly l Johnston4,5 1school of applied social studies,   Faculty of Health & social care,   robert gordon University, aberdeen,   UK; 2rowett Institute of Health &  nutrition, University of aberdeen,   st Mary’s, Kings college, aberdeen,   UK; 3centre for Obesity research,   Faculty of Health & social care,   robert gordon University, aberdeen,   UK; 4lighterlife, Harlow, essex, UK;   5Diabetes and nutritional sciences  Division, Faculty of Health and  Medical sciences, Kings college  london, london, UKAbstract:  Polycystic ovary syndrome (PCOS) is variously reported to affect between 5% and  26% of reproductive age women in the UK and accounts for up to 75% of women attending  fertility clinics due to anovulation.",Non-OADS,/arxiv_data1/oa_pdf/17/74/ijwh-8-299.PMC4959593.pdf
"PCOS has been associated not only with a variety of reproductive and skin  disorders, but also with an adverse metabolic profile that includes systemic dysfunc - tions such as insulin resistance with compensatory hyperinsulinemia, hypertension,  and dyslipidemia.4,5 In addition, at least half of the women with PCOS are obese.6,7  However, it is still debatable whether heavier women are predisposed to PCOS, correspondence: John g love school of applied social studies, Faculty  of Health & social care, robert gordon  University, garthdee House, garthdee  road, aberdeen aB10 7Qg, UK email j.g.love@rgu.ac.u k Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Love et al Running head recto: Experiences of women with PCOS on a VLCD DOI: http://dx.doi.org/10.2147/IJWH.S100385",Non-OADS,/arxiv_data1/oa_pdf/17/74/ijwh-8-299.PMC4959593.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/17/74/ijwh-8-299.PMC4959593.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/74/ijwh-8-299.PMC4959593.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 311–323International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  311RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S8540 3 Fetal alcohol-spectrum disorders: identifying  at-risk mothers Annika C Montag Department of Pediatrics, Division  of Dysmorphology and T eratology,   University of California San Diego,   San Diego, CA, USAAbstract:  Fetal alcohol-spectrum disorders (FASDs) are a collection of physical and neuro- behavioral disabilities caused by prenatal exposure to alcohol.",Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
"Recently published  data from the 2011–2013 National Survey of Family Growth estimated that 7.3% of Correspondence: Annika C Montag Department of Pediatrics, Division of  Dysmorphology and Teratology, University of California San Diego,  9500 Gilman Drive – MC 0828, La Jolla,  San Diego, CA 92093, USA Tel +1 619 890 0285 Fax +1 858 246 1793 email amontag@ucsd.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Montag Running head recto: Fetal alcohol spectrum disorders: identifying at-risk mothers DOI: http://dx.doi.org/10.2147/IJWH.S85403",Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
"Avail - able from: https://www.healthypeople.gov/2020/topics-objectives/topic/ maternal-infant-and-child-health/objective s. Accessed May 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/e2/ijwh-8-311.PMC4959594.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3305–3315International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3305OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10629 9 Endothelial glycocalyx conditions influence  nanoparticle uptake for passive targeting Ming J cheng1 rajiv Kumar2 srinivas sridhar1–3 Thomas J Webster1,4 eno e ebong1 1Department of chemical engineering,   2Department of Physics, Northeastern  University, 3Department of radiation  Oncology, harvard Medical school,   Boston, M a, Usa; 4center of  excellence for advanced Materials  research, King abdulaziz University,   Jeddah, saudi arabiaAbstract:  Cardiovascular diseases are facilitated by endothelial cell (EC) dysfunction and  coincide with EC glycocalyx coat shedding.",Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
"This porous structure greatly restricts the passage to  plasma proteins such as albumin of size 7 nm, as well as smaller solutes and water  molecules.2,3 The glycocalyx glycosaminoglycans, the most common of which is  heparan sulfate (HS),4–6 are anchored to endothelial cells (ECs) via transmembrane  proteoglycans.7 Sialic acid is another glycosaminoglycan of the glycocalyx that is  integral in the cellular-molecular interactions, while hyaluronic acid and its receptors, correspondence: eno e ebong Department of chemical engineering,  Northeastern University, 360 huntington  avenue, 313 snell, Boston,  Ma 02115, Usa Tel +1 617 373 8744 Fax +1 617 373 2209 email e.ebong@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Cheng et al Running head recto: Glycocalyx and cellular uptake of NPs DOI: http://dx.doi.org/10.2147/IJN.S106299 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
Or use: http://youtu.be/1Appq0F7_h 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/55/ijn-11-3305.PMC4959595.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/2d/ott-9-4411.PMC4959596.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4411–4424OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4411Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10954 9 Functions and mechanisms of long noncoding  RNAs in lung cancer Zhenzi Peng Chunfang Zhang Chaojun Duan institute of Medical Sciences, Key  Laboratory of Cancer Proteomics of  Chinese Ministry of Health, Xiangya  Hospital, Central South University,   Changsha, People’s Republic of ChinaAbstract:  Lung cancer is a heterogeneous disease, and there is a lack of adequate biomark - ers for diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/3e/2d/ott-9-4411.PMC4959596.pdf
"Recently,  Iyer et al6 demonstrated that there are ~60,000  ncRNAs in the human genome, and .68% of these are lncRNAs, of which ~80% Correspondence: Chaojun Duan institute of Medical Sciences, Key  Laboratory of Cancer Proteomics of  Chinese Ministry of Health, Xiangya  Hospital, Central South University,  No 87 Xiangya Road, Changsha 410008,  Hunan, People’s Republic of China Tel +86 731 8432 7069 Fax +86 731 8432 7332 email duancjxy@126.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Peng et al Running head recto: Role of lncRNAs in lung cancer DOI: http://dx.doi.org/10.2147/OTT.S109549",OADS,/arxiv_data1/oa_pdf/3e/2d/ott-9-4411.PMC4959596.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/2d/ott-9-4411.PMC4959596.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/2d/ott-9-4411.PMC4959596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/f7/ott-9-4483.PMC4959597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4483–4489OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4483Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10875 4 association between cyclin D1 g870a  polymorphism and hepatocellular carcinoma risk:  a meta-analysis Tao luo1,* Jie chen1,* Jun-Jie liu2,* hang li2 Xue-Mei Y ou1 hong-liang Wang1 shao-liang Zhu1 le-Qun li1 1Department of hepatobiliary surgery,   2Department of Ultrasound, affiliated  T umor hospital of guangxi Medical  University, nanning, People’s republic  of china *These authors contributed equally  to this workBackground:  Cyclin D1 (CCND1) G870A polymorphism may be associated with hepatocellular  carcinoma (HCC) risk, but the results of previous studies were inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/fc/f7/ott-9-4483.PMC4959597.pdf
"As a complex correspondence: le-Qun li;   shao-liang Zhu  Department of hepatobiliary surgery,  Affiliated Tumor Hospital of Guangxi  Medical University, 71 he Di road,  nanning 530021, People’s republic  of china Tel +86 771 533 0855 Fax +86 771 531 2000 email lilequn2016@aliyun.co m;  slzhu2014@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Luo et al Running head recto: G870A of CCND1 polymorphism and HCC risk DOI: http://dx.doi.org/10.2147/OTT.S108754",Non-OADS,/arxiv_data1/oa_pdf/fc/f7/ott-9-4483.PMC4959597.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/f7/ott-9-4483.PMC4959597.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/f7/ott-9-4483.PMC4959597.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/e9/ott-9-4441.PMC4959598.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4441–4451OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4441Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10523 9 Targeting breast cancer stem cells by dendritic  cell vaccination in humanized mice with breast  tumor: preliminary results Phuc Van Pham1 hanh Thi le1 Binh Thanh Vu1 Viet Quoc Pham1 Phong Minh le1 nhan lu-chinh Phan1 ngu Van Trinh1 huyen Thi-lam n guyen1 sinh Truong nguyen1 T oan linh nguyen2 ngoc Kim Phan1 1laboratory of stem cell research  and application, University of science,   Vietnam national University, ho chi  Minh city, 2Vietnam Military Medical  University, ha Dong, ha noi, VietnamBackground:  Breast cancer (BC) is one of the leading cancers in women.",Non-OADS,/arxiv_data1/oa_pdf/58/e9/ott-9-4441.PMC4959598.pdf
"Through interaction between  CD40 (on DCs) and CD40 ligand (on T-cells), DCs can proliferate and present the correspondence: Phuc Van Pham laboratory of stem cell research  and application, University of science,  Vietnam national University, 227 nguyen  Van cu, District 5, ho chi Minh city,  Vietnam Tel +84 9 0387 0153 email pvphuc@hcmuns.edu.v n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pham et al Running head recto: Targeting BCSCs by DC vaccination in humanized mice with breast tumor DOI: http://dx.doi.org/10.2147/OTT.S105239",OADS,/arxiv_data1/oa_pdf/58/e9/ott-9-4441.PMC4959598.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/58/e9/ott-9-4441.PMC4959598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/e9/ott-9-4441.PMC4959598.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 267–272Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 267 STUDY PROTOCOL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S107270 Design and methods for a Scandinavian  pharmacovigilance study of osteonecrosis of  the jaw and serious infections among cancer  patients treated with antiresorptive agents for the prevention of skeletal-related events John Acquavella,1 Vera Ehrenstein,1  Morten Schiødt,2 Uffe Heide- Jørgensen,1 Anders Kjellman,3,4  Svein Hansen,5 Cecilia Larsson  Wexell,6,7 Bente Brokstad  Herlofson,8 Sven Erik Noerholt,9  Haijun Ma,10 Katarina Öhrling,11  Rohini K Hernandez,12 Henrik T oft  Sørensen1 1Department of Clinical Epidemiology,   Aarhus University Hospital, Aarhus,   Denmark; 2Department of Oral and  Maxillofacial Surgery, Rigshospitalet,  Copenhagen, Denmark;  3Department of  Urology, Karolinska University Hospital,   4Department of Clinical Science,   Intervention, and T echnology, Karolinska Institutet, Stockholm, Sweden;  5Cancer  Registry of Norway, Oslo University Hospital, Oslo, Norway;  6Department  of Oral and Maxillofacial Surgery, Södra Älvsborg Hospital, Borås, Sweden;   7Department of Biomaterials, Institute of  Clinical Sciences, Sahlgrenska Academy,  University of Gothenburg, Gothenburg,   Sweden;  8Department of Oral Surgery  and Oral Medicine, Faculty of Dentistry,   University of Oslo, Oslo, Norway;   9Department of Oral and Maxillofacial  Surgery, Aarhus University Hospital,  Aarhus, Denmark;  10Global Biostatistical  Science, Amgen Inc., Thousand Oaks, CA,  USA;  11Clinical Development, Amgen Inc.,   Thousand Oaks, CA, USA; 12Center for  Observational Research, Amgen Inc.,  Thousand Oaks, CA, USAObjective: Osteonecrosis of the jaw (ONJ) is a recognized complication of potent antiresorptive  therapies, especially at the doses indicated to prevent skeletal complications for cancer patients  with bone metastases.",Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"Denosumab is a fully human IgG 2 monoclonal antibody that inhibits RANKL,  prevents Correspondence: Vera Ehrenstein Department of Clinical Epidemiology, Aarhus  University Hospital, Olof Palmes Allé 43-45,  8200 Aarhus N, Denmark Tel +45 8716 8063 Fax +45 8716 7215 Email ve@clin.au.dkJournal name: Clinical Epidemiology Article Designation: STUDY PROTOCOLY ear: 2016V olume: 8Running head verso: Acquavella et alRunning head recto: Design of pharmacovigilance study in cancer patientsDOI: http://dx.doi.org/10.2147/CLEP .S107270",Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_ QuickReference_5x7.pdf.,OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
Available from: http://www.ssb.no/en.,Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
Available from: http://www.skatteverket.se/privat/sjalvser - vice/blanketterbroschyrer/broschyrer/info/717b.4.39f16f103821c58f680008017.html.,OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"Available from:  http://www.cdc.gov/cancer/dcpc/resources/features/preventinfections/index.htm  Accessed May 7, 2016.31.",Non-OADS,/arxiv_data1/oa_pdf/87/96/clep-8-267.PMC4959599.pdf
"1, e1127310 (13 pages)http://dx.doi.org/10.1080/23262133.2015.1127310",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Neuron 2011; 70:597-613;PMID:21609819; http://dx.do i.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nat Rev Neurosci2011; 12:88-104; PMID:21248788; http://dx.doi.org/10.1038/nrn2978 [3] Zhao C, Deng W, Gage FH.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Cell 2008;132:645-60; PMID:18295581; http://dx.doi.org/ 10.1016/j.cell.2008.01.033e1127310-8 B. ASRICAN ET AL.,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neuron 2011; 70:674-86;PMID:21609824; http://dx.doi.org/10.1016/j.neuron.2011.05.004 [5] Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, Bostr €om E, Westerlund I, Vial C, Buchholz BA, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell 2013;153:1219-27; PMID:23746839; http://dx.doi.org/10.1016/j.cell.2013.05.002 [6] Ernst A, Alkass K, Bernard S, Salehpour M, Perl S, Tis- dale J, Possnert G, Druid H, Fris /C19en J. Neurogenesis in the striatum of the adult human brain.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell 2014;156:1072-83; PMID:24561062; http://dx.doi.org/ 10.1016/j.cell.2014.01.044 [7] Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Can-cer Cell 2009; 15:45-56; PMID:19111880; http://dx.doi.org/10.1016/j.ccr.2008.12.006 [8] Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Genes Dev 2015; 29:1203-17; PMID:26109046; http://dx.doi.org/10.1101/gad.261982.115 [9] Tomasetti C, Vogelstein B.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Science 2015; 347:78-81;PMID:25554788; http://dx.doi.org/10.1126/science.1260825 [10] Kelsch W, Sim S, Lois C. Watching synaptogenesis in the adult brain.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Annu Rev Neurosci 2010; 33:131-49; PMID:20572770; http://dx.doi.org/10.1146/annurev-neuro-060909-153252 [11] Lazarini F, Lledo PM.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nat Neurosci 2012;15:1613-20; PMID:23187693; http://dx.doi.org/10.1038/nn.3262 [13] Song J, Christian KM, Ming GL, Song H. Modi ﬁcation of hippocampal circuitry by adult neurogenesis.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"DevNeurobiol 2012; 72:1032-43; PMID:22354697; http://dx.doi.org/10.1002/dneu.22014 [14] Crowther AJ, Song J. Activity-dependent signaling mechanisms regulating adult hippocampal neural stemcells and their progeny.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neurosci Bull 2014; 30:542-56;PMID:25082534; http://dx.doi.org/10.1007/s12264-014-1453-5 [15] Yu DX, Marchetto MC, Gage FH.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Development2014; 141:2366-75; PMID:24917496; http://dx.doi.org/ 10.1242/dev.096776[16] Kempermann G, Song H, Gage FH.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Dynamic role of adult-born dentate granule cells in memory processing.Curr Opin Neurobiol 2015; 35:21-26; PMID:26100379;http://dx.doi.org/10.1016/j.conb.2015.06.002 [18] Braun SM, Jessberger S. Adult neurogenesis: mecha- nisms and functional signi ﬁcance.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Development 2014; 141:1983-6; PMID:24803647; http://dx.doi.org/10.1242/dev.104596 [19] Bergmann O, Spalding KL, Frisen J.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cold Spring Harb Perspect Biol 2015; 7:a018994; PMID:26134318; http://dx.doi.org/10.1101/cshperspect.a018994 [20] Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes areneural stem cells in the adult mammalian brain.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"TrendsNeurosci 2008; 31:392-400; PMID:18603310; http://dx.doi.org/10.1016/j.tins.2008.05.006 [22] Livneh Y, Adam Y, Mizrahi A.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neuron 2014; 81:1097-110;PMID:24508384; http://dx.doi.org/10.1016/j.neuron.2014.01.007 [23] Sakamoto M, Ieki N, Miyoshi G, Mochimaru D, Miya- chi H, Imura T, Yamaguchi M, Fishell G, Mori K,Kageyama R, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurosci 2014; 34:5788-99; PMID:24760839; http://dx.doi.org/10.1523/JNEUROSCI.0674-14.2014 [24] Benner EJ, Luciano D, Jo R, Abdi K, Paez-Gonzalez P, Sheng H, Warner DS, Liu C, Eroglu C, Kuo CT. Protec-tive astrogenesis from the SVZ niche after injury is con-trolled by Notch modulator Thbs4.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nature 2013;497:369-73; PMID:23615612; http://dx.doi.org/10.1038/ nature12069 [25] Faiz M, Sachewsky N, Gascon S, Bang KW, Morshead CM, Nagy A.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell Stem Cell 2015; 17:624-34;PMID:26456685; http://dx.doi.org/10.1016/j.stem.2015.08.002 [26] Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miya- kawa T, Yamaguchi M, Mori K, Ikeda T, Itohara S, Kageyama R. Roles of continuous neurogenesis in thestructural and functional integrity of the adult forebrain.Nat Neurosci 2008; 11:1153-61; PMID:18758458; http://dx.doi.org/10.1038/nn.2185 [27] Mak GK, Weiss S. Paternal recognition of adult off- spring mediated by newly generated CNS neurons.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Front Neurosci 2014; 8:121;PMID:24904263; http://dx.doi.org/10.3389/fnins.2014.00121 [29] Bedard A, Parent A.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Dev Brain Res 2004; 151:159-68; PMID:15246702; http://dx.doi.org/10.1016/ j.devbrainres.2004.03.021 [30] Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, Holta /C14s S, van Roon-Mom WM, Bj €ork- Eriksson T, Nordborg C, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Science 2007; 315:1243-9; PMID:17303719;http://dx.doi.org/10.1126/science.1136281 [31] Sanai N, Nguyen T, Ihrie RA, Mirzadeh Z, Tsai HH, Wong M, Gupta N, Berger MS, Huang E, Garcia-Ver-dugo JM, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nature2011; 478:382-6; PMID:21964341; http://dx.doi.org/10.1038/nature10487 [32] Kriegstein A, Alvarez-Buylla A.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Annu Rev Neu- rosci 2009; 32:149-84; PMID:19555289; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Annu Rev Cell Dev Biol 2009; 25:253-75;PMID:19575663; http://dx.doi.org/10.1146/annurev.cellbio.042308.113256 [34] Urban N, Guillemot F. Neurogenesis in the embryonic and adult brain: same regulators, different roles.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell Stem Cell 2008; 3:279-88;PMID:18786415; http://dx.doi.org/10.1016/j.stem.2008.07.025 [36] Paez-Gonzalez P, Abdi K, Luciano D, Liu Y, Soriano- Navarro M, Rawlins E, Bennett V, Garcia-Verdugo JM,Kuo CT. Ank3-dependent SVZ niche assembly isrequired for the continued production of new neurons.Neuron 2011; 71:61-75; PMID:21745638; http://dx.doi.org/10.1016/j.neuron.2011.05.029 [37] Ottone C, Krusche B, Whitby A, Clements M, Quad- rato G, Pitulescu ME, Adams RH, Parrinello S. Direct cell-cell contact with the vascular niche main- tains quiescent neural stem cells.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nat Cell Biol 2014;16:1045-56; PMID:25283993; http://dx.doi.org/10.1038/ncb3045 [38] Bjornsson CS, Apostolopoulou M, Tian Y, Temple S. It takes a village: constructing the neurogenic niche.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"DevCell 2015; 32:435-46; PMID:25710530; http://dx.doi.org/10.1016/j.devcel.2015.01.010 [39] Lennington JB, Pope S, Goodheart AE, Drozdowicz L, Daniels SB, Salamone JD, Conover JC.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neuro-sci 2011; 31:13078-87; PMID:21917791; http://dx.doi.org/10.1523/JNEUROSCI.1197-11.2011 [40] Young SZ, Taylor MM, Bordey A. Neurotransmitters couple brain activity to subventricular zone neurogene-sis.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Eur J Neurosci 2011; 33:1123-32; PMID:21395856; http://dx.doi.org/10.1111/j.1460-9568.2011.07611.x [41] Crowther AJ, Song J. Activity-dependent signaling mechanisms regulating adult hippocampal neural stemcells and their progeny.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neurosci Bull 2014; 30:542-56;PMID:25082534; http://dx.doi.org/10.1007/s12264-014-1453-5 [42] Pallotto M, Deprez F. Regulation of adult neurogenesis by GABAergic transmission: signaling beyond GABAA- receptors.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Front Cell Neurosci 2014; 8:166; PMID:24999317; http://dx.doi.org/10.3389/fncel.2014.00166 [43] Tong CK, Chen J, Cebrian-Silla A, Mirzadeh Z, Obernier K, Guinto CD, Tecott LH, Garc /C19ıa-Verdugo JM, Kriegstein A, Alvarez-Buylla A. Axonal control of the adult neural stemcell niche.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell Stem Cell 2014; 14:500-11; PMID:24561083;http://dx.doi.org/10.1 016/j.stem.2014.01.014 [44] Alenina N, Klempin F. The role of serotonin in adult hippocampal neurogenesis.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Behav Brain Res 2015;277:49-57; PMID:25125239; http://dx.doi.org/10.1016/j.bbr.2014.07.038 [45] Markwardt SJ, Dieni CV, Wadiche JI, Overstreet- Wadiche L. Ivy/neurogliaform interneurons coordinateactivity in the neurogenic niche.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nat Neurosci 2011;14:1407-9; PMID:21983681; http://dx.doi.org/10.1038/ nn.2935 [46] Song J, Zhong C, Bonaguidi MA, Sun GJ, Hsu D, Gu Y, Meletis K, Huang ZJ, Ge S, Enikolopov G, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nature 2012; 489:150-4;PMID:22842902; http://dx.doi.org/10.1038/nature11306 [47] Song J, Sun J, Moss J, Wen Z, Sun GJ, Hsu D, Zhong C, Davoudi H, Christian KM, Toni N, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nat Neurosci 2013;16:1728-30; PMID:24212671; http://dx.doi.org/10.1038/nn.3572 [48] Bigl V, Woolf NJ, Butcher LL.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Trends Neurosci 1985; 8:533-36;PMIDhttp://dx.doi.org/10.1016/0166-2236(85)90190-0 [52] Smiley JF, Mesulam MM.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Brain Res 2009; 1252:172-82; PMID:19084506; http://dx.doi.org/10.1016/j.brainres.2008.11.082 [57] Paez-Gonzalez P, Asrican B, Rodriguez E, Kuo CT. Identi ﬁcation of distinct ChAT( C) neurons and activ- ity-dependent control of postnatal SVZ neurogenesis.Nat Neurosci 2014; 17:934-42; PMID:24880216; http://dx.doi.org/10.1038/nn.3734 [58] Rossi J, Balthasar N, Olson D, Scott M, Berglund E, Lee CE, Choi MJ, Lauzon D, Lowell BB, Elmquist JK.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"CellMetab 2011; 13:195-204; PMID:21284986; http://dx.doi.org/10.1016/j.cmet.2011.01.010 [59] Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breake ﬁeld XO, Gage FH.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cereb Cortex 2006; 16:301-12;PMID:15958781; http://dx.doi.org/10.1093/cercor/bhi120 [61] Van der Borght K, Mulder J, Keijser JN, Eggen BJ, Luiten PG, Van der Zee EA.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"BrainRes Bull 2005; 67:117-25; PMID:16140170; http://dx.doi.org/10.1016/j.brainresbull.2005.06.018 [62] Itou Y, Nochi R, Kuribayashi H, Saito Y, Hisatsune T. Cholinergic activation of hippocampal neuralstem cells in aged dentate gyrus.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Hippocampus 2011; 21:446-59; PMID:20054812; http://dx.doi.org/ 10.1002/hipo.20761[63] Cooper-Kuhn CM, Winkler J, Kuhn HG.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurosci Res 2004; 77:155-65;PMID:15211583; http://dx.doi.org/10.1002/jnr.20116 [64] Calza L, Giuliani A, Fernandez M, Pirondi S, D ’Intino G, Aloe L, Giardino L. Neural stem cells and cholinergicneurons: regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Psychopharm2011; 217:239-53; PMID:21494789; http://dx.doi.org/10.1007/s00213-011-2279-3 [67] Kotani S, Yamauchi T, Teramoto T, Ogura H. Pharma- cological evidence of cholinergic involvement in adulthippocampal neurogenesis in rats.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neuroscience 2006; 142:505-14; PMID:16889901; http://dx.doi.org/10.1016/ j.neuroscience.2006.06.035 [68] Ma W, Maric D, Li BS, Hu Q, Andreadis JD, Grant GM, Liu QY, Shaffer KM, Chang YH, Zhang L, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Eur J Neurosci 2000; 12:1227-40; PMID:10762352 [69] Mudo G, Belluardo N, Mauro A, Fuxe K. Acute inter- mittent nicotine treatment induces ﬁbroblast growth factor-2 in the subventricular zone of the adult rat brainand enhances neuronal precursor cell proliferation.Neuroscience 2007; 145:470-83; PMID:17241745;http://dx.doi.org/10.1016/j.neuroscience.2006.12.012 [70] Narla S, Klejbor I, Birkaya B, Lee YW, Morys J, Sta- chowiak EK, Terranova C, Bencherif M, Stachowiak MK.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Biochem Pharmacol 2013;86:1099-104; PMID:23933384; http://dx.doi.org/10.1016/j.bcp.2013.07.028 [71] Abrous DN, Adriani W, Montaron MF, Aurousseau C, Rougon G, Le Moal M, Piazza PV.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
J Neurosci2002; 22:3656-62; PMID:11978841; http://dx.doi.org/ 20026324.,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurophysiol 2013; 109:867-72;PMID:23136348; http://dx.doi.org/10.1152/jn.00886.2012 [73] Kaneko N, Okano H, Sawamoto K. Role of the choliner- gic system in regulating survival of newborn neurons inthe adult mouse dentate gyrus and olfactory bulb.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Genes Cells 2006; 11:1145-59; PMID:16999735; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"[74] John D, Shelukhina I, Yanagawa Y, Deuchars J, Hender- son Z. Functional alpha7 nicotinic receptors are expressedon immature granule cells of the postnatal dentate gyrus.Brain Res 2015; 1601:15-30; PMID:25553616; http://dx.doi.org/10.1016/j.brainres.2014.12.041 [75] Mohapel P, Leanza G, Kokaia M, Lindvall O. Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neurobiol Aging 2005; 26:939-46; PMID:15718053; http://dx.doi.org/10.1016/j.neurobiolaging.2004.07.015 [76] Dutar P, Nicoll RA.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurobiol 2002; 53:447-56; PMID:12436412; http://dx.doi.org/10.1002/neu.10153 [80] Quick MW, Lester RA.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurobiol 2002; 53:457-78;PMID:12436413; http://dx.doi.org/10.1002/neu.10109 [81] Giniatullin R, Nistri A, Yakel JL.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Trends Neurosci 2005; 28:371-8; PMID:15979501; http://dx.doi.org/10.1016/j.tins.2005.04.009 [82] Smit AB, Celie PH, Kasheverov IE, Mordvintsev DY, van Nierop P, Bertrand D, Tsetlin V, Sixma TK.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J MolNeurosci 2006; 30:9-10; PMID:17192605; http://dx.doi.org/10.1385/JMN:30:1:9 [83] Mrzljak L, Levey AI, Goldman-Rakic PS.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Mol Neurobiol 2002; 25:79-112;PMID:11890459; http://dx.doi.org/10.1385/MN:25:1:079 [86] Loreti S, Vilaro MT, Visentin S, Rees H, Levey AI, Tata AM.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurosci Res 2006; 84:97-105; PMID:16634060; http://dx.doi.org/10.1002/jnr.20874 [87] De Angelis F, Bernardo A, Magnaghi V, Minghetti L, Tata AM.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Dev Neurobiol 2012;72:713-28; PMID:21913336; http://dx.doi.org/10.1002/ dneu.20976 [88] Parikh V, Kozak R, Martinez V, Sarter M. Prefrontal acetylcholine release controls cue detection on multipletimescales.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neuron 2007; 56:141-54; PMID:17920021;http://dx.doi.org/10.1016/j.neuron.2007.08.025 [89] Bennett BD, Callaway JC, Wilson CJ.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Ann NY Acad Sci 2008; 1129:225-35;PMID:18591483; http://dx.doi.org/10.1196/annals.1417.021 [92] Unal CT, Golowasch JP, Zaborszky L. Adult mouse basal forebrain harbors two distinct cholinergic popula-tions de ﬁned by their electrophysiology.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Front Behav Neurosci 2012; 6:21; PMID:22586380; http://dx.doi.org/ 10.3389/fnbeh.2012.00021 [93] Descarries L, Gisiger V, Steriade M. Diffuse transmis- sion by acetylcholine in the CNS.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neurosci Lett 2010; 479:157-60; PMID:20510338;http://dx.doi.org/10.101 6/j.neulet.2010.05.056 [96] Furukawa K, Abe Y, Sorimachi M, Akaike N. Nicotinic and muscarinic acetylcholine responses in the embryo chick ciliary ganglion cells.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Br J Pharmacol 2002; 135:1403-14;PMID:11906953; http://dx.doi.org/10.1038/sj.bjp.0704610 [98] Ishibashi M, Yamazaki Y, Miledi R, Sumikawa K. Nico- tinic and muscarinic agonists and acetylcholinesterase inhibitors stimulate a common pathway to enhancee1127310-12 B. ASRICAN ET AL.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Agonist-induced restora- tion of hippocampal neurogenesis and cognitiveimprovement in a model of cholinergic denervation.Neuropharm 2010; 58:921-9; PMID:20026137; http://dx.doi.org/10.1016/j.neuropharm.2009.12.005 [101] Takarada T, Nakamichi N, Kitajima S, Fukumori R, Nakazato R, Le NQ, Kim YH, Fujikawa K, Kou M, Yoneda Y.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"PLoS One 2012;7:e46177; PMID:23056257; http://dx.doi.org/10.1371/journal.pone.0046177 [102] He N, Wang Z, Wang Y, Shen H, Yin M. ZY-1, a novel nicotinic analog, promotes proliferation and migrationof adult hippocampal neural stem/progenitor cells.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Cell Mol Neurobiol 2013; 33:1149-57; PMID:24057433; http://dx.doi.org/10.1007/s10571-013-9981-0 [103] Harrist A, Beech RD, King SL, Zanardi A, Cleary MA, Caldarone BJ, Eisch A, Zoli M, Picciotto MR. Alterationof hippocampal cell proliferation in mice lacking the b2 subunit of the neuronal nicotinic acetylcholine receptor.Synapse 2004; 54:200-6; PMID:15472930; http://dx.doi.org/10.1002/syn.20081 [104] Knight ZA, Tan K, Birsoy K, Schmidt S, Garrison JL, Wysocki RW, Emiliano A, Ekstrand MI, Friedman JM.Molecular pro ﬁling of activated neurons by phosphory- lated ribosome capture.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Cell 2012; 151:1126-37;PMID:23178128; http://dx.doi.org/10.1016/j.cell.2012.10.039 [105] Woolf NJ.,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Annu Rev Psychol 1997; 48:649-84; PMID:9046571; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Neuron 2010; 67:294-307; PMID:20670836;http://dx.doi.org/10.1016/j.neuron.2010.06.017 [110] Straub C, Tritsch NX, Hagan NA, Gu C, Sabatini BL.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurosci 2014; 34:8557-69; PMID: 24948810; http://dx.doi.or g/10.1523/JNEUROSCI.0589- 14.2014 [111] Kimura M, Rajkowski J, Evarts E. Tonically discharg- ing putamen neurons exhibit set-dependentresponses.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"doi.org/10.1002/neu.10150 [113] Apicella P. Leading tonically active neurons of the stria- tum from reward detection to context recognition.Trends Neurosci 2007; 30:299-306; PMID:17420057;http://dx.doi.org/10.1016/j.tins.2007.03.011 [114] Boucetta S, Jones BE.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"J Neurosci 2009; 29:4664-74; PMID:19357291; http://dx.doi.org/10.1523/JNEUROSCI.5502-08.2009 [115] Liu X, Wang Q, Haydar TF, Bordey A. Nonsynaptic GABA signaling in postnatal subventricular zone con-trols proliferation of GFAP-expressing progenitors.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Front Cell Neurosci 2014; 8:10;PMID:24478632; http://dx.doi.org/10.3389/fncel.2014.00010 [117] Barres BA, Raff MC.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
"Nature 1993; 361:258-60; PMID:8093806; http://dx.doi.org/10.1038/361258a0 [118] Zonouzi M, Sca ﬁdi J, Li P, McEllin B, Edwards J, Dupree JL, Harvey L, Sun D, H €ubner CA, Cull-Candy SG, et al.",OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Cell 2015;161:803-16; PMID:25913192; http://dx.doi.org/10.1016/j.cell.2015.04.012NEUROGENESIS e1127310-13,OADS,/arxiv_data1/oa_pdf/4a/e4/kngs-03-01-1127310.PMC4959609.pdf
Sequence quality metrics were assessed using FastQC ( http://www.bioinformatics.babra- ham.ac.uk/projects/fastqc/ ).,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
"The human genome was obtained from the UCSC GenomeBrowser ( http://genome.ucsc.edu ), and the parasite genomes were ob- tained from the TriTrypDB database ( http://www.tritrypdb.org ).",OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
"Components ofthe statistical pipeline, named cbcbSEQ, were done in R and can be ac-cessed on GitHub ( https://github.com/kokrah/cbcbSEQ/ ).",OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pone.0035671 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Annu Rev Microbiol 55: 453– 483. http://dx.doi.org/10.1146/annurev.micro.55.1.453 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Nat Rev Microbiol 9:604 – 615. http://dx.doi.org/10.1038/ nrmicro2608 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/S0140 -6736(05)67629-5 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Science 309: 436 – 442. http://dx.doi.org/10.1126/ science.1112680 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Nat Genet 39: 839 – 847. http://dx.doi.org/10.1038/ng2053 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/dnares/dst031 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1101/gr.122945.111 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/S0966 -842X(03)00075-1 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1126/ science.1159194 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.ppat.1000755 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000222 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/S0952-7915(96)80040-9 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1128/IAI.02922-14 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1128/IAI.73.6.3330 -3341.2005 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/bfgp/elq009 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1371/journal.pone.0032034 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1111/ cmi.12397 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
BMC Genomics 14: 230. http://dx.doi.org/10.1186/1471-2164-14-230 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pone.0114914 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pone.0132249 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pntd.0002477 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1073/pnas.89.16.7481 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/0167-5699(94)90176-7 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Blood 102:672– 681. http://dx.doi.org/10.1182/blood-2002-10-3232 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pntd.0000252 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
BMC Genomics 10:119. http://dx.doi.org/10.1186/1471-2164-10 -119 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/ journal.pone.0128934 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pntd.0001763 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1371/journal.pntd.0001866 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1128/IAI.72.4.2111 -2122.2004 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.4049/jimmunol.166.5.3416 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
BMC Genomics 16:1108. http://dx.doi.org/ 10.1186/s12864-015-2237-2 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1371/journal.pone.0080597 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
BMCGenomics 15:806. http://dx.doi.org/10.1186/1471-2164-15-806 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Front Microbiol 3:85. http://dx.doi.org/10.3389/ fmicb.2012.00085 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Nat Rev Microbiol 10:618 – 630. http://dx.doi.org/10.1038/ nrmicro2852 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/j.immuni.2014.06.008 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1016/0300-483X(93)90040-Y .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1016/S0079-6603(00)66034-8 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1007/s12192-015 -0630-z .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1111/cmi.12311 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.4049/jimmunol.1202500 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1084/jem.189.10.1649 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1083/jcb.200605004 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.4049/jimmunol.181.8.5289 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.4049/jimmunol.1303043 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000628 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1099/ mic.0.050252-0 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Trends Cell Biol 15:626 – 631. http://dx.doi.org/10.1016/ j.tcb.2005.09.001 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Science 323: 474 – 477. http://dx.doi.org/ 10.1126/science.1161748 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1042/ BJ20020776 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/j.chom.2013.06.003 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1074/ jbc.M305030200 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2001.02286.x .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/ j.exppara.2012.06.001 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
"Role of cAMP signaling in the survival and infectivity of the protozoan parasite, Leishmania donovani.Mol Biol Int 2011: 782971. http://dx.doi.org/10.4061/2011/782971 .",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/j.protis.2013.05.002 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1371/journal.pntd.0000586 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Exp Cell Res 334: 61– 69. http://dx.doi.org/ 10.1016/j.yexcr.2015.02.010 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2005.04498.x .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/S0091-679X(08)94017-6 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1091/mbc.E05-10-0976 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1128/EC.2.4.769-777.2003 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/0169 -4758(95)80054-9 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/j.micinf.2012.05.014 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1038/327329b0 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1074/ jbc.274.36.25411 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Nucleic Acids Res 43:6799 – 6813. http://dx.doi.org/10.1093/nar/gkv656 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1016/0166-6851(95)02559-6 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
BMC EvolBiol 11:334. http://dx.doi.org/10.1186/1471-2148-11-334 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
Exp Parasitol 156: 42– 48. http://dx.doi.org/10.1016/j.exppara.2015.05.016 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1021/jm0505765 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/bioinformatics/btu638 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1038/nprot.2013.099 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/ 10.1093/bioinformatics/19.2.185 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1038/nrg2825 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/bioinformatics/bti525 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/nar/gkp851 .,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
http://dx.doi.org/10.1093/nar/gkq1156 .,OADS,/arxiv_data1/oa_pdf/cd/2b/mBio.00027-16.PMC4959658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 99–105Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 99 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S109919 Use of microdoses for induction of  buprenorphine treatment with overlapping full  opioid agonist use: the Bernese method Robert Hämmig1 Antje Kemter2 Johannes Strasser2 Ulrich von Bardeleben1 Barbara Gugger1 Marc Walter2 Kenneth M Dürsteler2 Marc Vogel2 1Division of Addiction, University  Psychiatric Services Bern, Bern,   Switzerland; 2Division of Substance  Use and Addictive Disorders,  University of Basel Psychiatric Hospital, Basel, SwitzerlandBackground: Buprenorphine is a partial µ-opioid receptor agonist used for maintenance treatment  of opioid dependence.",Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
"This time depends on the opioid used and ranges between Correspondence: Marc Vogel Division of Substance Use and Addictive Disorders, University of Basel Psychiatric Hospital,  Wilhelm Klein-Strasse 27, 4012 Basel, SwitzerlandTel +41 61 325 5111Fax +41 61 325 5583Email Marc.Vogel@upkbs.chJournal name: Substance Abuse and Rehabilitation Article Designation: CASE SERIESY ear: 2016V olume: 7Running head verso: Hämmig et alRunning head recto: Overlapping induction of buprenorphine with full opioid agonist useDOI: http://dx.doi.org/10.2147/SAR.S109919",Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
Available from: http://www.ssam.ch/SSAM/sites/default/files/Empfehlungen SGB_2012_FINAL_05 03 2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 105 Overlapping induction of buprenorphine with full opioid agonist use  6.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/Postmarket-  DrugSafetyInformationforPatientsandProviders/UCM191529.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
Available from: http://www.buprenorphine.samhsa.gov/Bup_Guide-lines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/sar-7-099.PMC4959756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 241–246Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 241 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S77657 New developments in the treatment of   early-onset spinal deformity: role of the Shilla  growth guidance system Sean M Morell1  Richard E McCarthy2 1Department of Orthopaedics,   University of Arkansas for  Medical Sciences, 2Department of  Orthopaedics, Arkansas Children’s Hospital, Little Rock, AR, USA Abstract:  Early-onset scoliosis is a complex condition with multiple facets.",Non-OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
"The vertical, expandable prosthetic titanium rib Correspondence: Richard E McCarthy Department of Orthopaedics, Arkansas Children’s Hospital, 1 Children’s Way, Slot 839, Little Rock, AR 72202, USATel +1 501 364 1421Fax +1 501 364 1522Email Rmccarthy@uams.eduJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Morell and McCarthyRunning head recto: Shilla growth guidance system for EOS deformityDOI: http://dx.doi.org/10.2147/MDER.S77657",Non-OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/09/73/mder-9-241.PMC4959757.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/25/ppa-10-1235.PMC4959758.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1235–1241Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1235OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10693 8 The psychometric properties of chinese version  of SCI Exercise Self-Efficacy Scale in patients with  stroke Xiaofang Dong1 Yanjin liu 2 Aixia Wang1 Min Wang1 1neurology Department, 2nursing  Department, The First Affiliated  hospital of Zhengzhou University,   Zhengzhou, henan Province, People’s  republic of chinaObjective:  To test the Chinese version of the SCI Exercise Self-Efficacy Scale (C-ESES) in  stroke patients and evaluate its validity and reliability.",Non-OADS,/arxiv_data1/oa_pdf/66/25/ppa-10-1235.PMC4959758.pdf
"Keywords:  psychometrics testing, self-efficacy, stroke, survey designs, chronic illness Introduction The estimated recurrence of stroke and the disability rate have been found to be higher  in the Chinese population as compared to that observed in Western countries.1 It is well  known that less exercise is a modifiable risk factor for stroke and recurrent stroke.2  The protective effects of exercise have been seen in a large study.3 Exercise plays an  important role in decreasing blood pressure, losing and maintaining weight, and pro - moting good mental health.4,5 Therefore, the American Heart Association recommends  that stroke patients spend 20–60 minutes on exercising, 3–7 days a week.6correspondence: Yanjin liu Nursing Department, The First Affiliated  hospital of Zhengzhou University,  1 eastern Jianshe road, Zhengzhou,  henan Province 450052, People’s  republic of china Tel +86 135 2354 8732 email luomeiruxue139@sina.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dong et al Running head recto: The psychometric properties of C-ESES in patients with stroke  DOI: http://dx.doi.org/10.2147/PPA.S106938",Non-OADS,/arxiv_data1/oa_pdf/66/25/ppa-10-1235.PMC4959758.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/66/25/ppa-10-1235.PMC4959758.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/ca/tcrm-12-1133.PMC4959760.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1133–1137Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1133ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8437 1 effect of biological factors on successful  measurements with skeletal-muscle 1h-MRs T omonori isobe1 Y oshikazu Okamoto1 Yuji hirano2 hiroki ando3 Kenta Takada1 eisuke sato4 Kazuya shinoda5 Kiichi Tadano4 hideyuki Takei2 satoshi Kamizawa1 Yutaro Mori3 hiroaki suzuki1 1Faculty of Medicine, University of  Tsukuba, ibaraki, Japan; 2Department  of Radiology, University of Tsukuba  hospital, ibaraki, Japan; 3graduate  school of Comprehensive human  sciences, University of Tsukuba,   ibaraki, Japan; 4Department of Medical  Radiological Technology, Faculty of  health sciences, Kyorin University,   T okyo, Japan; 5Department of  Radiology, Tsukuba Medical Center  hospital, ibaraki, JapanBackground:  Our purpose in this study was to clarify whether differences in subject group  attributes could affect data acquisition in proton magnetic resonance spectroscopy (1H-MRS).",Non-OADS,/arxiv_data1/oa_pdf/4f/ca/tcrm-12-1133.PMC4959760.pdf
"31P and 13C have been used mainly for assessment of the metabolisms of phosphate  compounds5,6 and glycogen.7,8 Boesch et al reported that skeletal muscle 1H-MRS could differentiate intramyocel - lular lipids (IMCL), which exist as droplets near the mitochondria of skeletal muscle  cells, from extramyocellular lipids (EMCL), which exist in the stroma.9 Skeletal muscle Correspondence: Tomonori isobe Faculty of Medicine, University of  Tsukuba, 1-1-1 Tennodai, Tsukuba,  ibaraki, 305-8575, Japan Tel +81 29 853 7834 Fax +81 29 853 7102 email tiso@md.tsukuba.ac.j p Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Isobe et al Running head recto: Success measurement skeletal-muscle 1H-MRS DOI: http://dx.doi.org/10.2147/TCRM.S84371",OADS,/arxiv_data1/oa_pdf/4f/ca/tcrm-12-1133.PMC4959760.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4f/ca/tcrm-12-1133.PMC4959760.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/ca/tcrm-12-1133.PMC4959760.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/18/ppa-10-1271.PMC4959761.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1271–1277Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1271OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11090 3 Alexithymia in patients with type 2 diabetes  mellitus: the role of anxiety, depression, and  glycemic control Dilek Avci1 Meral Kelleci2 1Department of nursing, Faculty  of health sciences, Bandirma  Onyedi eylul University, Balikesir,   2Department of nursing, Faculty  of health sciences, cumhuriyet  University, sivas, T urkeyObjective:  This study was aimed at determining the prevalence of alexithymia in patients with  type 2 DM and the factors affecting it.",Non-OADS,/arxiv_data1/oa_pdf/08/18/ppa-10-1271.PMC4959761.pdf
"Keywords:  diabetes mellitus, alexithymia, mental symptoms, HbA1c Introduction Type 2 diabetes mellitus (DM) is one of the most common chronic diseases all over  the world and is a major health problem due to its growing prevalence.1–5 Like all  other chronic diseases, DM can lead to physical, mental, and social problems.6,7  As blood glucose levels affect brain and mental functions, mental disorders particularly  depression and anxiety disorders are more prevalent in patients with DM than in the  general population.8–13 Several studies on the issue have demonstrated that ~30% of  the patients with DM exhibit depression symptoms and 20% exhibit anxiety symptoms  and that DM increases the risk of mental disorders.9,14,15 In patients with DM, poor metabolic control is reported to be associated not only  with psychiatric disorders but also with alexithymia.16,17 Alexithymia is defined as  the inability to distinguish between emotions, thoughts, and physiological responses  and difficulty in recognizing and describing emotions.18,19 Initially, alexithymia was  proposed to describe the symptoms observed in psychosomatic patients; however,  today it is recognized as a personality trait affecting various physical and psychiatric correspondence: Dilek Avci Department of nursing, Faculty of  health sciences, Bandirma Onyedi  eylul University, Kurtulus street, 10200  Bandirma/Balikesir, Turkey Tel +90 266 718 6400 Fax +90 266 718 6414 email daydinenator@gmail.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Avci and Kelleci Running head recto: Alexithymia in patients with DM DOI: http://dx.doi.org/10.2147/PPA.S110903",Non-OADS,/arxiv_data1/oa_pdf/08/18/ppa-10-1271.PMC4959761.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/08/18/ppa-10-1271.PMC4959761.pdf
Available from: http://www.who.int/diabetes/publications/report- hba1c_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/18/ppa-10-1271.PMC4959761.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 111–120The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 111 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S85354 Animal models of GM2 gangliosidosis: utility and  limitations Cheryl A Lawson1,2 Douglas R Martin2,3 1Department of Pathobiology,   2Scott-Ritchey Research Center,   3Department of Anatomy, Physiology  and Pharmacology, Auburn University  College of Veterinary Medicine,  Auburn, AL, USAAbstract: GM2 gangliosidosis, a subset of lysosomal storage disorders, is caused by a deficiency  of the glycohydrolase, β-N-acetylhexosaminidase, and includes the closely related Tay–Sachs  and Sandhoff diseases.",Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
"8–10 They  are involved in adhesion and cytokine signal transduction and cell membrane protein Correspondence: Douglas R Martin 245, Scott-Ritchey Research Center, Auburn University College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USATel +1 334 844 5951Fax +1 334 844 5850Email martidr@auburn.eduJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Lawson and MartinRunning head recto: Animal models of GM2 gangliosidosisDOI: http://dx.doi.org/10.2147/TACG.S85354",Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 120 Lawson and Martin 42.,Non-OADS,/arxiv_data1/oa_pdf/8d/b2/tacg-9-111.PMC4959762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 101–110The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 101 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S93933 Mevalonate kinase deficiency: current  perspectives Leslie A Favier   Grant S Schulert Division of Rheumatology, Cincinnati  Children’s Hospital Medical Center,  Cincinnati, OH, USAAbstract:  Mevalonate kinase deficiency (MKD) is a recessively inherited autoinflammatory  disorder with a spectrum of manifestations, including the well-defined clinical phenotypes of  hyperimmunoglobulinemia D and periodic fever syndrome and mevalonic aciduria.",Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
"As MKD remains mysterious in both Correspondence: Grant S Schulert   Division of Rheumatology, Children’s  Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA   Tel +1 513 636 4676   Fax +1 513 636 3328   Email Grant.schulert@cchmc.orgJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Favier and SchulertRunning head recto: Mevalonate kinase deficiencyDOI: http://dx.doi.org/10.2147/TACG.S93933",Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
Available from: http://fmf.igh.cnrs.fr/ISSAID/infevers/.,Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 110 Favier and Schulert  63.,Non-OADS,/arxiv_data1/oa_pdf/de/3d/tacg-9-101.PMC4959763.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/00/ndt-12-1787.PMC4959764.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1787–1793Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1787OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11201 7 The major risk factors for delirium in a  clinical setting harin Kim seockhoon chung Yeon ho Joo Jung sun lee Department of Psychiatry, asan  Medical center, University of Ulsan  college of Medicine, seoul, KoreaObjective:  We aimed to determine the major risk factors for the development of delirium in  patients at a single general hospital by comparison with a control group.",Non-OADS,/arxiv_data1/oa_pdf/9b/00/ndt-12-1787.PMC4959764.pdf
"The causes of delirium are old age, male sex,  underlying cognitive impairment,10,11 infection, fever,12,13 hypoxia, hypoglycemia, elec - trolyte imbalance, general medical conditions such as cardiovascular, renal, and hepatic  diseases,14 use of drugs such as benzodiazepine and narcotic analgesics,15,16 metabolic  disorders such as encephalopathy, and central nervous system diseases such as stroke, correspondence: Jung sun lee Department of Psychiatry, asan Medical  center, University of Ulsan college  of Medicine, 88 Olympic-ro 43-gil,  songpa-gu, seoul 05505, Korea Fax +82 2 485 8381 email js_lee@amc.seoul.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kim et al Running head recto: Determination of risk factors for delirium DOI: http://dx.doi.org/10.2147/NDT.S112017",Non-OADS,/arxiv_data1/oa_pdf/9b/00/ndt-12-1787.PMC4959764.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9b/00/ndt-12-1787.PMC4959764.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/00/ndt-12-1787.PMC4959764.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/cb/ppa-10-1279.PMC4959765.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1279–1287Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1279OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10657 7 sex differences in the quality of life of patients  with acute coronary syndrome treated with  percutaneous coronary intervention after a  3-year follow-up Beata Jankowska-Polańska1 izabella Uchmanowicz1 Krzysztof Dudek2 Krystyna Łoboz-Grudzień1,3 1Department of clinical nursing,   Wrocław Medical University,   2Department of logistics and  Transport systems, Faculty of  Mechanical Engineering, Wrocław  University of T echnology, 3cardiology  Unit, T Marciniak Lower Silesian  specialist hospital, emergency  Medicine Centre, Wrocław, PolandBackground:  The aims of this study were to analyze the dynamics of quality of life (QoL)  changes after 36 months from the percutaneous coronary intervention (PCI) depending on sex  and identify baseline predictors of the follow-up QoL of patients hospitalized for acute coronary  syndrome (ACS) and subjected to PCI.",Non-OADS,/arxiv_data1/oa_pdf/a0/cb/ppa-10-1279.PMC4959765.pdf
"At present, PCI is the method of choice in the treatment of ACS.1 It was shown  that females undergoing percutaneous revascularization exhibit worse immediate results  of the procedure; however, long-term results are similar for both sexes.2–7 The worse  prognosis of females hospitalized for ACS may result from their older age at the onset  of the disease, more frequent concomitant diseases, such as diabetes and hypertension,  as well as anatomical and pathophysiological differences in the structure of the heart  and coronary vessels (in females, coronary vessels are more angled and their diameter correspondence: izabella Uchmanowicz Department of Clinical Nursing, Wrocław  Medical University, ul K Bartla 5,   51-618 Wrocław, Poland Tel +48 71 784 1824 Fax +48 71 345 9324 email izabella.uchmanowicz@am.wroc.p lJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jankowska-Pola ńska et al Running head recto: QoL patients treated with PCI after 3 years DOI: http://dx.doi.org/10.2147/PPA.S106577",Non-OADS,/arxiv_data1/oa_pdf/a0/cb/ppa-10-1279.PMC4959765.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a0/cb/ppa-10-1279.PMC4959765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 303–310Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 303 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S107796Theoretical domains framework to assess  barriers to change for planning health care quality  interventions: a systematic literature review Mirkaber Mosavianpour1–3 Hamideh Helen Sarmast2,3 Niranjan Kissoon1–3 Jean-Paul Collet1–3 1Department of Pediatrics, Faculty  of Medicine, University of British  Columbia, 2British Columbia  Children’s Hospital, 3Child and Family  Research Institute, Vancouver, BC,  CanadaBackground: Theoretical domains framework (TDF) provides an integrative model for assess- ing barriers to behavioral changes in order to suggest interventions for improvement in behavior  and ultimately outcomes.",Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
"1,2,7,8 Low-quality care is estimated  to account for 20%–40% of total health care industry by health care professionals.8 Theoretical domains framework (TDF) has been developed for systematically  identifying and assessing barriers to change interventions and is an umbrella of 33 Correspondence: Jean-Paul Collet Department of Pediatrics, Faculty of Medicine, University of British Columbia, CFRI V3-320, 948 West 28th Avenue, Vancouver, BC V6H 3N1, CanadaTel +1 604 875 2186Email JCollet@cw.bc.caJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Mosavianpour et alRunning head recto: TDF for planning health care quality interventionsDOI: http://dx.doi.org/10.2147/JMDH.S107796",Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
Available from: http://www.ncddr.org/kt/products/ktintro/ktintro.pdf.,OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
Available  from: http://www.criticalcarenutrition.com/index.php?option= com_con tent&view= article&id= 171%3Ains-barriers-questionnaire&catid= 16% 3Anewsroom&Itemid=1.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 310 Mosavianpour et al  67.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/jmdh-9-303.PMC4959766.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 249–258Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  249 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S99353A novel implantable device for a minimally  invasive surgical treatment of obstructive sleep  apnea: design and preclinical safety assessment Edward Gillis   Charles Rampersaud   Emmanuelle Pease   Paul Buscemi ReVENT Medical, Inc., Newark,   CA, USABackground: In obstructive sleep apnea (OSA), occlusion of the upper airway by soft tissue  causes intermittent hypoxemia and can have serious sequelae.",Non-OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
"The consequences of untreated OSA include sudden death,2 hypertension,3  stroke,4 coronary artery disease and congestive heart failure,5 noninsulin-dependent  diabetes,6 depressive symptoms,7 and decreased quality of life.8 OSA is common,  affecting an estimated range of 3%–7% of adults.9Correspondence: Edward Gillis   ReVENT Medical, Inc., Suite 350,  39899 Balentine Drive, Newark, CA 94560, USA Tel +1 510 279 0700   Email ed@reventmedical.comJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Gillis et alRunning head recto: Implantable device for the treatment of obstructive sleep apneaDOI: http://dx.doi.org/10.2147/NSS.S99353",Non-OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/63/ed/nss-8-249.PMC4959767.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 201–205International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 201 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S108746A newborn with very rare von Voss-Cherstvoy  syndrome: a case report Deepak Sharma1  Basudev Gupta2  Sweta Shastri3  Pradeep Sharma4 1Department of Pediatrics, Pt.",Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
"The Correspondence: Basudev Gupta Department of Pediatrics, Civil Hospital, Palwal, Haryana, India   Tel +91 94 1673 8222Email drbdgupta78@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Sharma et alRunning head recto: von V oss-Cherstvoy syndromeDOI: http://dx.doi.org/10.2147/IMCRJ.S108746",Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 205 von Voss-Cherstvoy syndrome  8.,Non-OADS,/arxiv_data1/oa_pdf/b2/81/imcrj-9-201.PMC4959768.pdf
https://www.bhchp.org/sites/default/files/BHCHPManual/pdf_ files/Part1_PDF/Strep.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/b6/10.1177_2333794X16657943.PMC4959792.pdf
http://www.niaid.nih.gov/topics/commoncold/pages/default.aspx.,OADS,/arxiv_data1/oa_pdf/1a/d8/10.1177_2333794X16654851.PMC4959794.pdf
http://www.who.int/mediacentre/factsheets/2003/fs211/en/.,Non-OADS,/arxiv_data1/oa_pdf/1a/d8/10.1177_2333794X16654851.PMC4959794.pdf
http://www.cdc.gov/flu/professionals/antivirals/summary-clini- cians.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/d8/10.1177_2333794X16654851.PMC4959794.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/30/main.PMC4959796.pdf
http://dx.doi.org/10.1016/j.ijrobp.2016.03.031Radiation OncologyInternational Journal of biology physics www.redjournal.org,OADS,/arxiv_data1/oa_pdf/e8/30/main.PMC4959796.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/30/main.PMC4959796.pdf
"Analyses were done with the R software(version 3.2.4, http://www.R-project.org ) or Stata software version 12.0 (StataCorp LP, College Station,TX).",OADS,/arxiv_data1/oa_pdf/72/09/i2164-2591-5-4-5.PMC4959815.pdf
"17In contrast to Humphrey visual field (HVF), POP is a freely available, online program at the KeepYour- SightFoundation website (available in the publicdomain at http://www.keepyoursight.org ) that pro- vides unlimited home access.",Non-OADS,/arxiv_data1/oa_pdf/c8/2d/i2164-2591-5-4-4.PMC4959820.pdf
"A unique account was created for each patient to store Peristat data via the Keepyoursightfoundation (available: http://keepyoursight.org/ ).Outcomes Presence of glaucoma was defined by two authors’ clinical assessment (YH and RC) on the basis of neuroretinal rim thinning, excavation, or retinal nervefiber layer defects in conjunction with characteristicHVF abnormality confirmed on at least two HVF.Severity of glaucoma was defined by HVF meandeviation (MD) using thresholds of the Hodapp- Parrish-Anderson criteria where MD values of mild glaucoma are ./C06 dB, moderate between /C06 and /C012 dB, and severe is ,/C012 dB.",Non-OADS,/arxiv_data1/oa_pdf/c8/2d/i2164-2591-5-4-4.PMC4959820.pdf
Available: http://www.aao.org/preferred- practice-pattern/comprehensive-adult-medical- eye-evaluation-2015.,Non-OADS,/arxiv_data1/oa_pdf/c8/2d/i2164-2591-5-4-4.PMC4959820.pdf
Available at: https://www.cms.gov/apps/ physician-fee-schedule/search/search-results.,Non-OADS,/arxiv_data1/oa_pdf/c8/2d/i2164-2591-5-4-4.PMC4959820.pdf
53. http://www.merriam-webster.com/dictionary/fad 54.,Non-OADS,/arxiv_data1/oa_pdf/2e/79/hvp-24-257.PMC4959824.pdf
At http://www.hsj.co.,Non-OADS,/arxiv_data1/oa_pdf/2e/79/hvp-24-257.PMC4959824.pdf
"12 Mendelian randomization is regarded  as nature’s analogue of randomized controlled trials and has successfully been used in cardiovascular research to investi- gate potential etiologic mechanisms, 13 validate and prioritize  novel drug targets,14 and increase understanding of current  therapies.15Clinical Track Circulation Research is available at http://circres.ahajournals.org DOI: 10.1161/CIRCRESAHA.116.308716Rationale:  Hypoadiponectinemia correlates with several coronary heart disease (CHD) risk factors.",Non-OADS,/arxiv_data1/oa_pdf/73/e2/res-119-491.PMC4959825.pdf
The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/doi:10.1161/CIRCRESAHA.,OADS,/arxiv_data1/oa_pdf/73/e2/res-119-491.PMC4959825.pdf
Data on adiponectin have been contrib- uted by ADIPOGen Consortium and have been downloaded from https://www.mcgill.ca/genepi/adipogen-consortium.,OADS,/arxiv_data1/oa_pdf/73/e2/res-119-491.PMC4959825.pdf
Data on anthropometric traits have been contributed by Genetic Investigation of ANthropometric Traits (GIANT) consor - tium and have been downloaded from http://www.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files.,OADS,/arxiv_data1/oa_pdf/73/e2/res-119-491.PMC4959825.pdf
"6,7 Sustained sympathetic signaling results Integrative Physiology Circulation Research is available at http://circres.ahajournals.org DOI: 10.1161/CIRCRESAHA.115.308278Rationale:  Catheter-based renal denervation (RDN) is currently under development for the treatment of resistant  hypertension and is thought to reduce blood pressure via interruption of sympathetic pathways that modulate  cardiovascular function.",Non-OADS,/arxiv_data1/oa_pdf/86/d3/res-119-470.PMC4959827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Electroconvulsive therapyForced normalizationSeizure 1.,Non-OADS,/arxiv_data1/oa_pdf/81/80/main.PMC4959916.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.05.004 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/80/main.PMC4959916.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/80/main.PMC4959916.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
On  one  hand  response  assessment  during  CRT  could  possi- bly  re-orientate  non-responding  patients  to  a  different  treatment http://dx.doi.org/10.1016/j.ejro.2016.06.003 2352-0477/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"83  (2014) 1036–1043,  http://dx.doi.org/10.1016/j.ejrad.2014.03.012 .",OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"23  (2013)  253–261,  http://dx.doi.org/10.1007/s00330-012-2578-z .",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"113  (2014)  158–165,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"Choi,  Locally advanced rectal cancer: added  value  of  diffusion-weighted  MR  imaging  in  the evaluation  of tumor  response  to  neoadjuvant  chemo-  and  radiation  therapy, Radiology  253  (2009)  116–125,  http://dx.doi.org/10.1148/radiol.2532090027 .",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"Kim,  Restaging  of rectal cancer with  MR  imaging  after  concurrent  chemotherapy  and  radiation therapy,  Radiographics  30  (2010)  503–516,  http://dx.doi.org/10.1148/rg.",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"Vecchio,  L.  Santoro,  V.  Valentini,  C. Coco, F. Pacelli, A.  Crucitti,  R.  Persiani,  L.  Bonomo,  Restaging  locally  advanced rectal cancer  with  MR  imaging  after  chemoradiation  therapy,  Radiographics 30  (2010)  699–716,  http://dx.doi.org/10.1148/rg.303095085 .",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"Imaging  (2015),  http://dx.doi.",OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"84  (2015)  2438–2443,  http://dx.doi.org/10.1016/j.ejrad.2015.08.008 .",OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"117  (2012) 1112–1124,  http://dx.doi.org/10.1007/s11547-012-0829-3 .",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"49  (2010)  956–963,  http://dx.doi.org/10.3109/0284186X.2010.",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
"2013  (2013)  740195,  http://dx.doi.org/10.1155/2013/740195 .",Non-OADS,/arxiv_data1/oa_pdf/14/d5/main.PMC4959919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/48/main.PMC4959920.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.002 2049-0801/Crown Copyright ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/4f/48/main.PMC4959920.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/9d/mdw151.PMC4959921.pdf
In http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/6a/9d/mdw151.PMC4959921.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/93/mdw177.PMC4959922.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in a ny medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/58/mdw203.PMC4959925.pdf
"http://seer.cancer.gov/statfacts/html/breast.html (5 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/ba/58/mdw203.PMC4959925.pdf
Version 3.2015. http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/ba/58/mdw203.PMC4959925.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/ea/mdw209.PMC4959927.pdf
"We considered SNVs that resulted in the change of one amino acid as deleterious if they were annotated as class 5 (pathogenic) in theBreast Cancer Information Core (BIC) [ 22], or pathogenic in ClinVar [ 23], or if Align-GVGD ( http://agvgd.iarc.fr ) predicted a class of C65 (deleterious).",Non-OADS,/arxiv_data1/oa_pdf/b2/ea/mdw209.PMC4959927.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/c2/mdw214.PMC4959928.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"ESMO 2020 Vision 2015. http://www.esmo.org/content/download/68849/ 1233986/ ﬁle/ESMO-2020-vision-brochure.pdf (May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"http://www.esmo.org/Career-Development/ Global-Curriculum-in-Medical-Oncology (29 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"http://www.asco.org/international-programs/ global-curriculum (29 May 2016, date last accessed).13.",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"ESMO/ASCO Global Curriculum Log Book, 2008. https://www.esmo.org/content/ download/8176/168808/ ﬁle/The-ESMO-ASCO-Global-Core-Curriculum-for-Training- in-Medical-Oncology-Log-Book.pdf (29 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"ESMO/ASCO Global Curriculum Log Book, 2008. http://www.asco.org/sites/new- www.asco.org/ ﬁles/content- ﬁles/international-programs/documents/2008-ESMO- ASCO-Log-Book-pdf.pdf (16 June 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
http://www.asco.org/sites/default/ ﬁles/esmo-asco_revised_recommendations.,Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"ESMO/ASCO Global Curriculum Log Book Update 2016. http://www.esmo.org/ content/download/81967/1487517/ ﬁle/The-ESMO-ASCO-Global-Curriculum-for- Training-in-Medical-Oncology-Log-Book-2016.pdf (30 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"ESMO/ASCO Global Curriculum Log Book Update 2016. http://www.asco.org/ sites/new-www.asco.org/ ﬁles/content- ﬁles/international-programs/documents/ 2016-ESMO-ASCO-Log-Book-interactive.pdf (16 June 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0d/53/mdw239.PMC4959930.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/62/mdw253.PMC4959931.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/7b/main.PMC4959932.pdf
"However, a mobile,  indurated  2.5  cm  right  inguinal  mass was  found  and  an  excisional  biopsy  of  the  entire  mass  was  per- http://dx.doi.org/10.1016/j.ijscr.2016.07.006 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c8/7b/main.PMC4959932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AdolescentChild developmentDeterminants of healthFamiliesHolismPopulation health 1.,Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
"However, holism suggests that there arePreventive Medicine Reports 4 (2016) 313 –319 http://dx.doi.org/10.1016/j.pmedr.2016.07.002 2211-3355/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
Bible Study Tools Available from http://www.biblestudytools.com/concordances/strongs-exhaustive-concordance/ .,Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
181– 216 Available from http://fnigc.ca/sites/ default/ ﬁles/ENpdf/RHS_1997/rhs_1997_ ﬁnal_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/86/e3/main.PMC4959933.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/da/main.PMC4959934.pdf
Other  labora- http://dx.doi.org/10.1016/j.ijscr.2016.07.004 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5d/da/main.PMC4959934.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inﬂuenza vaccines Place of vaccinationAdultsAged 1.,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
The study was approved by the University of Michigan Medical SchoolInstitutional Review Board.Preventive Medicine Reports 4 (2016) 320 –323 http://dx.doi.org/10.1016/j.pmedr.2016.07.004 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
(Available from: https://www.pharmacist.com/sites/default/ ﬁles/ﬁles/Annual%20Immunization%20Survey%20Report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
Operational Framework for Partnering With Pharmacies for Administration of 2009 H1N1 Vaccine September16 (Available from: http://www.cidrap.umn.edu/sites/default/ ﬁles/public/php/404/ 404_framework.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"Flu Vaccination Coverage, United States, 2012 –13 In ﬂuenza Season Available from: http://www.cdc.gov/ ﬂu/ ﬂuvaxview/coverage-1213estimates.htm Accessed June 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"Seasonal Inﬂ uenza Vaccine & Total Doses Distributed, 2012 –13 In ﬂuenza Season Available from: http://www.cdc.gov/ ﬂu/professionals/vaccination/vaccinesupply-2012.htm Accessed: April 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"Flu Vaccination Coverage, United States, 2013 –14 In ﬂuenza Season Available from: http://www.cdc.gov/ ﬂu/ ﬂuvaxview/coverage-1314estimates.htm Accessed June 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"Seasonal In ﬂuenza Vaccine & Total Doses Distributed, 2013 –14 In ﬂuenza SeasonAvailable from: http://www.cdc.gov/ ﬂu/professionals/vaccination/vaccinesupply-2013.htm Accessed: April 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
(Available from: http://www.hhs.gov/nvpo/nvac/ inﬂuenza_subgroup_ ﬁnal_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"National Early Season Flu Vaccination Coverage, United States, 2012 –13 In ﬂuenza Season Available from: http://www.cdc.gov/ ﬂu/ﬂuvaxview/nifs-estimates-nov2012.",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
"National Early Season Flu Vacci- nation Coverage, United States November (Available from: http://www.cdc.gov/ ﬂu/ ﬂuvaxview/nifs-estimates-nov2013.htm ).",Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
Fact Sheet: The Affordable Care Act and Wellness ProgramsAvailable from: http://www.dol.gov/ebsa/newsroom/fswellnessprogram.,Non-OADS,/arxiv_data1/oa_pdf/67/01/main.PMC4959935.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Abdominal obesityBody mass indexSmokingWaist circumference 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"Fourth, some studies have reported that BMI among the smokers waspositively associated with the number of cigarettes smoked per day (Bamia et al., 2004; Berlin, 2008; Chiolero et al., 2007 ;De Oliveira Fontes Gasperin et al., 2014; Pisinger et al., 2009 ) although other studiesPreventive Medicine Reports 4 (2016) 324 –330 http://dx.doi.org/10.1016/j.pmedr.2016.07.003 2211-3355/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1038/clpt.2011.105 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.7326/0003-4819-111-10- 783.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.diabet.2008.01.008 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
10(1).http://dx.doi.org/10.1186/1617-9625-10-9 (pp.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1111/sms.12401 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1093/ eurpub/cku174 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"Health 54 (1), 35 –39.http://dx.doi.org/10.1007/s00038-008-7061-x .",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1038/oby.2005.177 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1111/j.1753-4887.2011.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"http://dx.doi.org/ 10.1016/j.mayocp.2013.11.011 .Chiolero, A., Faeh, D., Paccaud, F., Cornuz, J., 2008.",OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
Health 11. http://dx.doi.org/10.1186/1471- 2458-11-23 (pp.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"11 (1), 12 –24.http://dx.doi.org/10.1093/ntr/ntn010 .",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1371/journal.pmed.1000058 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
Scandinavian Journal of Pub-lic Health http://dx.doi.org/10.1177/1403494815569865 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1177/1359105309341005 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/ 10.1016/j.psyneuen.2015.08.014 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1371/journal.pone.0045815 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1371/journal.pone.0124586 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1093/ntr/ntp062 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/ 10.1001/jama.2013.284692 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.3349/ymj.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.metabol.2009.,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.atherosclerosis.2006.07.002 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00008 (Jan 7).,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.ypmed.2006.11.015 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.puhe.2008.10.021 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1046/j.1467-789x.2001.00031.x .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.2337/dc12-0913 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1016/j.ijpsycho.2005.10.012 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"849, 49 –56.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1006/ pmed.2002.1064 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1093/geronj/44.2.M66 .,OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"http://dx.doi.org/10.1371/journal.pone.0102587 .Slagter, S.N., Van Vliet-Ostaptchouk, J.V., Vonk, J.M., et al., 2013.",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
11. http://dx.doi.org/10.1186/1741-7015-11-195 (pp.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1177/1403494807088453 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/ 10.1093/ije/dyp330 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1136/jech.56.3.167 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.1093/ije/dyu276 .,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
"Available from: http://www.who.int/ mediacentre/factsheets/fs311/en/ [03/26, 2015].",Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
http://dx.doi.org/10.3961/jpmph.,Non-OADS,/arxiv_data1/oa_pdf/0f/fb/main.PMC4959936.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ictal single photon emission computed tomog-raphyElectrical microstimulationFunctional magnetic resonance imagingAmygdala kindlingMesial temporal lobe epilepsy 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/9b/main.PMC4959940.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.0202213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9b/main.PMC4959940.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/9b/main.PMC4959940.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Faciobrachial dystonic-like seizureLeucine-rich glioma inactivated-1 Limbic encephalitis Basal gangliaInsular epilepsy 1.,Non-OADS,/arxiv_data1/oa_pdf/a2/7b/main.PMC4959944.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.06.001 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/7b/main.PMC4959944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/7b/main.PMC4959944.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/31/main.PMC4959945.pdf
http://dx.doi.org/10.1016/j.ejro.2016.07.001 2352-0477/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/d6/31/main.PMC4959945.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/31/main.PMC4959945.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/66/main.PMC4959946.pdf
http://dx.doi.org/10.1016/j.ejro.2016.06.002 2352-0477/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/66/main.PMC4959946.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/00/66/main.PMC4959946.pdf
DSI  studio  (http://dsi-studio.labsolver.org ) DSI Studio  is  a  non-commercial  software  for  diffusion  MR  images analysis.,OADS,/arxiv_data1/oa_pdf/00/66/main.PMC4959946.pdf
"Adultfemale A.suum worms were collected from Marshalltown PorkTables of Links TARGETS Ligand –gated ion channels Asu-ACR-16 ACR-16Nicotinic ACh receptor α7 subunitLIGANDS A844606 Dimethyl-4-phenyllpiperazinium Morantel Acetylcholine Epibatidine Nicotine Bephenium Genistein Oxantel Betaine Hexamethonium ParaherquamideBromocytisine Ivermectin PNU120596α-Bungarotoxin Levamisole Pyrantel Choline Lobeline Thenium Cytisine Mecamylamine TribendimidineDerquantel Methyllycaconitine d-Tubocurarine Dihydro- β-erythroidine Methyridine These Tables list key protein targets and ligands in this article which are h yperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) or the PubChem or Wormbase databases.",Non-OADS,/arxiv_data1/oa_pdf/e5/a1/BPH-173-2463.PMC4959957.pdf
", 2010) with the neighbour- joining method and bootstrapped with 1000 replicates.The resulting tree was visualized and edited using FigTree1.4 (http://tree.bio.ed.ac.uk/software/ ﬁgtree/).",OADS,/arxiv_data1/oa_pdf/e5/a1/BPH-173-2463.PMC4959957.pdf
Supporting Information Additional Supporting Information may be found in the on- line version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13524Figure S1 Amino acid sequence alignment of Asu-ACR-16 and Cel-ACR-16 nAChR subunits.,Non-OADS,/arxiv_data1/oa_pdf/e5/a1/BPH-173-2463.PMC4959957.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/5a/aps-43-309.PMC4959971.pdf
Available from: http://www.medicaltimes.com/  Users4/News/newsView.html?ID=1098327.,Non-OADS,/arxiv_data1/oa_pdf/64/5a/aps-43-309.PMC4959971.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/24/aps-43-311.PMC4959972.pdf
"316Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/40/aps-43-316.PMC4959973.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/c6/aps-43-321.PMC4959974.pdf
"328Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/55/aps-43-328.PMC4959975.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/99/aps-43-339.PMC4959976.pdf
"344Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/d1/aps-43-344.PMC4959977.pdf
"352Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/3e/aps-43-352.PMC4959978.pdf
"360Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/e6/aps-43-360.PMC4959979.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/6d/aps-43-365.PMC4959980.pdf
ORCID Mohammad Atari http://orcid.org/0000-0002-4358-7783 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/34/6d/aps-43-365.PMC4959980.pdf
"Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/b4/aps-43-371.PMC4959981.pdf
"374Copyright © 2016  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/46/aps-43-374.PMC4959982.pdf
"Received: 18 Nov 2015 • Revised: 10 May 2016 • Accepted: 24 May 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.379   Arch Plast Surg 2016;43:379-381 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/25/aps-43-379.PMC4959983.pdf
"Received: 23 Oct 2015 • Revised: 31 Jan 2016 • Accepted: 15 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.381   Arch Plast Surg 2016;43:381-384 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/25/aps-43-379.PMC4959983.pdf
"Received: 23 Oct 2015 • Revised: 31 Jan 2016 • Accepted: 15 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.381   Arch Plast Surg 2016;43:381-384 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/9b/aps-43-381.PMC4959984.pdf
ORCID Fra ncisco Javier Pacheco Compaña   http://orcid.org/0000-0003-2791-5799  References 1.,Non-OADS,/arxiv_data1/oa_pdf/26/9b/aps-43-381.PMC4959984.pdf
"Received: 18 Nov 2015 • Revised: 18 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.384   Arch Plast Surg 2016;43:384-387 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/9b/aps-43-381.PMC4959984.pdf
ORCID Fra ncisco Javier Pacheco Compaña   http://orcid.org/0000-0003-2791-5799  References 1.,Non-OADS,/arxiv_data1/oa_pdf/13/3c/aps-43-384.PMC4959985.pdf
"Received: 18 Nov 2015 • Revised: 18 Jan 2016 • Accepted: 7 Feb 2016   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.384   Arch Plast Surg 2016;43:384-387 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/3c/aps-43-384.PMC4959985.pdf
"Received: 23 Sep 2015 • Revised: 21 Dec 2015 • Accepted: 21 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.387   Arch Plast Surg 2016;43:387-389 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/3c/aps-43-384.PMC4959985.pdf
"Received: 23 Sep 2015 • Revised: 21 Dec 2015 • Accepted: 21 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.387   Arch Plast Surg 2016;43:387-389 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/ea/aps-43-387.PMC4959986.pdf
"Received: 27 Jul 2015 • Revised: 11 Nov 2015 • Accepted: 28 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.389   Arch Plast Surg 2016;43:389-390 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/ea/aps-43-387.PMC4959986.pdf
"Received: 27 Jul 2015 • Revised: 11 Nov 2015 • Accepted: 28 Dec 2015   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2016.43.4.389   Arch Plast Surg 2016;43:389-390 Copyright  2016 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/e4/aps-43-389.PMC4959987.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: E-cigarettes Warning labels CommunicationHarm reductionModi ﬁed risk Tobacco 1.,Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
However the FDAPreventive Medicine Reports 4 (2016) 309 –312 http://dx.doi.org/10.1016/j.pmedr.2016.07.005 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
"2), ii3–ii7.http://dx.doi.org/10.1136/tc.2004.008334 (accessed September 2015).",Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
"(Retrieved February 1, 2016 from https://www.gov.uk/government/publications/e-cigarettes-an-evidence- update ).",Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
"RCP, London (Retrieved from http://www.tobaccoprogram.org/pdf/ 4fc74817-64c5-4105-951e-38239b09c5db.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
"(Retrieved February 1, 2016, from http://www.fda.gov/TobaccoProducts/ GuidanceComplianceRegulatoryInformation/ucm297750.htm ).",Non-OADS,/arxiv_data1/oa_pdf/83/2b/main.PMC4960008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/10/main.PMC4960009.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/10/main.PMC4960009.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.013Urology Case Reports 8 (2016) 38 e39,Non-OADS,/arxiv_data1/oa_pdf/08/10/main.PMC4960009.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Race/ethnicityObesity biasCare experienceWeight management 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/28/main.PMC4960010.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0152211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/f1/28/main.PMC4960010.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/28/main.PMC4960010.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f1/28/main.PMC4960010.pdf
"Keywords: Thyroxine-binding globulin, Hyperthyroxinemia, TriiodothyronineHye Young Jin, MD, PhD Department of Pediatrics, Inje  University Haeundae Paik Hospital, Inje University College of Medicine,  Busan, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.105Ann Pediatr Endocrinol Metab 2016;21:105-108 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 14 April, 2016 Revised: 19 May, 2016 Accepted: 1 June, 2016 Address for correspondence:  Hye Young Jin, MD, PhD Department of Pediatrics, Haeundae Paik Hospital, Inje University College  of Medicine, 875 Haeun-daero,  Haeundae-gu, Busan 48108, KoreaTel: +82-51-797-0609 Fax: +82-51-797-0298 E-mail: jinex79@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Thyroxine binding globulin (TBG), prealbumin or transthyretin, and albumin are all thyroid  hormone (TH) binding proteins1).",Non-OADS,/arxiv_data1/oa_pdf/e1/8d/apem-21-105.PMC4960012.pdf
"Letter to the Editor: Endocrine and metabolic  emergencies in children: hypocalcemia, hypoglycemia, adrenal insufficiency, and metabolic acidosis including diabetic ketoacidosis Letter Viktor Rosival, PhD SYNLAB Department of Laboratory  Medicine, Derers Hospital,  Bratislava, Slovakhttp://dx.doi.org/10.6065/apem.2016.21.2.109Ann Pediatr Endocrinol Metab 2016;21:109-110 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 8 March, 2016 Accepted: 17 June, 2016 Address for correspondence:  Viktor Rosival, PhD SYNLAB Department of Laboratory Medicine, Dérer’s Hospital, Limbová 5, SK-833 01 Bratislava, SlovakiaTel: +421-335511831 Fax: +421-335511831 E-mail: rosivalv@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) In the paper entitled “Endocrine and metabolic emergencies in children: hypocalcemia,  hypoglycemia, adrenal insufficiency, and metabolic acidosis including diabetic ketoacidosis”1)  are some discrepancies with the literature.",Non-OADS,/arxiv_data1/oa_pdf/23/31/apem-21-109.PMC4960013.pdf
"Letter http://dx.doi.org/10.6065/apem.2016.21.2.111Ann Pediatr Endocrinol Metab 2016;21:111-112 ©2016 Annals of Pediatric Endocrinology & MetabolismThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online)",Non-OADS,/arxiv_data1/oa_pdf/e1/d6/apem-21-111.PMC4960014.pdf
"Keywords: Skeletal muscle, Glucose uptake, Exercise, Obesity, InsulinHo-Jin Koh, PhD Applied Physiology Division,  Department of Exercise Science, Arnold School of  Public Health,  University of South Carolina,  Columbia, SC, USA http://dx.doi.org/10.6065/apem.2016.21.2.61 Ann Pediatr Endocrinol Metab 2016;21:61-65 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 25 May, 2016 Accepted: 26 June, 2016  Address for correspondence:  Ho-Jin Koh, PhD Applied Physiology Division, Department of Exercise Science, University of South Carolina, 921 Assembly St. Columbia, SC 29208, USATel: +1-803-777-1462 Fax: +1-803-777-0558 E-mail: kohh@mailbox.sc.edu This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction The incidence of type 2 diabetes is increasing at epidemic rates worldwide and skeletal  muscle is the tissue responsible for the majority of glucose disposal upon insulin stimulation and exercise, which have been known to increase glucose uptake into the tissue 1).",Non-OADS,/arxiv_data1/oa_pdf/42/fc/apem-21-61.PMC4960015.pdf
"Keywords: Central precocious puberty, Kisspeptins, MKRN3 gene, MutationYoung-Lim Shin, MD, PhD Department of Pediatrics,  Soonchunhyang University Bucheon Hospital, Soonchunhyang  University College of Medicine,  Bucheon, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.66 Ann Pediatr Endocrinol Metab 2016;21:66-69 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 17 June, 2016 Accepted: 27 June, 2016  Address for correspondence:  Young-Lim Shin, MD, PhD Department of Pediatrics, Soon - chunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, KoreaTel: +82-32-621-5407 Fax: +82-32-621-5016 E-mail: ylshin@schmc.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Gonadotropin-releasing hormone (GnRH) secretion is active in infancy and then  becomes quiescent in childhood.",Non-OADS,/arxiv_data1/oa_pdf/2d/25/apem-21-66.PMC4960016.pdf
"Consequently, we  Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013 Sun Mi Hwang, MD1, Min Sun Kim, MD1,2, Dae-Yeol Lee, MD1,2 1Department of Pediatrics, Chonbuk  National University Medical School,  2Research I nstitute of Clinical  Medicine of Chonbuk National  University-Biomedical Institute of Chonbuk National University Hospital, Jeonju, Korea  Received: 1 July , 2015 Revised: 12 October, 2015 Accepted: 12 February, 2016 Address for correspondence: Min Sun Kim, MD Department of Pediatrics, Chonbuk  National University Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 54907,  Korea Tel: +82-63-250-2573,Fax: +82-63-250-1464, E-mail: children@jbnu.ac.krhttp://dx.doi.org/10.6065/apem.2016.21.2.70 Ann Pediatr Endocrinol Metab 2016;21:70-74",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/apem-21-70.PMC4960017.pdf
"Furthermore, the  prevalence of nonalcoholic fatty liver disease (NAFLD), which is linked with high abdominal  Ultrasound measurement of pediatric visceral fat thickness: correlations with metabolic and liver profiles Jae Hwa Jung, MD1, Mo Kyung Jung, MD1, Ki Eun Kim, MD1, Ah Reum Kwon, MD1, Hyun Wook Chae, MD1, Choon Sik Yoon, MD, PhD2, Ho Seong Kim, MD, PhD1, Duk-Hee Kim, MD, PhD3 Departments of 1Pediatrics and  2Radiology, Yonsei University College  of Medicine, Seoul, 3Sowha Children’s  Hospital, Seoul, Korea Received: 24 October, 2015 Revised: 28 October, 2015 Accepted: 30 November, 2015 Address for correspondence: Hyun-Wook Chae, MD Department of Pediatrics, Gangnam  Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2019-3355,Fax: +82-2-3461-9473, E-mail: hopechae@yuhs.achttp://dx.doi.org/10.6065/apem.2016.21.2.75 Ann Pediatr Endocrinol Metab 2016;21:75-80",Non-OADS,/arxiv_data1/oa_pdf/a3/85/apem-21-75.PMC4960018.pdf
"The changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over the last 20 years  Eun Byul Kwon, MD1,  Hae Sang Lee, MD, PhD2,  Young Seok Shim, MD3,  Hwal Rim Jeong, MD4,  Jin Soon Hwang, MD, PhD2 1Department of Pediatrics, CHA  Bundang Medical Center, CHA  University, Seongnam, 2Department  of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon,  3Department of Pediatrics,  Hallym University Medical Center, Hallym University College of Medicine, Seoul,  4Department of Pediatrics,  Masan medical center, Changwon, Korea Received: 4 February, 2016 Revised: 10 March, 2016 Accepted: 29 March, 2016 Address for correspondence: Jin Soon Hwang, MD, PhD Department of Pediatrics, Ajou  University Hospital, Ajou University School of Medicine, 164 World cup- ro, Yeongtong-gu, Suwon 16499,  Korea Tel: +82-31-219-5166, Fax: +82-31-219-5169, E-mail: pedhwang@ajou.ac.krhttp://dx.doi.org/10.6065/apem.2016.21.2.81 Ann Pediatr Endocrinol Metab 2016;21:81-85",Non-OADS,/arxiv_data1/oa_pdf/ef/1f/apem-21-81.PMC4960019.pdf
"Keywords: Insulin, Glucagon, Fetal blood, Hypoglycemia, Premature infant Jae Hyun Park, MD1, Jin Gon Bae, MD2, Shin Kim, MD3, Chun Soo Kim, MD1, Sang Lak Lee, MD1, Heung Sik Kim, MD, PhD1 D e p a r t m e n t s  o f  1Pe d i a t r i c s ,  2Obstetrics and Gynecology, and  3Immunology, Keimyung University  Dongsan Medical Center, Keimyung  University School of Medicine, Daegu, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.86Ann Pediatr Endocrinol Metab 2016;21:86-91 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 18 March, 2016 Revised: 13 May, 2016 Accepted: 7 June, 2016 Address for correspondence:  Heung Sik Kim, MD, PhD Department of Pediatrics, Keimyung University Dongsan Medical Center;  Keimyung University School of  Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea Tel: +82-53 -250-7516 Fax: +82-53-250-7833E-mail: kimhs@dsmc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Fetus is dependent on the mother for energy metabolism and the synthesis of other  metabolic substrates1).",Non-OADS,/arxiv_data1/oa_pdf/ea/ac/apem-21-86.PMC4960020.pdf
"Keywords: Dilated cardiomyopathy, Child, Graves diseaseYu Jung Choi, MD, Jun Ho Jang, MD, So Hyun Park, MD,Jin-Hee Oh, MD, Dae Kyun Koh, MD Depar tment of Pediatrics, St.  Vincent’s Hospital, The Catholic  University of Korea, Suwon, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.92Ann Pediatr Endocrinol Metab 2016;21:92-95 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 6 November, 2015 Revised: 2 Dcember, 2015 Accepted: 8 Dcember, 2015 Address for correspondence:  So Hyun Park, MD Department of Pediatrics, St. Vincent Hospital, The Catholic University of  Korea, 93 Jungbu-daero, Paldal-gu,  Suwon 16247, Korea Tel: +82-31-249-8220 Fax: +82-31-257-9111 E-mail: nicedoc@catholic.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Graves disease (GD) is an autoimmune thyroid disease that leads to hyperactivity of the  sympathetic nervous system, resulting in heat intolerance, tachycardia, hypertension, and a raised metabolic state 1).",Non-OADS,/arxiv_data1/oa_pdf/65/2b/apem-21-92.PMC4960021.pdf
"Keywords: Diabetic ketoacidosis, Infant, Type 1 diabetes mellitusJi Hyun Park, MD, So Young Shin, MD, Ye Jee Shim, MD,Jin Hyeok Choi, MD, Heung Sik Kim, MD, PhD Department of Pediatrics, Keimyung  University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.96Ann Pediatr Endocrinol Metab 2016;21:96-98 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 13 December, 2015 Revised: 28 January, 2016 Accepted: 5 February, 2016 Address for correspondence:  Heung Sik Kim, MD, PhD Department of Pediatrics, Keimyung University Dongsan Medical Center,  Keimyung University School of  Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea Tel: +82-53-250-7516 Fax: +82-53-250-7783E-mail: kimhs@dsmc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Diabetic ketoacidosis (DKA) is a complex metabolic state of hyperglycemia, ketosis, and  acidosis.",Non-OADS,/arxiv_data1/oa_pdf/d8/00/apem-21-96.PMC4960022.pdf
"Keywords: Hypercalcemia, Leukemia, Osteoclast activating factorHye-Jin Park, MD, Eun-Jin Choi, MD, PhD,  Jin-Kyung Kim, MD, PhD Department of Pediatrics, Catholic  University of Daegu School of  Medicine, Daegu, Koreahttp://dx.doi.org/10.6065/apem.2016.21.2.99Ann Pediatr Endocrinol Metab 2016;21:99-104 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 15 March, 2016 Revised: 18  April, 2016 Accepted:  24 May, 2016 Address for correspondence:  Jin-Kyung Kim, MD, PhD Department of Pediatrics, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17- gil, Nam-gu, Daegu 42472, KoreaTel: +82-53-650-4240 Fax: +82-53-621-4106 E-mail: kimjk@cu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction The clinical presentation of hypercalcemia is often asymptomatic or vague.",Non-OADS,/arxiv_data1/oa_pdf/40/bd/apem-21-99.PMC4960023.pdf
"Many key regulators of bone formation and bone structural proteins are ex - pressed in atherosclerotic plaques, including bone morphogenetic protein-2, 6 osteopontin,7  matrix γ-carboxyglutamic acid protein, and osteoprotegerin.8 Coronary artery calcification (CAC) is by far the best-studied type of vascular calcifica - tion.9 A CAC score has been used as a noninvasive marker to predict acute coronary dis - ease, and this has prompted researchers to explore the potential predictive values of calci -Xiao Hong Wua   Xiang-Yan Chena  Li Juan Wangb  Ka Sing Wonga a Department of Medicine and   Therapeutics, Chinese University   of Hong Kong, Hong Kong Special  Administrative Region, China b Department of Neurology, The First  Hospital of Jilin University, Jilin, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):253-261   /   http://dx.doi.org/10.3988/jcn.2016.12.3.253 Received  November 2, 2015 Revised  December 20, 2015 Accepted  December 21, 2015 Correspondence Xiang-Y an Chen, MD    Department of Medicine and  Therapeutics, Prince of Wales Hospital,  30-32 Ngan Shing Street, Shatin,  New Territories, Hong Kong SAR  Tel    +852 26352130 Fax   +852 26493761 E-mail    fionachen@cuhk.edu.hkcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/10/ce/jcn-12-253.PMC4960208.pdf
"This situation prompted the development of new methods for evaluating the functional integrity of the motor pathways passing through the brainstem based on recording the corticospinal motor evoked potentials (MEPs) in limb muscles 1 and  the corticobulbar MEPs (CoMEPs) in cranial-nerve-innervated muscles.2-4 However, these Vedran Deletisa  Isabel Fernández-Conejerob a Laboratory for Human and Experimental   Neurophysiology, School of Medicine,   Split, Croatia b Department of Intraoperative   Neurophysiology, University Hospital  of Bellvitge, Barcelona, SpainpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):262-273   /   http://dx.doi.org/10.3988/jcn.2016.12.3.262 Received  D ecember 14, 2015 Revised  J anuary 23, 2016 Accepted  J anuary 26, 2016 Correspondence Vedran Deletis, MD, PhD Laboratory for Human and Experimental Neurophysiology, School of Medicine, Soltanska, 2, Split 21000, CroatiaTel    +385-91-754-1385 E-mail    vdeletis@chpnet.org cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/f1/89/jcn-12-262.PMC4960209.pdf
"P ATIENT 1 Mr. A, a 69-year-old male, presented to us with a two month history of shooting pains in the bilateral gluteal regions and the back of the thigh, followed 1 month later by pin prick paresthesias in both upper limbs and the right half of the face, along with asymmetrical quadriparesis affecting the legs more than the arms, low-grade fever, dry cough, orthop -Ritu Shreea   Manoj Kumar Goyala   Manish Modia  Balan Louis Gasparb  Bishan Dass Radotrab   Chirag Kamal Ahujac  Bhagwant Rai Mittald  Gaurav Prakashe a Departments of Neurology  b Histopathology, cRadiodiagnosis,  dNuclear Medicine and   e Clinical Hematology,   Postgraduate Institute   of Medical Education and   Research (PGIMER), Chandigarh, IndiapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):274-281   /   http://dx.doi.org/10.3988/jcn.2016.12.3.274 Received  January 29, 2016 Revised  February 22, 2016 Accepted  February 25, 2016 Correspondence Manoj Kumar Goyal, MD, DM Department of Neurology,  Postgraduate Institute  of Medical Education  and Research (PGIMER), Chandigarh, IndiaTel    +917087008271 E-mail    goyal_mk@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access REVIEW",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/jcn-12-274.PMC4960210.pdf
"Although rare, some patients presenting with recurrence or a multi - phasic course have been reported, indicating diagnostic difficulties.2,3 Previous studies have  mostly involved pediatric populations,4 with relatively few studies involving adult patients.5  Here we present a series of 42 adult patients in Zhengzhou City, China with the purpose of identifying the clinical manifestations and laboratory and neuroimaging features of this dis -Hong-Qi Yanga   Wen-Cong Zhaob   Wei-Min Yangc   Yong-Li Lid   Zhi-Kun Suna   Shuai Chena   Wei Lia  Jian-Jun Maa a Departments of Neurology and  d Radiology, Henan Provincial People’s   Hospital of Zhengzhou University,   Zhengzhou, China b Department of Pharmacology,   Zhengzhou Maternal and   Child Health Hospital,   Zhengzhou, China c Department of Neurology,   the First Affiliated Hospital   of Zhengzhou University,   Zhengzhou, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):282-288   /   http://dx.doi.org/10.3988/jcn.2016.12.3.282 Received  August 19, 2014 Revised  March 1, 2015 Accepted  March 1, 2015 Correspondence Wei Li, MD, PhD  Department of Neurology, Henan Provincial People’s Hospital of Zhengzhou University, No 7, Weiwu Road,Zhengzhou 450003, ChinaTel    +86-371-65580602 Fax   +86-371-65897739 E-mail    liwei71@126.com Jian-Jun Ma, MD Department of Neurology, Henan Provincial People’s Hospital of Zhengzhou University, No 7, Weiwu Road,Zhengzhou 450003, ChinaTel    +86-371-65580602 Fax   +86-371-65897739 E-mail    majj.1124@yahoo.com.cn cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/15/36/jcn-12-282.PMC4960211.pdf
"3,4 is the first to describe the US characteristic features of CTS, and suggested basing  the diagnosis of CTS on the following measurements: 1) increased cross-sectional area at the level of the pisiform bone (CSA pisiform ) and, to a lesser extent, at the level of the hook of ha-Ozan Volkan Yurdakula  Nіlgün Mescіb  Yilmaz Çetіnkayac  Duygu Geler Külcüb a Department of Physical Medicine   and Rehabilitation, Gaziosmanpasa  Taksim Education and Research Hospital, Istanbul, Turkey b Departments of Physical Medicine   and Rehabilitation and cNeurology,  Haydarpasa Numune Education and Research Hospital, Istanbul, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):289-294   /   http://dx.doi.org/10.3988/jcn.2016.12.3.289 Received  A ugust 17, 2015 Revised  N ovember 14, 2015 Accepted  N ovember 17, 2015 Correspondence Ozan Volkan Yurdakul, MD Department of Physical Medicine and Rehabilitation, Gaziosmanpasa Taksim Education and Research Hospital Karayollari mah.",Non-OADS,/arxiv_data1/oa_pdf/fb/57/jcn-12-289.PMC4960212.pdf
"No:120 Gaziosmanpasa-Istanbul, TurkeyTel    +90-5543725127 Fax   +90-2129453180 E-mail    yurdakul_ozan@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/fb/57/jcn-12-289.PMC4960212.pdf
"8 In terms  of the spectrum of neuropsychological dysfunction, investigations about emotion process - ing abilities, as well as cognitive or behavioral features, are important for understanding the Seong-il Oha*   Ki-Wook Ohb*   Hee-Jin Kimb  Jin-Seok Parkb  Seung Hyun Kimb a Department of Neurology,   Busan Paik Hospital, Inje University  College of Medicine, Busan, Korea b Department of Neurology,   College of Medicine, Hanyang University,   Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):295-300   /   http://dx.doi.org/10.3988/jcn.2016.12.3.295 Received  September 18, 2015 Revised  November 20, 2015 Accepted  November 23, 2015 Correspondence Seung Hyun Kim, MD, PhD  Department of Neurology,  College of Medicine, Hanyang University,   222 Wangsimni-ro, Seongdong-gu,  Seoul 04763, KoreaTel    +82-2-2290-8371 Fax   +82-2-2296-8370 E-mail    kimsh1@hanyang.ac.kr *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/84/a8/jcn-12-295.PMC4960213.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/84/a8/jcn-12-295.PMC4960213.pdf
"Recognition of these un-Sun-Uk Leea*  Seong-Ho Parkb*  Hyo-Jung Kimc  Ja-Won Kood  Ji-Soo Kimb a Department of Neurology, Ajou University  School of Medicine, Ajou University  Hospital, Suwon, Korea bDepartments of Neurology and   d Otolaryngology-Head and Neck Surgery,  Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea c Department of Biomedical Laboratory  Science, Kyungdong University,  Goseong, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):301-307   /   http://dx.doi.org/10.3988/jcn.2016.12.3.301 Received  S eptember 23, 2015 Revised  N ovember 22, 2015 Accepted  N ovember 25, 2015 Correspondence Ji-Soo Kim, MD, PhD Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, KoreaTel    +82-31-787-7463 Fax   +82-31-719-6828 E-mail    jisookim@snu.ac.kr *These authors equally contributed to  this study.",Non-OADS,/arxiv_data1/oa_pdf/78/25/jcn-12-301.PMC4960214.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/78/25/jcn-12-301.PMC4960214.pdf
"7 Sykora et al.8 also  found that the fluctuation of beat-to-beat BPV played an important role in the outcome after Ge Tian *  Li Xiong *  Wenhua Lin  Jinghao Han Xiangyan Chen Thomas Wai Hong Leung Yannie Oi Yan Soo Lawrence Ka Sing Wong Department of Medicine & Therapeutics,  The Chinese University of Hong Kong, Hong Kong, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):308-315   /   http://dx.doi.org/10.3988/jcn.2016.12.3.308 Received  A ugust 24, 2015 Revised  D ecember 1, 2015 Accepted  D ecember 2, 2015 Correspondence Lawrence Ka Sing Wong, MD Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, SAR, ChinaTel    +852-2632-3144 Fax   +852-2649-3761 E-mail    ks-wong@cuhk.edu.hk *   Th ese authors contributed equally to  this work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3a/60/jcn-12-308.PMC4960215.pdf
"MOH are usually refractory to treat - ment, and patients with CDH experience a remarkable degree of disability.5-8 Recent advances in medicine may provide an opportunity for the successful treatment of  CM and MOH, but most CM and MOH patients do not receive the correct diagnosis at Myoung-Jin Chaa, Heui-Soo Moonb  Jong-Hee Sohnc, Byung-Su Kimd  Tae-Jin Songe, Jae-Moon Kimf   Jeong Wook Parkg, Kwang-Yeol Parkh   Soo-Kyoung Kimi, Byung-Kun Kimj  Soo-Jin Chok a Department of Neurology,   National Police Hospital, Seoul, Korea b Department of Neurology,   Kangbuk Samsung Hospital,   Sungkyunkwan University School   of Medicine, Seoul, Korea c Department of Neurology,   Chuncheon Sacred Heart Hospital,   Hallym University College of Medicine,  Chuncheon, Korea d Department of Neurology,   Bundang Jesaeng General Hospital,   Daejin Medical Center, Seongnam, Korea e Department of Neurology, Ewha Womans  University School of Medicine, Seoul, Korea f Department of Neurology,   Chungnam National University   College of Medicine, Daejeon, Korea g Department of Neurology,   Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine,   Uijeongbu, Korea h Department of Neurology,   Chung-Ang University Hospital, Chung-Ang   University College of Medicine, Seoul, Korea i  Department of Neurology,     Gyeongsang National University     School of Medicine, Jinju, Korea j   Department of Neurology, Eulji University     School of Medicine, Seoul, Korea k Department of Neurology, Dongtan Sacred  Heart Hospital, Hallym University College   of Medicine, Hwaseong, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):316-322   /   http://dx.doi.org/10.3988/jcn.2016.12.3.316 Received  November 6, 2015 Revised  December 15, 2015 Accepted  December 17, 2015 Correspondence Soo-Jin Cho, MD, PhD Department of Neurology,   Dongtan Sacred Heart Hospital,  Hallym University College of Medicine,  7 Keunjaebong-gil,   Hwaseong 18450, Korea Tel    +82-31-8086-2310 Fax   +82-31-8086-2317 E-mail    dowonc@naver.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/cc/ca/jcn-12-316.PMC4960216.pdf
"Key Words zz mesial temporal lobe epilepsy, gray matter volume, voxel-based morphometry,  hippocampal sclerosis, magnetic resonance imaging.Asymmetric Gray Matter Volume Changes Associated   with Epilepsy Duration and Seizure Frequency  in Temporal-Lobe-Epilepsy Patients with Favorable Surgical Outcome INTRODUCTION Mesial temporal lobe epilepsy (MTLE) is the most common type of refractory partial epi - lepsy, and is commonly associated with hippocampal sclerosis (HS).1,2 Voxel-based mor - phometry (VBM) has emerged from recent developments in neuroimaging analysis tech - niques to become a popular technique for whole-brain magnetic resonance imaging (MRI)  that allows focal differences between patients and matched healthy controls to be investi - gated.3Jeong Sik Kima,b*   Dae Lim Kooc*  Eun Yeon Jooa,b   Sung Tae Kimd  Dae Won Seoa,b  Seung Bong Honga,b a Department of Neurology, Neuroscience  Center, Samsung Medical Center and  Samsung Advanced Institute for Health Sciences & Technology (SAIHST),  Sungkyunkwan University School   of Medicine, Seoul, Korea b Samsung Biomedical Research Institute  (SBRI), Seoul, Korea c Department of Neurology, Seoul National  University Boramae Hospital,   Seoul, Korea d Department of Radiology, Samsung  Medical Center, Sungkyunwan University  School of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):323-331   /   http://dx.doi.org/10.3988/jcn.2016.12.3.323 Received  November 19, 2015 Revised  December 25, 2015 Accepted  December 28, 2015 Correspondence Seung Bong Hong, MD, PhD  Department of Neurology,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 06351 KoreaTel    +82-2-3410-3592 Fax   +82-2-3410-0052 E-mail    sbhong@skku.edu *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/61/75/jcn-12-323.PMC4960217.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/61/75/jcn-12-323.PMC4960217.pdf
"Data preprocessing For all subjects, Digital Imaging and Communications in  Medicine format images were transformed into the ANA - LYZE format specified by the Mayo Clinic using ITK-SNAP  freeware (Paul Yushkevich; http://www.itksnap.org).",OADS,/arxiv_data1/oa_pdf/61/75/jcn-12-323.PMC4960217.pdf
"A recent  VBM approach, including the new segmentation toolbox  (http://www.fil.ion.ucl.ac.uk/spm/software/spm8) and  DARTEL17 algorithm in SPM8, was applied to anatomical  T1-weighted MRI data to detect GMV differences between  unilateral MTLE patients and healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/61/75/jcn-12-323.PMC4960217.pdf
"First, the initial presentation of tuberculosis meningitis may be similar to other types Jinseung Kima*  Si Eun Kimb*  Bong Soo Parkc  Kyong Jin Shinb  Sam Yeol Hab  JinSe Parkb  Sung Eun Kimb  Kang Min Parkb a  Department of Family Medicine,   Busan Paik Hospital, Inje University  College of Medicine, Busan, Korea  Departments of bNeurology and   c Internal Medicine, Haeundae Paik  Hospital, Inje University College  of Medicine, Busan, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):332-339   /   http://dx.doi.org/10.3988/jcn.2016.12.3.332 Received  O ctober 16, 2015 Revised  D ecember 28, 2015 Accepted  D ecember 30, 2015 Correspondence Kang Min Park, MD Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeundae-ro, Haeundae-gu, Busan 48108, KoreaTel    +82-51-797-1195 Fax   +82-51-797-1196 E-mail    smilepkm@hanmail.net *   Th ese authors contributed equally to  this work.cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/c2/bd/jcn-12-332.PMC4960218.pdf
"To our knowledge, no population-based epidemiological data Su-Yeon Parka*  Jin Yong Leeb*  Nam Gu Limc  Yoon-Ho Hongd a Department of Neurology,   Korea Cancer Center Hospital,   Seoul, Korea b Public Health Medical Service,   Boramae Medical Center,  Seoul National University  College of Medicine,  Seoul, Korea c Department of Medical Administration,  Daejeon Health Sciences College, Daejeon, Korea d Department of Neurology,   Boramae Medical Center,  Seoul National University  College of Medicine,  Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):340-344   /   http://dx.doi.org/10.3988/jcn.2016.12.3.340 Received  N ovember 23, 2015 Revised  D ecember 28, 2015 Accepted  D ecember 30, 2015 Correspondence Y oon-Ho Hong, MD Department of Neurology, Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu,Seoul 07061, KoreaTel    +82-2-870-2474 Fax   +82-2-831-2826 E-mail    nrhong@gmail.com Nam Gu Lim, MD Department of Medical Administration, Daejeon Health Sciences College, 21 Chungjeong-ro, Dong-gu,Daejeon 34504, KoreaTel    +82-42-670-9215 Fax   +82-42-670-9583 E-mail    ing1973@hit.ac.kr *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/b5/5f/jcn-12-340.PMC4960219.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/b5/5f/jcn-12-340.PMC4960219.pdf
"The available literature reflects difficulties in establishing concrete risk factors for both disease occurrence and disability progression: for instance, some stud - ies found advanced age at disease onset to be associated with a shorter time to disease pro - gression 3,4 while other studies did not find such an association.5,6 Obesity, mainly during  early life, was shown to increase the risk of MS development7,8 but in other studies this as - sociation was found to be dependent upon certain demographic parameters.9 Smoking was  demonstrated to increase the risk of disease occurrence in some studies and to a lesser ex - tent enhance disease progression.10-13 Amir Dagana,b  Irina Gringouza,b  Iris Kliersa,b  Gad Segala,b a Department of Internal Medicine “T”,  Chaim Sheba Medical Center,   Tel-Hashomer, Israel b Sackler Faculty of Medicine,   Tel Aviv University, Tel Aviv, IsraelpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):345-350   /   http://dx.doi.org/10.3988/jcn.2016.12.3.345 Received  September 16, 2015 Revised  January 2, 2016 Accepted  January 5, 2016 Correspondence Gad Segal, MD Department of Internal Medicine “T” ,  Chaim Sheba Medical Center,  Tel-Hashomer 5262000, Israel  Tel    +972-52-6669580 Fax   +972-3-5307281 E-mail    gad.segal@sheba.health.gov.ilcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/33/1b/jcn-12-345.PMC4960220.pdf
"Muscle biopsies of patients with DMD re-Fuchen Liua,b  Zonglai Lianga  Jingwen Xua  Wei Lia  Dandan Zhaoa  Yuying Zhaoa  Chuanzhu Yana,c,d a Department of Neurology, Qilu Hospital  of Shandong University, Jian, China b Department of Neurobiology,   Yale University School of Medicine,  New Haven, CT, USA c Key Laboratory for Experimental  Teratology of the Ministry of Education, School of Medicine, Shandong University, Jian, China d Brain Science Research Institute,  Shandong University, Jian, ChinapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):351-360   /   http://dx.doi.org/10.3988/jcn.2016.12.3.351 Received  S eptember 15, 2015 Revised  J anuary 13, 2016 Accepted  J anuary 13, 2016 Correspondence Chuanzhu Y an, MD, PhD Department of Neurology, Qilu Hospital of Shandong University, Jian 250012, ChinaTel    +86-053182169217 Fax   +86-053182169217 E-mail    chuanzhuyan@163.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/1c/6c/jcn-12-351.PMC4960221.pdf
"3 The normal value of FVC in the Korean population has been reported  previously.4 However, reference ranges of MIP , MEP , and SNIP have not been reported for  the Korean population, and these parameters may be affected by racial differences.5 We analyzed the respiratory muscle strength in healthy controls and applied the obtained Kee Hong Parka  Rock Bum Kimb   Jiwon Yangc   Jung-Hwan Ohd   Su-Yeon Parke   Dong-Gun Kimf   Je-Young Shing   Jung-Joon Sungg a Department of Neurology,   Gyeongsang National University  Hospital, Jinju, Korea b Regional Cardiocerebrovascular Center,  Gyeongsang National University Hospital, Jinju, Korea c Department of Neurology,   Gil Medical Center,  Gachon University, Incheon, Korea d Department of Neurology,   Jeju National University   School of Medicine, Jeju, Korea e Department of Neurology,   Korea Cancer Center Hospital,   Seoul, Korea f  Department of Neurology,   Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea g Department of Neurology,   Seoul National University Hospital,   Seoul National University   College of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):361-367   /   http://dx.doi.org/10.3988/jcn.2016.12.3.361 Received  January 6, 2016 Revised  March 20, 2016 Accepted  March 22, 2016 Correspondence Jung-Joon Sung, MD Department of Neurology,  Seoul National University Hospital, Seoul National University  College of Medicine,  101 Daehak-ro, Jongno-gu,  Seoul 03080, KoreaTel    +82-2-2072-2820 Fax   +82-2-3672-7553 E-mail    jjsaint@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/96/31/jcn-12-361.PMC4960222.pdf
"Statistical methods The reference ranges were analyzed statistically using the R program (version 2.15.1, http://cran.r-project.org).",OADS,/arxiv_data1/oa_pdf/96/31/jcn-12-361.PMC4960222.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.12.3.361.,Non-OADS,/arxiv_data1/oa_pdf/96/31/jcn-12-361.PMC4960222.pdf
"Moisés León Ruiza  Miguel Ángel García-Soldevillaa  Julián Benito-Leónb  María Belén Vidal Díaza  José Tejeiro-Martíneza  Esteban García-Albea Ristola a Department of Neurology,   Hospital Universitario Príncipe de  Asturias, Alcalá de Henares, Madrid, Spain b Department of Neurology,   Hospital Universitario 12 de Octubre, Madrid, SpainpISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):368-370   /   http://dx.doi.org/10.3988/jcn.2016.12.3.368  Received  September 25, 2015 Revised  November 8, 2015 Accepted  November 10, 2015 Correspondence Moisés León Ruiz, MD Department of Neurology,  Hospital Universitario Príncipe de Asturias, Carretera Alcalá-Meco s/n, ES-28805 Alcalá de Henares, Madrid, Spain Tel    +34 918 878100 Fax   +34 918 836863 E-mail    pistolpete271285@hotmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/jcn-12-368.PMC4960223.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.12.3.368.,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/jcn-12-368.PMC4960223.pdf
"Avail - able at: http://www.uptodate.com/contents/migraine-with-brain - stem-aura-basilar-type-migraine (updated Feb 10, 2015; accessed Oct  10, 2015).",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/jcn-12-368.PMC4960223.pdf
"Although the exact mechanism of PM remains unclear, the fusiform face area and occipital Ryul Kima  Jin-Sun Juna  Shin-Hye Baekb  Chang-Ho Yunb  Seong-Ho Parkb a Department of Neurology,   Seoul National University   College of Medicine,   Seoul National University Hospital,   Seoul, Korea b Department of Neurology,   Seoul National University   College of Medicine,   Seoul National University   Bundang Hospital, Seongnam, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):371-372   /   http://dx.doi.org/10.3988/jcn.2016.12.3.371  Received  October 7, 2015 Revised  December 2, 2015 Accepted  December 3, 2015 Correspondence Seong-Ho Park, MD, PhD Department of Neurology,  Seoul National University  College of Medicine,  Seoul National University  Bundang Hospital, 82 Gumi-ro  173beon-gil, Bundang-gu,  Seongnam 13620, Korea Tel    +82-31-787-7461 Fax   +82-31-719-6828  E-mail    nrpsh@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/52/a6/jcn-12-371.PMC4960224.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.12.3.371.Conflicts of Interest The authors have no financial conflicts of interest.,Non-OADS,/arxiv_data1/oa_pdf/52/a6/jcn-12-371.PMC4960224.pdf
"Electron microscopy re -Hyung Jun Parka  Yoonkyung Changa  Jee Eun Leea  Heasoo Koob  Jeeyoung Ohc  Young-Chul Choid  Kee Duk Parka a Departments of Neurology and b Pathology, Mokdong Hospital,   Ewha Womans University   School of Medicine, Seoul, Korea c Department of Neurology,   Konkuk University School of Medicine,  Seoul, Korea d Department of Neurology,   Yonsei University College of Medicine, Seoul, KoreapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):373-375   /   http://dx.doi.org/10.3988/jcn.2016.12.3.373  Received  December 22, 2015 Revised  December 29, 2015 Accepted  December 30, 2015 Correspondence Kee Duk Park, MD, PhD Department of Neurology,  Ewha Womans University  College of Medicine,  1071 Anyangcheon-ro, Y angcheon-gu, Seoul 07985, Korea Tel       +82-2-2650-6010 Fax   +82-2-2650-2652 E-mail    pkd1165@ewha.ac.krcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/1c/07/jcn-12-373.PMC4960225.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.3988/jcn.2016.13.3.373.,Non-OADS,/arxiv_data1/oa_pdf/1c/07/jcn-12-373.PMC4960225.pdf
"Develop - mental delay is the most common neurologic finding of IV A. Epileptic seizures have rarely Taner Sezera  Oya Balcib a Department of Pediatric Neurology,  Baskent University Faculty of Medicine,  Ankara, Turkey b Department of Pediatric Gastroenterology  and Nutrition, Kecioren Research and Training Hospital, Ankara, TurkeypISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):376-377   /   http://dx.doi.org/10.3988/jcn.2016.12.3.376  Received  December 2, 2015 Revised  January 19, 2016 Accepted  January 22, 2016 Correspondence Taner Sezer, MD Department of Pediatric Neurology, Baskent University Faculty of Medicine, Ankara 06490, Turkey Tel       +90 (312) 212 68 68  Fax   +90 (312) 215 75 97 E-mail    mdtanersezer@yahoo.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/61/c4/jcn-12-376.PMC4960226.pdf
"5Aastha Takkar  Manish Modi   Vivek Lal Department of Neurology, PGIMER,  Chandigarh, IndiapISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2016 ;12(3):378-379   /   http://dx.doi.org/10.3988/jcn.2016.12.3.378  Received  January 21, 2016 Revised  January 25, 2016 Accepted  January 27, 2016 Correspondence Manish Modi, MD Department of Neurology,  PGIMER, Chandigarh 160012, India Tel       +91-172-2756691 Fax   +91-172-2744401 E-mail    modim72@yahoo.comcc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, provided the original work is properly cited.JCN  Open Access LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/76/07/jcn-12-378.PMC4960227.pdf
Tracking cuckoos to Africa y. and back again http://www.bto.org/cuckoos (2016).,Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
Available http://www.cms.int/en/document/action-plan-migratory-landbirds-african-eurasian- region-aemlap.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
Available http://www.argos-system.org/ﬁles/ pmedia/public/r363_9_argos_users_manual-v1.6.6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
2 are licensed under the Open Database License (http://www.openstreetmap.org/copyright).,Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hewson, C. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12296 8 NATURE COMMUNICATIONS | 7:12296 | DOI: 10.1038/ncomms12296 | www.nature.com/naturecommunications",Non-OADS,/arxiv_data1/oa_pdf/d4/34/ncomms12296.PMC4960304.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.04.023 2049-0801/ ©2016 Dascena.,Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
"[6] World Health Organization, Management of Substance Abuse: Alcohol [on- line]., 2016 http://www.who.int/substance_abuse/facts/alcohol/en/ (accessed 25.04.16) [7]M. De Wit, A.M. Best, C. Gennings, E.L. Burnham, M. Moss, Alcohol use dis- orders increase the risk for mechanical ventilation in medical patients, Alcohol.",Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 27025567 .,Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
[35] https://github.com/MIT-LCP/mimic-code .,Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
Archived at: http://www.webcita tion.org/6ffJC48Mj .,Non-OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
"(2016), http://dx.doi.org/10.1016/ j.compbiomed.2016.05.003 .J.",OADS,/arxiv_data1/oa_pdf/76/44/main.PMC4960347.pdf
" Case Rep Oncol 2016;9:379 –386  DOI: 10.1159/000445677   Published online: July 9, 20 16  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services /OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/bb/c5/cro-0009-0379.PMC4960360.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Received: December 19, 2015   Accepted after revision: May 24, 2016   Published online: July 6, 2016 EXTRA  Shinichiro Sugiyama, MD, PhD   Department of Neuroanesthesia, Kohnan Hospital   4-20-1, Nagamachi-minami, Taihaku-ku   Sendai 982-8523 (Japan)   E-Mail sugiyama   @   nsg.med.tohoku.ac.jp www.karger.com/cee DOI: 10.1159/000447330  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/18/bc/cee-0006-0032.PMC4960366.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1053-1053 http://dx.doi.org/10.3349/ymj.2016.57.5.1053 Modern medical principles must be supported by strong evi - dence from high quality studies.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/ymj-57-1053.PMC4960368.pdf
"Key Words:   Intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, prostatic ductal adenocarcinomaYonsei Med J 2016 Sep;57(5):1054-1062 http://dx.doi.org/10.3349/ymj.2016.57.5.1054Review Article pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 26, 2016    Corresponding author:  Dr. Jae Y. Ro, Department of Pathology and Genomic  Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University,  6565 Fannin Street, Houston, TX 77030, USA.",Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
1055 http://dx.doi.org/10.3349/ymj.2016.57.5.1054Mukul K. Divatia and Jae Y. Ro oncologists.,OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1054 1056Intraductal Carcinoma of Prostate 53%, respectively.23 TMPRSS2:ERG gene fusion, which is the  most common recurrent chromosomal alteration seen in pros - tatic adenocarcinoma and identified in approximately 50% of  cases, is present in greater than two-thirds of cases of IDC-P  and absent in HGPIN.22,24,25 This finding has been confirmed by  using both break-apart probes in a fluorescent in situ  hybrid - ization (FISH) assay as well as by employing IHC for ERG pro - tein, which shows ERG positivity in a significantly large  number of cases of IDC-P (30 –58%) in comparison to HGPIN  (0–18%).22,26,27 The recognition of IDC-P in a specimen is understood to rep - resent a late-stage occurrence in cases with high-grade, high- stage prostate adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
1057 http://dx.doi.org/10.3349/ymj.2016.57.5.1054Mukul K. Divatia and Jae Y. Ro that of adjacent benign nuclei (Fig.,OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1054 1058Intraductal Carcinoma of Prostate Prostatic ductal adenocarcinoma Prostatic ductal adenocarcinoma is an aggressive form of ade - nocarcinoma of the prostate, representing less than 1% of pros - tatic adenocarcinoma cases, and is usually seen in association  with high-grade prostatic acinar adenocarcinoma.4,33,34 It may  arise from both large-sized periurethral or peripheral prostatic  ducts, and is associated with hematuria and/or obstructive uri - nary symptoms.33-35 This malignancy also presents as an exo - phytic, papillary mass protruding into the urethral lumen in con - tinuity with periurethral ducts.",Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
1059 http://dx.doi.org/10.3349/ymj.2016.57.5.1054Mukul K. Divatia and Jae Y. Ro when the cribriforming architecture is prominent and the ma - lignant glands have relatively round contours.,Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1054 1060Intraductal Carcinoma of Prostate seminal vesicle invasion apart from lower biochemical-free sur - vival subsequent to radical prostatectomy.33,41-44 Prostatic intraepithelial neoplasia-like (PIN-like) adenocarci - noma of prostate, which is a variant of prostatic ductal adeno - carcinoma, is also included in the differential diagnosis of IDC- P and prostatic ductal adenocarcinoma as it demonstrates a  pattern of medium to large sized dilated glands lined by pseu - dostratified, columnar epithelial cells.45 This tumor does not be - have as aggressively as the aforementioned classic type of pros - tatic ductal adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
1061 http://dx.doi.org/10.3349/ymj.2016.57.5.1054Mukul K. Divatia and Jae Y. Ro REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1054 1062Intraductal Carcinoma of Prostate cinomas of the prostate.,Non-OADS,/arxiv_data1/oa_pdf/30/75/ymj-57-1054.PMC4960369.pdf
"Key Words:  Lung neoplasm, dyspnea, prognosisYonsei Med J 2016 Sep;57(5):1063-1069 http://dx.doi.org/10.3349/ymj.2016.57.5.1063Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 14, 2015   Revised:  February 15, 2016 Accepted:  March 10, 2016    Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1063 1064Prognostic Value of Dyspnea in Lung Cancer agement of lung cancer, most patients with advanced lung can - cer usually suffer from dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"1065 http://dx.doi.org/10.3349/ymj.2016.57.5.1063Wooho Ban, et al.",OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1063 1066Prognostic Value of Dyspnea in Lung Cancer substantial amount of missing data on mMRC.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"1067 http://dx.doi.org/10.3349/ymj.2016.57.5.1063Wooho Ban, et al.",OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1063 1068Prognostic Value of Dyspnea in Lung Cancer results showed that the prevalence and severity of COPD in  patients with NSCLC is higher than that in the general popu - lation.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"1069 http://dx.doi.org/10.3349/ymj.2016.57.5.1063Wooho Ban, et al.",OADS,/arxiv_data1/oa_pdf/4e/af/ymj-57-1063.PMC4960370.pdf
"Key Words:   Prostatic neoplasms, castration-resistant; neoplasm metastasis; disease-free survival; docetaxel; drug therapy, com- bination; gonadotropin-releasing hormoneYonsei Med J 2016 Sep;57(5):1070-1078 http://dx.doi.org/10.3349/ymj.2016.57.5.1070Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: December 3, 2015   Revised: January 19, 2016 Accepted: February 17, 2016Corresponding author: Dr. Byung Ha Chung, Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gang-nam-gu, Seoul 06273, Korea.Tel: 82-2-2019-3470, Fax: 82-2-3462-8887, E-mail: chung646@yuhs.ac •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"1071 http://dx.doi.org/10.3349/ymj.2016.57.5.1070Ho Seong Jang, et al.",OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1070 1072Concurrent ADT during Docetaxel Chemotherapy Statistical analysis The descriptive values of the variables are expressed as medi- an and interquartile range (IQR) according to the results of normality testing.,OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"1073 http://dx.doi.org/10.3349/ymj.2016.57.5.1070Ho Seong Jang, et al.",OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1070 1074Concurrent ADT during Docetaxel Chemotherapy cant predictor in multivariable analysis (Table 5).,OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"1075 http://dx.doi.org/10.3349/ymj.2016.57.5.1070Ho Seong Jang, et al.",OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1070 1076Concurrent ADT during Docetaxel Chemotherapy propriate for evaluating the superiority of a treatment in small- scale retrospective studies.,Non-OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"1077 http://dx.doi.org/10.3349/ymj.2016.57.5.1070Ho Seong Jang, et al.",OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1070 1078Concurrent ADT during Docetaxel Chemotherapy al.,Non-OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
Available  at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.,OADS,/arxiv_data1/oa_pdf/d7/7d/ymj-57-1070.PMC4960371.pdf
"Key Words:   Multidetector computed tomography, coronary artery disease, myocardial revascularizationYonsei Med J 2016 Sep;57(5):1079-1086 http://dx.doi.org/10.3349/ymj.2016.57.5.1079Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 26, 2015   Revised:  December 21, 2015   Accepted:  December 22, 2015 Corresponding author:  Dr. Myeong-Ki Hong, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae - mun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1079 1080CCTA and Revascularization INTRODUCTION Coronary computed tomographic angiography (CCTA) is con - sidered as an appropriate non-invasive test for the detection  and exclusion of coronary artery disease.1-4 Thus, CCTA has an  increasing role in the decision-making process evaluating the  necessity of invasive conventional coronary angiography, par - ticularly in patients with a low to intermediate risk of coronary  artery disease.5-7 However, considering that the primary role of  any diagnostic test is to inform the decision making process for  the best therapeutic strategy, understanding the clinical useful - ness of CCTA for further therapeutic strategies, such as the need  for coronary revascularization in the symptomatic patients, is  important.",Non-OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"1081 http://dx.doi.org/10.3349/ymj.2016.57.5.1079Sung-Jin Hong, et al.",OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1079 1082CCTA and Revascularization ameter of stenosis on coronary angiogram without actual revas - cularization in the cardiac catheterization laboratory in 19 pa - tients (7%).,OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"1083 http://dx.doi.org/10.3349/ymj.2016.57.5.1079Sung-Jin Hong, et al.",OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1079 1084CCTA and Revascularization disease.1,2,13 Meta-analysis has also demonstrated a false posi - tive rate of up to 35% for detection of significant coronary artery  disease even in a low- to intermediate-risk population.14 These  limitations of using CCTA as a diagnostic tool, as well as the  current finding of it’s being insufficient to predict the therapeu - tic decision, may be attributed to several factors.",Non-OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"1085 http://dx.doi.org/10.3349/ymj.2016.57.5.1079Sung-Jin Hong, et al.",OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1079 1086CCTA and Revascularization PL, Meyer M, et al.",OADS,/arxiv_data1/oa_pdf/92/a0/ymj-57-1079.PMC4960372.pdf
"Key Words:   Coronary artery disease, coronary vessels, ultrasonography, cholesterol, anticholesteremic agentsYonsei Med J 2016 Sep;57(5):1087-1094 http://dx.doi.org/10.3349/ymj.2016.57.5.1087Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 11, 2015   Revised:  February 23, 2016 Accepted:  March 11, 2016 Corresponding author:  Dr. Myeong-Ki Hong, Division of Cardiology, Severance  Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1087 1088Lipid-Lowering vs. Plaque demonstrated the benefits of statin treatments, which were sig - nificantly associated with regression or no progression of coro - nary plaque.11-13 Statin treatments have been recommended for the stabili - zation of vulnerable plaque and improvements of long-term  clinical outcomes in patients with acute coronary syndrome  (ACS).14,15 Several studies have reported the long-term effects of  statin treatments on coronary plaque composition.16-18 How - ever, studies evaluating the early effects of lipid-lowering treat - ment on coronary plaque composition are limited.19 In the pres - ent study, using virtual histology (VH)-IVUS, we evaluated and  compared short-term (three months) quantitative and qualita - tive changes in plaque components in ACS patients who received  either intensive lipid-lowering or low-dose statin treatment.",Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"1089 http://dx.doi.org/10.3349/ymj.2016.57.5.1087Jung-Hee Lee, et al.",OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1087 1090Lipid-Lowering vs. Plaque Table 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"1091 http://dx.doi.org/10.3349/ymj.2016.57.5.1087Jung-Hee Lee, et al.",OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1087 1092Lipid-Lowering vs. Plaque 12-month treatment with fluvastatin (60 mg/day, n=40) result - ed in a significant regression of plaque volume and significant  reduction of fibro-fatty volume compared with a control group  (n=40).16 The results from a randomized study that evaluated  six-months of statin treatment showed that there were higher  percentages of plaque volume regression and lower percentag - es of necrotic core expansion in higher-dose atorvastatin (40  mg)-treated (n=20) than in lower-dose atorvastatin (10 mg)- treated patients (n=20),17 and a randomized study involving only  two to three weeks of statin treatment showed significant  plaque regression and reduction of fibro-fatty components in  pitavastatin (2 mg)-treated (n=80), but not in atorvastatin (10  mg)-treated patients (n=80).19 In the present study, three-month intensive lipid-lowering treatment resulted in a significant reduction in fibro-fatty plaque  volume, which is in accordance with previous studies.16,18,19  Plaque regression was not significantly different between the  control statin and intensive lipid-lowering treatment groups  (0.3±17.0 mm3 vs. -3.7±9.0 mm3, respectively; p=0.231).",Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"1093 http://dx.doi.org/10.3349/ymj.2016.57.5.1087Jung-Hee Lee, et al.",OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1087 1094Lipid-Lowering vs. Plaque metric virtual histology intravascular ultrasound analysis.,Non-OADS,/arxiv_data1/oa_pdf/3a/f5/ymj-57-1087.PMC4960373.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1095-1105 http://dx.doi.org/10.3349/ymj.2016.57.5.1095",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"1096Advanced Atherosclerotic Rabbit Model http://dx.doi.org/10.3349/ymj.2016.57.5.1095dothelium with thick fibroatheroma.2,4 The formation of vulner - able plaques and the development of sudden thrombus have  been observed in postmortem humans with cardiovascular  disease.3  Due to the lack of adequate animal models, pre-thrombotic  pathophysiology and plaque vulnerability have been difficult  to investigate in vivo .",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1095dovascular intramural injection using a CricketTM Micro-Infu - sion catheter was performed.,Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"1098Advanced Atherosclerotic Rabbit Model http://dx.doi.org/10.3349/ymj.2016.57.5.1095room temperature for 1 hour, and were subsequently washed  three times in TBS-T. Membranes were incubated in TBS-T  with primary antibodies against HMGB1, TNF- α, and RAGE  (all 1:1000 in 5% BSA, Biosesang, Seongnam, Korea) overnight  at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1095flammatory proteins group, compared with the saline group.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"1100Advanced Atherosclerotic Rabbit Model http://dx.doi.org/10.3349/ymj.2016.57.5.1095was significantly higher in the HMGB1 group, compared to  the saline group, and tended to be higher in the TNF- α group  than the saline group ( p=0.054).",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1095OCT evaluation comparing histology Figs.,OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"1102Advanced Atherosclerotic Rabbit Model http://dx.doi.org/10.3349/ymj.2016.57.5.1095more, this model has a risk of lipid toxicity resulting from a  prolonged exposure to a high cholesterol diet.6 In addition, bal - loon injury followed by a high cholesterol diet usually results  in the induction of early stage atherosclerotic plaques rather  than advanced plaques.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1095that activates immune competent cells, which in turn augment  the inflammatory responses through the discharge of pro-in - flammatory cytokines.17 Studies have shown that HMGB1 is  highly expressed in the human carotid endarterectomy speci - mens.18 In this study, injection of HMGB1 into the vessel wall  was associated with increased expression of RAGE and with  increased recruitment of macrophages to the lesion.",Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
1104Advanced Atherosclerotic Rabbit Model http://dx.doi.org/10.3349/ymj.2016.57.5.1095for evaluations of device or screening therapeutic substances  for treatment cardiovascular disease in the atherosclerosis re - search field.,Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1095ological mechanisms to translational medicine.,Non-OADS,/arxiv_data1/oa_pdf/ae/0d/ymj-57-1095.PMC4960374.pdf
"Key Words:   Colorectal neoplasm, gastrointestinal endoscopy, colonoscopyYonsei Med J 2016 Sep;57(5):1106-1114 http://dx.doi.org/10.3349/ymj.2016.57.5.1106Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 14, 2015   Revised:  December 20, 2015 Accepted:  December 22, 2015 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"1107 http://dx.doi.org/10.3349/ymj.2016.57.5.1106Bun Kim, et al.",OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1106 1108Endoscopic Treatment Outcome for Large Polyps of tumor (en bloc resection is essential), incomplete resection  when the tumor extended into the lateral or basal margins, or  not evaluable when the margins were not evaluable as a result  of the artificial effects of coagulation necrosis or multipiece re - section.21 We defined negative margin involvement as instances  where both lateral mucosal margins of a specimen were free of  neoplastic cells.",Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"1109 http://dx.doi.org/10.3349/ymj.2016.57.5.1106Bun Kim, et al.",OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1106 1110Endoscopic Treatment Outcome for Large Polyps Table 2.,Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"1111 http://dx.doi.org/10.3349/ymj.2016.57.5.1106Bun Kim, et al.",OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1106 1112Endoscopic Treatment Outcome for Large Polyps clipping if it is detected during the procedure.,Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"1113 http://dx.doi.org/10.3349/ymj.2016.57.5.1106Bun Kim, et al.",OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1106 1114Endoscopic Treatment Outcome for Large Polyps submucosal dissection vs endoscopic mucosal resection for colorec - tal tumors: a meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/42/ba/ymj-57-1106.PMC4960375.pdf
"Key Words:  Neutrophils, lymphocytes, prognosis, hepatocellular carcinoma, hepatectomyYonsei Med J 2016 Sep;57(5):1115-1123 http://dx.doi.org/10.3349/ymj.2016.57.5.1115Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: July 31, 2015   Revised: November 30, 2015 Accepted: December 24, 2015Corresponding author: Dr. Hee-Jung Wang, Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Ajou University School of Medicine, 164 World cup-ro, Yeongtong-gu, Suwon 16499, Korea.Tel: 82-31-219-5204, Fax: 82-31-219-5755, E-mail: wanghj@ajou.ac.kr •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1115 1116NLR Predicts HCC Recurrence after Hepatectomy rameter for monitoring and evaluation of systemic inflamma- tory response.5 And NLR is easily and repeatedly obtained from  peripheral blood.,Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"1117 http://dx.doi.org/10.3349/ymj.2016.57.5.1115Xu-Guang Hu, et al.",OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1115 1118NLR Predicts HCC Recurrence after Hepatectomy metastasis, microvascular invasion, high grade of cirrhosis  (grade 4) and serum HBsAg-positive.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"1119 http://dx.doi.org/10.3349/ymj.2016.57.5.1115Xu-Guang Hu, et al.",OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1115 1120NLR Predicts HCC Recurrence after Hepatectomy Prognostic factors of early recurrence in HCC patients  within Milan criteria The elevated NLR (1.945), combined with multiple tumor num - ber, mircovascular invasion, portal vein invasion and intrahe- patic metastasis were considered as risk factors for early re-currence, when determined by univariate regression analysis.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"1121 http://dx.doi.org/10.3349/ymj.2016.57.5.1115Xu-Guang Hu, et al.",OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1115 1122NLR Predicts HCC Recurrence after Hepatectomy reflect in peripheral blood of TAMS through the cytokines such  as IL-6, IL-8, and IL-17.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"1123 http://dx.doi.org/10.3349/ymj.2016.57.5.1115Xu-Guang Hu, et al.",OADS,/arxiv_data1/oa_pdf/b3/37/ymj-57-1115.PMC4960376.pdf
"Key Words:  Hydroxymethylglutaryl-CoA reductase inhibitors, pancreatic neoplasms, erlotinib, gemcitabineYonsei Med J 2016 Sep;57(5):1124-1130 http://dx.doi.org/10.3349/ymj.2016.57.5.1124Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: September 7, 2015   Revised: December 21, 2015 Accepted: January 5, 2016Corresponding author: Dr. Seungmin Bang, Division of Gastroenterology, Depart-ment of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.Tel: 82-2-2228-1995, Fax: 82-2-393-6884, E-mail: bang7028@yuhs.ac *Do Chang Moon and Hee Seung Lee contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
"1125 http://dx.doi.org/10.3349/ymj.2016.57.5.1124Do Chang Moon, et al.",OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1124 1126Statin in Advanced Pancreatic Cancer equivalent to 30 mg of simvastatin.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
"1127 http://dx.doi.org/10.3349/ymj.2016.57.5.1124Do Chang Moon, et al.",OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1124 1128Statin in Advanced Pancreatic Cancer Statistical analysis to determine “long-term response”  factors We used univariate and multivariate analyses to determine fac - tors associated with “long-term response.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
"1129 http://dx.doi.org/10.3349/ymj.2016.57.5.1124Do Chang Moon, et al.",OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1124 1130Statin in Advanced Pancreatic Cancer 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/ymj-57-1124.PMC4960377.pdf
"Key Words:  Adenocarcinoma of lung, neoplasm invasiveness, volumetric computed tomography, receiver operating characteristic Yonsei Med J 2016 Sep;57(5):1131-1138 http://dx.doi.org/10.3349/ymj.2016.57.5.1131Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 26, 2015   Revised:  February 24, 2016 Accepted:  February 25, 2016    Corresponding author:  Dr. Chang Young Lee, Department of Thoracic and Car - diovascular Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seo - daemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1131 1132Radiologic Parameters Predict Tumor Invasiveness  to be established to help guide the application of alternative  treatments, such as limited resection, stereotactic radiation th- erapy, ablative therapy, or even watchful waiting, instead of  standard lobectomy in cases of indolent cancer, thereby de - creasing healthcare costs and the risks associated with aggres - sive treatment, such as increased mortality and morbidity, par - ticularly in elderly and high-risk populations.4 In the new International Association for the Study of Lung  Cancer (IASLC)/American Thoracic Society (ATS)/European  Respiratory Society (ERS) classification, the term BAC is no lon - ger used.",Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"1133 http://dx.doi.org/10.3349/ymj.2016.57.5.1131Woo Sik Yu, et al.",OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1131 1134Radiologic Parameters Predict Tumor Invasiveness  non-small cell lung cancer underwent complete resection at  our institute and were confirmed to have pathologic stage IA  cancer.,Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"1135 http://dx.doi.org/10.3349/ymj.2016.57.5.1131Woo Sik Yu, et al.",OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1131 1136Radiologic Parameters Predict Tumor Invasiveness  Fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"1137 http://dx.doi.org/10.3349/ymj.2016.57.5.1131Woo Sik Yu, et al.",OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1131 1138Radiologic Parameters Predict Tumor Invasiveness  ACKNOWLEDGEMENTS This study was supported by a faculty research grant of Yonsei  University College of Medicine for (6-2013-0111).,Non-OADS,/arxiv_data1/oa_pdf/4a/9b/ymj-57-1131.PMC4960378.pdf
"Key Words:  Procalcitonin, acute gouty arthritis, infectionYonsei Med J 2016 Sep;57(5):1139-1144 http://dx.doi.org/10.3349/ymj.2016.57.5.1139Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: October 21, 2015   Revised: January 7, 2016 Accepted: January 28, 2016Corresponding author: Dr.",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1139 1140Procalcitonin in Acute Gouty Attack several studies have reported the role of PCT in differential di- agnosis between bacterial infection and disease flares in auto-immune diseases.,Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
"1141 http://dx.doi.org/10.3349/ymj.2016.57.5.1139Sang Tae Choi and Jung-Soo Song ability of PCT, uric acid, and CRP to distinguish between acute  gouty attack and bacterial infection was evaluated using a re-ceiver-operating characteristic (ROC) analysis.",OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1139 1142Procalcitonin in Acute Gouty Attack value of serum uric acid was 5.75 mg/dL, with a sensitivity of  70.2% and specificity of 85.1%.",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
"1143 http://dx.doi.org/10.3349/ymj.2016.57.5.1139Sang Tae Choi and Jung-Soo Song rent gouty attack.20 In fact, 13 out of the 61 acute gouty patients  (21.3%) in this study had serum uric acid levels <6.0 mg/dL.",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1139 1144Procalcitonin in Acute Gouty Attack 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/cb/ymj-57-1139.PMC4960379.pdf
"Key Words:   Continence, intravesical prostatic protrusion, robot assisted radical prostatectomy, transrectal ultrasonographyYonsei Med J 2016 Sep;57(5):1145-1151 http://dx.doi.org/10.3349/ymj.2016.57.5.1145Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 27, 2015   Revised:  December 29, 2015 Accepted:  January 4, 2016 Corresponding author:  Prof.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1145 1146The Impact of IPP on Continence after RALP identified as a measurable predictor of bladder outlet obstruc - tion in patients with benign prostatic hyperplasia9,10 and it can  be regarded as a more objective and accurate way of assessing a  median prostatic lobe.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"1147 http://dx.doi.org/10.3349/ymj.2016.57.5.1145Jung Ki Jo, et al.",OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1145 1148The Impact of IPP on Continence after RALP early recovery of urinary continence after RALP .,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"1149 http://dx.doi.org/10.3349/ymj.2016.57.5.1145Jung Ki Jo, et al.",OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1145 1150The Impact of IPP on Continence after RALP cult cases were patients who underwent holmium laser enucle- ation of the prostate.,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"1151 http://dx.doi.org/10.3349/ymj.2016.57.5.1145Jung Ki Jo, et al.",OADS,/arxiv_data1/oa_pdf/6f/ee/ymj-57-1145.PMC4960380.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1152-1158 http://dx.doi.org/10.3349/ymj.2016.57.5.1152",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1152also been conducted.3-5 Recent studies have shown that adi - pose-derived stem cells (ASCs) can differentiate into various  type of cells, such as myoblasts, fibroblasts, endothelial cells,  smooth muscle cells, or neurogenic cells.6 With regard to treat - ment of SUI, ASCs are of special concern for promoting revas - cularization and neuronal and mesodermal regeneration.",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
"1154Regenerative Cell Therapy for Incontinence http://dx.doi.org/10.3349/ymj.2016.57.5.1152cell-processing device extracts and concentrates the mono - nuclear fraction of adipose tissue automatically and aseptical - ly, and removes matrix fragments and unwarranted or delete - rious cells.",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1152tween the lower rim of the pubic bone and bladder neck.,Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
1156Regenerative Cell Therapy for Incontinence http://dx.doi.org/10.3349/ymj.2016.57.5.1152ment.,Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1152and requires no cell culture; furthermore, it is carried out in a  single surgical procedure.11 Before this study, most informa - tion was from several animal studies using rats to confirm the  effect of periurethral injection of ASCs on urethral resistance  and sequential changes.21 In our study, two patients initially experienced greater uri - nary incontinence after periurethral injection.",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
1158Regenerative Cell Therapy for Incontinence http://dx.doi.org/10.3349/ymj.2016.57.5.115220.,Non-OADS,/arxiv_data1/oa_pdf/e2/57/ymj-57-1152.PMC4960381.pdf
"Key Words:   Vitamin D deficiency, anemia, end-stage renal diseaseYonsei Med J 2016 Sep;57(5):1159-1164 http://dx.doi.org/10.3349/ymj.2016.57.5.1159Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 5, 2015   Revised:  January 6, 2016 Accepted:  January 7, 2016 Corresponding author:  Shin-Wook Kang, MD, PhD, Department of Internal Med - icine, College of Medicine, Severance Biomedical Science Institute, Brain Korea  21 PLUS, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1159 1160Vitamin D Deficiency and Anemia in ESRD Patients plored in patients with end-stage renal disease (ESRD).,Non-OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
"1161 http://dx.doi.org/10.3349/ymj.2016.57.5.1159Yung Ly Kim, et al.",OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1159 1162Vitamin D Deficiency and Anemia in ESRD Patients tween Hb concentration and serum 25(OH)D3 level ( β=0.263;  p<0.001), age ( β=0.122; p=0.010), and ESA dose ( β=-0.069;  p=0.005) remained significant on multivariate linear regression  analysis (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
"1163 http://dx.doi.org/10.3349/ymj.2016.57.5.1159Yung Ly Kim, et al.",OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1159 1164Vitamin D Deficiency and Anemia in ESRD Patients 16.,Non-OADS,/arxiv_data1/oa_pdf/72/ce/ymj-57-1159.PMC4960382.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1165-1177 http://dx.doi.org/10.3349/ymj.2016.57.5.1165",Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
1166SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.1165annual growth rate for robotic surgery was 51.4% from 2005 to  2011.,OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1165tween the two procedures.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"1168SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.1165ever, RARP was associated with lower rates of bladder neck  contracture (five studies with 2846 participants; RR 0.26, 95%  CI 0.09–0.73; p=0.010), organ injury (ten studies with 6715  participants; RR 0.54, 95% CI 0.30–0.99; p=0.040), and pulmo - nary embolism (three studies with 3159 participants; RR 0.24,  95% CI 0.07–0.83; p=0.002), compared to RRP (Supplementary  Fig.",Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1165gression test, and showed only one example of publication bias  associated with reported transfusion rates (Supplementary  Table 4, only online).",Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
1170SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.1165 Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1165tional outcomes, and oncologic outcomes.",OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
1172SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.1165 Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1165and as the mean operative time of hernia repair.28 Our results are comparable with those of a propensity-score  matching study that adjusted for among-series differences in  preoperative Gleason scores, preoperative PSA levels, and  pathological stages.",Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"1174SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.1165potency, outcome measures, and follow-up periods.29 To opti - mize our evaluation of functional outcomes, we included only  outcome data obtained using objective measures or reliable  and valid measurement instruments.",Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1165follow-up are needed to determine clinical efficacy and safety  of RARP .,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
Available at: https://effectivehealthcare.ahrq.gov/repFiles/meth - odsguide/systematicreviewsreplacedenovo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
1176SR and MA of RARP Compared to RRP for Prostate Cancer http://dx.doi.org/10.3349/ymj.2016.57.5.116532.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1165operative data after open radical retropubic prostatectomy or ro - botic-assisted laparoscopic prostatectomy.,Non-OADS,/arxiv_data1/oa_pdf/43/1a/ymj-57-1165.PMC4960383.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1178-1184 http://dx.doi.org/10.3349/ymj.2016.57.5.1178",Non-OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1178tional ethics committee.,Non-OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
1180Rupture Risk of Bifurcation Intracranial Aneurysms http://dx.doi.org/10.3349/ymj.2016.57.5.1178another angle between the parent artery and DA B was defined  as angle B; the LA ratio (angle A/angle B) was then calculated  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1178data and categorical data, respectively.",OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
"1182Rupture Risk of Bifurcation Intracranial Aneurysms http://dx.doi.org/10.3349/ymj.2016.57.5.1178AUC, threshold value, and sensitivity and specificity values  were calculated for a range of thresholds (Table 5).",OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1178increased rupture risk after a long period of follow-up,12,23-25  which is consistent with our study.",Non-OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
1184Rupture Risk of Bifurcation Intracranial Aneurysms http://dx.doi.org/10.3349/ymj.2016.57.5.1178bral aneurysms evaluated at CT angiography: growth and rupture  incidence and correlation with epidemiologic risk factors.,Non-OADS,/arxiv_data1/oa_pdf/03/81/ymj-57-1178.PMC4960384.pdf
"Key Words:   Crohn disease, nutrition therapy, remission induction, maintenance, childYonsei Med J 2016 Sep;57(5):1185-1191 http://dx.doi.org/10.3349/ymj.2016.57.5.1185Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 31, 2015   Revised:  December 4, 2015 Accepted:  March 11, 2016 Corresponding author:  Dr. Kyung Mo Kim, Department of Pediatrics, Asan Medi - cal Center Children’s Hospital, University of Ulsan College of Medicine, 88 Olym - pic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.",Non-OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1185 1186Efficacy of Enteral Nutrition in Crohn’s Disease treatment for active CD.9,10 As a result, in 2014, the European  Crohn’s and Colitis Organization (ECCO) issued revised con- sensus guidelines that recommend exclusive enteral nutrition (EEN) as the first-line treatment for inducing remission in pa - tients with luminal CD.",Non-OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"1187 http://dx.doi.org/10.3349/ymj.2016.57.5.1185Hyun Jin Kim, et al.",OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1185 1188Efficacy of Enteral Nutrition in Crohn’s Disease adherent than children receiving continuous polymeric for - mula via a nasogastric tube.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"1189 http://dx.doi.org/10.3349/ymj.2016.57.5.1185Hyun Jin Kim, et al.",OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1185 1190Efficacy of Enteral Nutrition in Crohn’s Disease play critical roles in modulating and exacerbating intestinal  immune reaction.32 However, double blind randomized study  by Leiper, et al.33 showed no difference in the response of ac - tive CD to whole protein feeds that have a high content of long  chain triglyceride (30% vs. 5%).",Non-OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"1191 http://dx.doi.org/10.3349/ymj.2016.57.5.1185Hyun Jin Kim, et al.",OADS,/arxiv_data1/oa_pdf/65/f6/ymj-57-1185.PMC4960385.pdf
"Key Words:   Breast neoplasms; mastectomy, segmental; triple negative breast neoplasmsYonsei Med J 2016 Sep;57(5):1192-1198 http://dx.doi.org/10.3349/ymj.2016.57.5.1192Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 22, 2015   Revised:  January 18, 2016 Accepted:  January 21, 2016 Corresponding author:  Dr. Seung Il Kim, Department of Surgery, Yonsei Univer - sity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"1193 http://dx.doi.org/10.3349/ymj.2016.57.5.1192Sanghwa Kim, et al.",OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1192 1194Triple-Negative Breast Cancer Therapy groups: the TNBC group had more young patients than the  non-TNBC group.,Non-OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"1195 http://dx.doi.org/10.3349/ymj.2016.57.5.1192Sanghwa Kim, et al.",OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1192 1196Triple-Negative Breast Cancer Therapy ized by younger patients, larger and higher grade tumors, and  more instances of lymph node metastasis.15 Our results showed  that TNBC patients were younger, had larger tumors with a higher histologic grade than non-TNBC patients, and had clini - copathological features that were similar to TNBC patients in  prior studies, except in terms of lymph node metastasis.",Non-OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"1197 http://dx.doi.org/10.3349/ymj.2016.57.5.1192Sanghwa Kim, et al.",OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1192 1198Triple-Negative Breast Cancer Therapy cancers managed with breast-conserving therapy.,Non-OADS,/arxiv_data1/oa_pdf/2c/78/ymj-57-1192.PMC4960386.pdf
"Key Words:   Anterior cruciate ligament, double bundle, selective bundle, reconstructionYonsei Med J 2016 Sep;57(5):1199-1208 http://dx.doi.org/10.3349/ymj.2016.57.5.1199Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 27, 2015   Revised:  December 12, 2015 Accepted:  February 17, 2016 Corresponding author:  Dr. Young-Jin Seo, Department of Orthopedic Surgery,  Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong  18450, Korea.",Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1199 1200ACL Double Bundle vs.,Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"1201 http://dx.doi.org/10.3349/ymj.2016.57.5.1199Yon-Sik Yoo, et al.",OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1199 1202ACL Double Bundle vs.,Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"1203 http://dx.doi.org/10.3349/ymj.2016.57.5.1199Yon-Sik Yoo, et al.",OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1199 1204ACL Double Bundle vs.,Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"1205 http://dx.doi.org/10.3349/ymj.2016.57.5.1199Yon-Sik Yoo, et al.",OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1199 1206ACL Double Bundle vs.,Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"1207 http://dx.doi.org/10.3349/ymj.2016.57.5.1199Yon-Sik Yoo, et al.",OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1199 1208ACL Double Bundle vs.,Non-OADS,/arxiv_data1/oa_pdf/67/28/ymj-57-1199.PMC4960387.pdf
"Key Words:  Low molecular weight heparin, deep vein thrombosis, pulmonary embolism, hip fracture Yonsei Med J 2016 Sep;57(5):1209-1213 http://dx.doi.org/10.3349/ymj.2016.57.5.1209Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 5, 2015   Revised:  February 4, 2016 Accepted:  February 17, 2016    Corresponding author:  Dr. Yougun Won , Department of Orthopaedic Surgery,  Konyang University School of Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon  35365, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1209 1210The Efficacy of LMWH to Prevent DVT for Hip Fracture Surgery in Koreans ber 1, 2013, 308 patients were admitted to our hospital, be - cause of femur intertrochanteric or neck fractures.",Non-OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"1211 http://dx.doi.org/10.3349/ymj.2016.57.5.1209Kwang-Kyoun Kim, et al.",OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1209 1212The Efficacy of LMWH to Prevent DVT for Hip Fracture Surgery in Koreans tors of VTE, such as old age, sex, obesity, malignant tumor,  heart failure or a recent myocardial infarction, increases the  occurrence of VTE by two- to nine-fold.",Non-OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"1213 http://dx.doi.org/10.3349/ymj.2016.57.5.1209Kwang-Kyoun Kim, et al.",OADS,/arxiv_data1/oa_pdf/b9/c9/ymj-57-1209.PMC4960388.pdf
"Key Words:  Lumbar vertebrae, outcome assessment, surgical procedure, degenerative, spinal diseaseYonsei Med J 2016 Sep;57(5):1214-1221 http://dx.doi.org/10.3349/ymj.2016.57.5.1214Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: December 17, 2015   Revised: February 19, 2016 Accepted: March 11, 2016Corresponding author: Dr. Seong-Hwan Moon, Department of Orthopaedic Sur - gery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.Tel: 82-2-2228-2180, Fax: 82-2-363-1139, E-mail: shmoon@yuhs.ac •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"1215 http://dx.doi.org/10.3349/ymj.2016.57.5.1214Byung Ho Lee, et al.",OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1214 1216Outcome Predictor in Lumbar Spine Surgery health status=0, from postoperative 1 year measure to preoper - ative measure.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"1217 http://dx.doi.org/10.3349/ymj.2016.57.5.1214Byung Ho Lee, et al.",OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1214 1218Outcome Predictor in Lumbar Spine Surgery Subgroup analysis (Table 7) Among 68 patients with a formula score of ≤8, only 18 (27.3%)  patients showed improvement in the cEQ-5D at 1 year postop-eratively (p <0.05, CART analysis).",Non-OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"1219 http://dx.doi.org/10.3349/ymj.2016.57.5.1214Byung Ho Lee, et al.",OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1214 1220Outcome Predictor in Lumbar Spine Surgery In the general health status using the EQ-5D VAS scale, only  the worst preoperative M scores demonstrated significant cor - relation with the better surgical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"1221 http://dx.doi.org/10.3349/ymj.2016.57.5.1214Byung Ho Lee, et al.",OADS,/arxiv_data1/oa_pdf/09/bd/ymj-57-1214.PMC4960389.pdf
"Key Words:  Knowledge, human papillomavirus (HPV), cervical cancer, surgeryYonsei Med J 2016 Sep;57(5):1222-1229 http://dx.doi.org/10.3349/ymj.2016.57.5.1222Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 26, 2015   Revised:  January 27, 2016 Accepted:  February 17, 2016    Corresponding author:  Dr. Myong Cheol Lim , Center for Uterine Cancer and Gy - necologic Cancer Branch, Research Institute and Hospital, National Cancer Center,  323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"1223 http://dx.doi.org/10.3349/ymj.2016.57.5.1222So Yeun Jun, et al.",OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1222 1224Knowledge of HPV and Cervical Conization 2014 at five different educational hospitals: National Cancer  Center, Pusan National University Yangsan Hospital, Seoul  National University Hospital, Inje University Ilsan Paik Hospi - tal, and National Health Insurance Service Hospital, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"1225 http://dx.doi.org/10.3349/ymj.2016.57.5.1222So Yeun Jun, et al.",OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1222 1226Knowledge of HPV and Cervical Conization Fig.,Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"1227 http://dx.doi.org/10.3349/ymj.2016.57.5.1222So Yeun Jun, et al.",OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1222 1228Knowledge of HPV and Cervical Conization the proportion of Internet users is lower in older populations  than in the average population.23 Older patients with less ex - posure to the Internet might demonstrate both lower infor - mation literacy and lower level of knowledge.,Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
Available  at: http://jkma.kma.org/contents/intro/intro03.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"1229 http://dx.doi.org/10.3349/ymj.2016.57.5.1222So Yeun Jun, et al.",OADS,/arxiv_data1/oa_pdf/bb/29/ymj-57-1222.PMC4960390.pdf
"Key Words:  Thrombophilia, pregnancy outcome, LMWHYonsei Med J 2016 Sep;57(5):1230-1235 http://dx.doi.org/10.3349/ymj.2016.57.5.1230Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: September 24, 2015   Revised: December 21, 2015 Accepted: December 23, 2015Corresponding author: Dr. Vedran Stefanovic, Department of Obstetrics and Gy-necology, Helsinki University Central Hospital, Haartmaninkatu 2, Helsinki 00290, Finland.Tel: 358-40-7605581, Fax: 358-9-471-74906, E-mail: vedran.stefanovic@yahoo.com •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"1231 http://dx.doi.org/10.3349/ymj.2016.57.5.1230Nada Aracic, et al.",OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1230 1232Inherited Thrombophilia Types, Adverse Pregnancy Outcome (4%) women.",Non-OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"1233 http://dx.doi.org/10.3349/ymj.2016.57.5.1230Nada Aracic, et al.",OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1230 1234Inherited Thrombophilia Types, Adverse Pregnancy Outcome some novel data.",Non-OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"1235 http://dx.doi.org/10.3349/ymj.2016.57.5.1230Nada Aracic, et al.",OADS,/arxiv_data1/oa_pdf/e7/c1/ymj-57-1230.PMC4960391.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1236-1242 http://dx.doi.org/10.3349/ymj.2016.57.5.1236",Non-OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1236gery without CTR implantation.4 The authors suggested that  CTR implantation reduced secondary fibrosis, stabilized the  capsule diaphragm during irrigation and aspiration maneuvers,  and maintained the position of the IOL.4 The CTR (Ophtec, Groningen, the Netherlands) used in the  present study comprised a single-piece polymethyl methacry - late ring that has open rings with eyelets at each end.",Non-OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
This study is regis - tered at http://www.clinicaltrials.gov (identification no.,Non-OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
1238Effect of Co-Implantation of CTR and Monofocal IOL http://dx.doi.org/10.3349/ymj.2016.57.5.1236(target luminance value=3 cd/m2).,OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1236spherical equivalents (goal diopters) from the SRK/T formula  were -0.46±0.58 D for group 1 and -0.31±0.46 D for group 2  (p=0.337).,OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
"1240Effect of Co-Implantation of CTR and Monofocal IOL http://dx.doi.org/10.3349/ymj.2016.57.5.123630 cycles per degree ( p=0.034, 0.017, and 0.017, respectively).",OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1236lated at 1 month and 3 months after surgery, positive values  were observed at all time points and increased as time passed  in both groups.",OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
1242Effect of Co-Implantation of CTR and Monofocal IOL http://dx.doi.org/10.3349/ymj.2016.57.5.1236quality and clinical outcomes.,Non-OADS,/arxiv_data1/oa_pdf/eb/97/ymj-57-1236.PMC4960392.pdf
"Key Words:  Fine needle aspiration, lung cancer, positron-emission tomographyYonsei Med J 2016 Sep;57(5):1243-1251 http://dx.doi.org/10.3349/ymj.2016.57.5.1243Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: May 27, 2015   Revised: December 14, 2015 Accepted: December 22, 2015Corresponding author: Dr. Jin Hur, Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medi-cine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.Tel: 82-2-2228-7400, Fax: 82-2-393-3035, E-mail: khuhz@yuhs.ac *Young Joo Suh and Jae-hoon Lee contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1243 1244Predictor of False-Negative Results of FNAB tive results.6,8 However, those studies mostly included small  population sizes and only a few parameters that predict false- negative lesions.",Non-OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"1245 http://dx.doi.org/10.3349/ymj.2016.57.5.1243Young Joo Suh, et al.",OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1243 1246Predictor of False-Negative Results of FNAB A  B  C Fig.,OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"1247 http://dx.doi.org/10.3349/ymj.2016.57.5.1243Young Joo Suh, et al.",OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1243 1248Predictor of False-Negative Results of FNAB 0.988 (95% CI, 0.964 –1.0) for presence of necrosis, and 1.0 (95%  CI, 1.0) for presence of cavitation.",Non-OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"1249 http://dx.doi.org/10.3349/ymj.2016.57.5.1243Young Joo Suh, et al.",OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1243 1250Predictor of False-Negative Results of FNAB a small number of false-negative lesions (5 cases) showed an  upgrade in staging at the time of final diagnosis, the impact of delayed diagnosis on prognosis in cases with false-negative results on FNAB could not be determined.",Non-OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"1251 http://dx.doi.org/10.3349/ymj.2016.57.5.1243Young Joo Suh, et al.",OADS,/arxiv_data1/oa_pdf/51/16/ymj-57-1243.PMC4960393.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1252-1259 http://dx.doi.org/10.3349/ymj.2016.57.5.1252",Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1252NHE1 is an 815 amino acid glycoprotein that functions by  extruding intracellular protons in exchange for extracellular  sodium.,Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"1254NHE1 Promotes Diabetic Nephropathy Progression http://dx.doi.org/10.3349/ymj.2016.57.5.1252bridge, UK) for 8 h, and then a rabbit anti-mouse IgG-FITC was  added.",Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1252RESULTS High glucose induces apoptosis and oxidative stress in  HK-2 cells In order to observe the injury effects of HG on renal proximal  tubule cells, we first determined changes in apoptosis and ox - idative stress in HK-2 cells in response to HG stimulation.",OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"1256NHE1 Promotes Diabetic Nephropathy Progression http://dx.doi.org/10.3349/ymj.2016.57.5.1252Patients with DN manifest with disturbances in electrolytes and  in the acid-base balance, as well as circulating uremia toxins  caused by disorder of glucose metabolism or other medica - tions.9,10 NHE1 is a critical Na+/H+ exchanger and plays an im - portant role in maintaining the balance of pH i.",Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1252can be surmounted, cells proceed toward apoptosis when they  are exposed to overloaded or sustained apoptotic stimulus.18 As  reported by Li, et al.,5 advanced glycation end products (AGEs)  induce kidney dysfunction accompanied by a marked increase  in NHE1.",Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"1258NHE1 Promotes Diabetic Nephropathy Progression http://dx.doi.org/10.3349/ymj.2016.57.5.1252Collectively, our study demonstrated that HG induces high - er oxidative stress and cell apoptosis in renal tubular epithelia  cells.",Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1252Asian people.,Non-OADS,/arxiv_data1/oa_pdf/51/b6/ymj-57-1252.PMC4960394.pdf
"Key Words:   Sepsis, septic shock, shock, meta-analysisYonsei Med J 2016 Sep;57(5):1260-1270 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 7, 2015   Revised:  December 31, 2015 Accepted:  January 6, 2016 Corresponding author:  Dr. Sungwon Na, Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"1261 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Woo Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1260 1262Protocol-Based Resuscitation for Septic Shock Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"1263 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Woo Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1260 1264Protocol-Based Resuscitation for Septic Shock Statistical analysis Whether heterogeneity between study effects was significant or  not was evaluated by using the Q statistical value obtained via  chi-squared distribution analysis in order to identify appropri - ate studies.,OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"1265 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Woo Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1260 1266Protocol-Based Resuscitation for Septic Shock spectively.,Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"1267 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Woo Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1260 1268Protocol-Based Resuscitation for Septic Shock riods; period 1, before 2003; period 2, 2004 –2007; and period 3,  2008 –2015.",Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"1269 http://dx.doi.org/10.3349/ymj.2016.57.5.1260Woo Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1260 1270Protocol-Based Resuscitation for Septic Shock Additionally, as we aimed to investigate the effectiveness of  GDT, the treatment duration goal was heterogeneous.",Non-OADS,/arxiv_data1/oa_pdf/8e/59/ymj-57-1260.PMC4960395.pdf
"Key Words:   Mycoplasma hominis , Ureaplasma urealyticum , antimicrobial susceptibility breakpoint determinationYonsei Med J 2016 Sep;57(5):1271-1275 http://dx.doi.org/10.3349/ymj.2016.57.5.1271Brief Communication pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 11, 2015   Revised:  January 13, 2016 Accepted:  January 28, 2016 Corresponding author:  Dr. Myeong Hee Kim, Department of Laboratory Medi - cine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea.",Non-OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1271 1272Genital Mycoplasmas Infection in Pregnant Women tification and antimicrobial susceptibilities of U. urealyticum   and M. hominis  were determined using a commercially avail - able Mycoplasma IST-2 kit (bioMerieux, Marcy-l’Etoile, France),  according to the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"1273 http://dx.doi.org/10.3349/ymj.2016.57.5.1271Min Young Lee, et al.",OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1271 1274Genital Mycoplasmas Infection in Pregnant Women josamycin, or pristinamycin for two isolates of M. hominis ; how - ever, they were all resistant to azithromycin, clarithromycin,  and erythromycin.",Non-OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"1275 http://dx.doi.org/10.3349/ymj.2016.57.5.1271Min Young Lee, et al.",OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
http://dx.doi.ort/10.1016/ j.jmii.2014.06.007.,OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
Infect Dis Obstet Gynecol 2010;2010.  http://dx.doi.org/10.1155/2010/521921.,Non-OADS,/arxiv_data1/oa_pdf/50/2c/ymj-57-1271.PMC4960396.pdf
"Key Words:  Concurrent chemoradiation, hepatocellular carcinoma, living donor liver transplantation, thrombus, down-stagingYonsei Med J 2016 Sep;57(5):1276-1281 http://dx.doi.org/10.3349/ymj.2016.57.5.1276Brief Communication pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 16, 2015   Revised:  January 2, 2016 Accepted:  January 4, 2016    Co-corresponding authors:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"1277 http://dx.doi.org/10.3349/ymj.2016.57.5.1276Dai Hoon Han, et al.",OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1276 1278Liver Transplantation for Advanced HCC gically resected with no further progression of disease.,Non-OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"1279 http://dx.doi.org/10.3349/ymj.2016.57.5.1276Dai Hoon Han, et al.",OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1276 1280Liver Transplantation for Advanced HCC formed LDLTs as life-saving interventions in five patients, who  suffered from rapid hepatic functional deterioration after CCRT  and HAIC.",Non-OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"1281 http://dx.doi.org/10.3349/ymj.2016.57.5.1276Dai Hoon Han, et al.",OADS,/arxiv_data1/oa_pdf/79/90/ymj-57-1276.PMC4960397.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1282-1285 http://dx.doi.org/10.3349/ymj.2016.57.5.1282",Non-OADS,/arxiv_data1/oa_pdf/26/05/ymj-57-1282.PMC4960398.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1282ing photoaged skin.,Non-OADS,/arxiv_data1/oa_pdf/26/05/ymj-57-1282.PMC4960398.pdf
"1284Platelet-Rich-Fibrin Lysate for Skin Rejuvenation http://dx.doi.org/10.3349/ymj.2016.57.5.1282dence of cellular senescence, such as senescence-associated  galactosidase staining, was not collected in this experiment.",OADS,/arxiv_data1/oa_pdf/26/05/ymj-57-1282.PMC4960398.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1282ACKNOWLEDGEMENTS This research funded by Gadjah Mada University-Public Funds,  2012.",Non-OADS,/arxiv_data1/oa_pdf/26/05/ymj-57-1282.PMC4960398.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1286-1289 http://dx.doi.org/10.3349/ymj.2016.57.5.1286",Non-OADS,/arxiv_data1/oa_pdf/17/cd/ymj-57-1286.PMC4960399.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1286karyocytes were relatively preserved in the section (Fig.,Non-OADS,/arxiv_data1/oa_pdf/17/cd/ymj-57-1286.PMC4960399.pdf
1288Cytopenia in SFTS Patients http://dx.doi.org/10.3349/ymj.2016.57.5.1286patients with SFTS.,Non-OADS,/arxiv_data1/oa_pdf/17/cd/ymj-57-1286.PMC4960399.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1286of the thrombocytopenia is destruction by splenic macroph- ages.4 QuanTai, et al.2 compared the BM findings of five Chi - nese patients with SFTS with those of patients with aplastic an- emia and normal healthy volunteers, and found no significant  differences in cell morphology, cellularity, or numbers of me- gakaryocytes between them.",OADS,/arxiv_data1/oa_pdf/17/cd/ymj-57-1286.PMC4960399.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1290-1293 http://dx.doi.org/10.3349/ymj.2016.57.5.1290",Non-OADS,/arxiv_data1/oa_pdf/d9/82/ymj-57-1290.PMC4960400.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.5.1290erythrocyte sedimentation rate (ESR), C-reactive protein (CRP),  rheumatoid factor (RF), anti-cyclic citrullinated peptide anti - body (anti-CCP), and antinuclear antibody (ANA) showed nor - mal results.",OADS,/arxiv_data1/oa_pdf/d9/82/ymj-57-1290.PMC4960400.pdf
"1292SED Tarda in One Family http://dx.doi.org/10.3349/ymj.2016.57.5.1290Autosomal recessive SED tarda is attributed to loss-of-func - tion mutations of Wnt1-inducible signaling pathway protein 3  (WISP3) gene located on chromosome 6q22.11 WISP3 up-reg - ulates the expression of the cartilage specific gene encoding  type II collagen (COL2A1) and aggrecan in chondrocytes, and  is an important molecule in the regulation of cartilage homeo - stasis.12  In the family reported herein, none of the parents or siblings  of the case showed any sign of SED tarda.",Non-OADS,/arxiv_data1/oa_pdf/d9/82/ymj-57-1290.PMC4960400.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1290al.,Non-OADS,/arxiv_data1/oa_pdf/d9/82/ymj-57-1290.PMC4960400.pdf
"Key Words:  Gastric cancer, gastrectomy, lymphadenectomy, CaucasiansYonsei Med J 2016 Sep;57(5):1294-1297 http://dx.doi.org/10.3349/ymj.2016.57.5.1294Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 11, 2015   Revised:  September 7, 2015 Accepted:  October 8, 2015    Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
"1295 http://dx.doi.org/10.3349/ymj.2016.57.5.1294Masatoshi Nakagawa, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
http://dx.doi.org/10.3349/ymj.2016.57.5.1294 1296Gastrectomy with D2 in Caucasians The results of this case series suggest that morbidity and  mortality rates in CPs undergoing gastrectomy with lymphad - enectomy may be reduced if performed by experienced sur - geons.,Non-OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
"1297 http://dx.doi.org/10.3349/ymj.2016.57.5.1294Masatoshi Nakagawa, et al.",OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
Available at: http://www.acgme.,Non-OADS,/arxiv_data1/oa_pdf/52/c0/ymj-57-1294.PMC4960401.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Sep;57(5):1298-1299 http://dx.doi.org/10.3349/ymj.2016.57.5.1298Letter to the Editor Fig.",Non-OADS,/arxiv_data1/oa_pdf/f0/f6/ymj-57-1298.PMC4960402.pdf
1299 http://dx.doi.org/10.3349/ymj.2016.57.5.1298Seon-Cheol Park and Joonho Choi symptoms in patients with schizophrenia is reasonable.,Non-OADS,/arxiv_data1/oa_pdf/f0/f6/ymj-57-1298.PMC4960402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Adjunct atypical antipsychotic therapy following mania LN Yatham et al 1056 Molecular Psychiatry (2016), 1050 –1056 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d1/80/mp2015158a.PMC4960445.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Cytokines de ﬁne a schizophrenia subgroup SG Fillman et al 1098 Molecular Psychiatry (2016), 1090 –1098 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/16/cc/mp201590a.PMC4960447.pdf
We thank the personnel of the Genetic Service Facility of the VIB Department of Molecular Genetics (http://www.vibgeneticservicefacility.be) and the Antwerp Biobank of the InstituteBorn-Bunge for their expert support.,Non-OADS,/arxiv_data1/oa_pdf/34/e2/mp2015159a.PMC4960451.pdf
"Online bookchapter http://www.ncbi.nlm.nih.gov/books/NBK268647/.C9orf72 repeat size correlates with onset age and promoter activity I Gijselinck et al 1123 © 2016 Macmillan Publishers Limited Molecular Psychiatry (2016), 1112 –1124",Non-OADS,/arxiv_data1/oa_pdf/34/e2/mp2015159a.PMC4960451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)C9orf72 repeat size correlates with onset age and promoter activity I Gijselinck et al 1124 Molecular Psychiatry (2016), 1112 –1124 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/34/e2/mp2015159a.PMC4960451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Disrupting lactate transfer persistently reduces cocaine memory B Boury-Jamot et al 1076 Molecular Psychiatry (2016), 1070 –1076 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/f4/c8/mp2015157a.PMC4960452.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.SURGICAL INFECTIONS Volume 17, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/sur.2015.223 427",Non-OADS,/arxiv_data1/oa_pdf/a9/05/sur.2015.223.PMC4960475.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.VECTOR-BORNE AND ZOONOTIC DISEASES Volume 16, Number 8, 2016Mary Ann Liebert, Inc.DOI: 10.1089/vbz.2016.1942 507",Non-OADS,/arxiv_data1/oa_pdf/6d/68/vbz.2016.1942.PMC4960477.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/81/29/hum.2016.087.PMC4960479.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.SURGICAL INFECTIONS Volume 17, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/sur.2015.075 402",Non-OADS,/arxiv_data1/oa_pdf/70/7f/sur.2015.075.PMC4960493.pdf
"4, 324–338 http://dx.doi.org/10.1080/16506073.2016.1178800 © 2016 the a uthor(s).",Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"p ublished by i nforma uK Limited, trading as taylor & Francis group this is an open a ccess article distributed under the terms of the Creative Commons a ttribution-nonCommercial-noDerivatives License  (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Development and validation of the Shy Bladder and Bowel Scale (SBBS) Simon R. Knowlesa,b,c  and Jason Skuesa aFaculty of health, arts and Design, Swinburne university of technology, Melbourne, australia; bFaculty  of Medicine, Dentistry, & health Sciences, the university of Melbourne, Melbourne, a ustralia; cColorectal  Medicine and g enetics, the royal Melbourne hospital, Melbourne, a ustralia ABSTRACT Currently research exploring paruresis and parcopresis, anxiety  relating to urinating and having bowel motions in public respectively  is limited.",Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
ORCID Simon R. Knowles   http://orcid.org/0000-0001-8000-1000 References American Psychiatric Association.,Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
doi:http://dx.doi.org/10.1002/ da.20367,Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10789535 Deacon, B. J., Lickel, J. J., Abramowitz, J. S., & McGrath, P .",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.108 0/16506073.2012.658852 Hammelstein, P ., Pietrowsky, R., Merbach, M., & Braehler, E. (2005).",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.1159/000086322 Hammelstein, P ., & Soifer, S. (2006).",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
doi:http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.1017/S1352465813000726 Lovibond, S. H., & Lovibond, P .",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.1177/01454455850092006 Muthen, L. K., & Muthen, B. O.",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.1016/j.jocrd.2013.04.005 Rogers, G. M. (2003).",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9881538 Simon, H. B.",OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"Retrieved  from http://www.health.harvard.edu/PDFs/20Q_Premium_C.pdf Soifer, S., Himle, J., & Walsh, K. (2010).",Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
doi:http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
doi:http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"doi:http://dx.doi.org/10.1080/16506073.2012.661452 Williams, G. W ., & Degenhardt, E. T. (1954).",Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
doi:http://dx.doi.org/10.1080/00221309.1954.9920203,Non-OADS,/arxiv_data1/oa_pdf/71/c4/sbeh-45-324.PMC4960499.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.gov /pubmed /15728813 .,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /26193078 3 Burger JA, Quiroga MP, Hartmann E, Bürkle A, Wierda WG, Keating MJ, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /19074730 4 Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.bloodjour nal.org /content /117/5/1662.abstract 5 Mittal AK, Chaturvedi NK, Rai KJ, Gilling-Cutucache CE, Nordgren TM, Moragues M, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.pubmedcentral.nih.gov /articlerender.fcgi?ar tid=4107103&tool =pmcentrez&rendertype =abstract 6 Miyagaki T, Sugaya M, Murakami T, Asano Y, Tada Y, Kadono T,et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.gov /pubmed /21406396Kubeczko et al.,OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /20505746 8 Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G. Differential chemokine expression in tissues involvedby Hodgkin ’s disease: direct correlation of eotaxin expression and tissue eosinophilia.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /18398743 10 Trimarco V, Ave E, Facco M, Chiodin G, Frezzato F, Martini V, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed/ 26522085 13 Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, et al.Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /20809185 15 Piechnik A, Dmoszynska A, Omiotek M, Mlak R, Kowal M, Stilgenbauer S, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed/ 8562930 17 Molica S, Vitelli G, Levato D, Gandolfo GM, Liso V. Increased serum levels of vascular endothelial growth factor predict risk ofprogression in early B-cell chronic lymphocytic leukaemia.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /105832 66 18 Bogusz J, Majchrzak A, Me ˛dra A, Cebula-Obrzut B, Robak T, Smolewski P. Mechanisms of action of the anti-VEGF mono- clonal antibody bevacizumab on chronic lymphocytic leukemiacells.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.pubmedcentral.nih.gov /articlerender.fcgi?ar tid=2974606&tool =pmcentrez&rendertype =abstract 20 Ho C-L, Hsu L-F, Phyliky RL, Li C-Y .",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.karger.com /Article /FullText / 420761 22 Li A, Dubey S, Varney ML, Dave BJ, Singh RK.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov / pubmed /22475215 24 Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival inan autocrine fashion.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov / pubmed /8388271 27 Wang L-F, Chien C-Y, Tai C-F, Chiang F-Y, Chen JY-F. Vitamin D decreases the secretion of eotaxin and RANTES innasal polyp fibroblasts derived from Taiwanese patients withchronic rhinosinusitis with nasal polyps.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /25645983 28 Banerjee A, Damera G, Bhandare R, Gu S, Lopez-Boado Y, Panettieri R, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.pubmedcentral.nih.gov /arti clerender.fcgi?artid =2440089&tool =pmcentrez&rendertype =ab stract 29 Bao B-Y, Yao J, Lee Y-F. 1 alpha, 25-dihydroxyvitamin D3 sup- presses interleukin-8-mediated prostate cancer cell angiogenesis.Carcinogenesis [Internet].",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.pubmedcenKubeczko et al.,OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.pubmedcentral.nih.gov /articlerender.,OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://czasopisma.viamedica.pl /ep/ article/view/EP.2013.0012 37 Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.pubmedcentral.nih.gov / articlerender.fcgi?artid =2861286&tool =pmcentrez&rendertype =abstract 38 Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, Sidelnikov E, Willett WC, Edel JO, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.pubmedcentral.nih.gov /articleren der.fcgi?artid =3525834&tool =pmcentrez&rendertype =abstract 44 Kokic V, Martinovic Kaliterna D, Radic M, Perkovic D, Cvek M, Capkun V. Relationship between vitamin D, IFN-, and E2levels in systemic lupus erythematosus.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov / pubmed/ 25791938 46 Smolej L, Andrýs C, Krejsek J, Belada DZ, Zák P, Siroký O, et al.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /18277626 47 Malavaki CJ, Roussidis AE, Gialeli C, Kletsas D, Tsegenidis T, Theocharis AD, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed /26580599 49 Singer MK, Assem M, Abdel Ghaffar AB, Morcos NY .",Non-OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"Available from: http://www.ncbi.nlm.nih.gov /pubmed / 26415519 51 Jamka M, Woz ´niewicz M, Walkowiak J, Bogdan ´ski P, Jeszka J, Stelmach-Mardas M. The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight sub- jects: a systematic review with meta-analysis.",OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
Available from: http://www.ncbi.nlm.nih.gov /pubmed /26538075Kubeczko et al.,OADS,/arxiv_data1/oa_pdf/46/2f/yhem-21-343.PMC4960500.pdf
"3, 367–373, http://dx.doi.org/10.1080/10803548.2015.1131069 Workstations for people with disabilities: an example of a virtual reality approach Paweł Budziszewski∗, Andrzej Grabowski, Marcin Milanowicz and Jarosław Jankowski Central Institute for Labour Protection – National Research Institute (CIOP-PIB), Poland This article describes a method of adapting workstations for workers with motion disability using computer simulation and virtual reality (VR) techniques.",Non-OADS,/arxiv_data1/oa_pdf/5b/5a/tose-22-367.PMC4960503.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/5b/5a/tose-22-367.PMC4960503.pdf
"KEYWORDS chaplaincy, mental health, military, moral injury,  stigma  © Jessica Kelley Morgan, Laurel Hourani, Marian E. Lane, and Stephen Tueller  This is an Open Access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by- nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited, and is not altered, transformed, or built  upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/83/9e/whcc-22-102.PMC4960506.pdf
"Retrieved  February 13, 2013 from http://www.ptsd.va.gov/professional/pages/  assessments/assessment-pdf/pcl-handout.pdf 116 J. K. Morgan et al.",OADS,/arxiv_data1/oa_pdf/83/9e/whcc-22-102.PMC4960506.pdf
"3, 176 –200 http://dx.doi.org/10.1080/87565641.2016.1186167",Non-OADS,/arxiv_data1/oa_pdf/4f/59/hdvn-41-176.PMC4960507.pdf
"10, 1227–1232http://dx.doi.org/10.1080/00365521.2016.1193219",Non-OADS,/arxiv_data1/oa_pdf/23/d5/igas-51-1227.PMC4960508.pdf
[15] The RIVM [Internet] Available from: http://www.rivm.nl/Onder werpen/B/Bevolkingsonderzoek_d armkanker/Wat_is_darmkanker .,Non-OADS,/arxiv_data1/oa_pdf/23/d5/igas-51-1227.PMC4960508.pdf
"Available from: http://ww.mdl.nl [23] Dekker N, van Rossum LG, van Vugt-van Pinxteren M, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/d5/igas-51-1227.PMC4960508.pdf
"6, 494–501http://dx.doi.org/10.1080/00016357.2016.1206211",Non-OADS,/arxiv_data1/oa_pdf/af/0c/iode-74-494.PMC4960510.pdf
"ORCID Amal Al-Khotani http://orcid.org/0000-0001-7168-9835 Nikolaos Christidis http://orcid.org/0000-0002-8199-7863 References [1] Bankole OO, Aderinokun GA, Denloye OO, et al.",Non-OADS,/arxiv_data1/oa_pdf/af/0c/iode-74-494.PMC4960510.pdf
"3, 350–359, http://dx.doi.org/10.1080/10803548.2015.1136111 Gloves against mineral oils and mechanical hazards: composites of carboxylated acrylonitrile–butadiene rubber latex Sylwia Krzemi ´nskaa∗, Władysław M. Rzymskib, Monika Malesac, Urszula Borkowskacand Mariusz Oleksyd aCentral Institute for Labour Protection – National Research Institute (CIOP-PIB), Poland;bTechnical University of Łód´ z, Poland; cSecura B.C.",Non-OADS,/arxiv_data1/oa_pdf/21/3c/tose-22-350.PMC4960512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/21/3c/tose-22-350.PMC4960512.pdf
"10, 1159–1164http://dx.doi.org/10.1080/00365521.2016.1183225",Non-OADS,/arxiv_data1/oa_pdf/a8/ed/igas-51-1159.PMC4960513.pdf
"18, 1840–1885 http://dx.doi.org/10.1080/09500340.2016.1178820 OPEN ACCESS Fifteen years of cold matter on the atom chip: promise, realizations, and prospects Mark Keil, Omer Amit, Shuyu Zhou†, David Groswasser, Yonathan Japha and Ron Folman Department of Physics, Ben-Gurion University of the Negev, Be’er Sheva, Israel ABSTRACT Here we review the ﬁeld of atom chips in the context of Bose–Einstein Condensates (BEC) as well as cold matter in general.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"(18)http://www.dlr-gsoc.de/moraba/ (19) Jones,M.P.A.;Vale,C.J.;Sahagun,D.;Hall,B.V.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"(224)http://coldquanta.com (225) Gullans, M.; Tiecke, T.G.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"(351)http://www.agence-nationale-recherche.fr/en/ (352) deAngelis,M.;Angonin,M.C.;Beauﬁls,Q.;Becker,Ch.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"(355)http://matterwave.eu/ (356) Barrett, B.; Geiger, R.; Dutta, I.; Meunier, M.; Canuel, B.; Gauguet, A.; Bouyer, P.; Landragin, A.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
"(366)http://www.agence-nationale-recherche.fr/en/ (367) Monroe, C.M.",Non-OADS,/arxiv_data1/oa_pdf/ad/93/tmop-63-1840.PMC4960518.pdf
Available from: http://www.mciindia.org/ RulesandRegulations/GraduateMedicalEducationRegulations1997.,Non-OADS,/arxiv_data1/oa_pdf/67/62/JEHP-5-17.PMC4960763.pdf
Available from: http://www.hospitalmanagment.ir/,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from:  http://www.congress.tbzmed.ac.ir/ccgcqi/Abstract/2854.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.congress.tbzmed.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.journals.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available  from: http://www.congress.tbzmed.ac.ir/mbak/Abstract/4441.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from:  http://www.congress.tbzmed.ac.ir/ccgcqi/Abstract/3162.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.congress.tbzmed.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.congress.tbzmed.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
http://journals.nkums.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from:  http://www.congress.tbzmed.ac.ir/ccgcqi/Abstract/3240.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available  from: http://www.congress.tbzmed.ac.ir/ccgcqi/Abstract/3345.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.congress.tbzmed.ac.ir/ ccgcqi/Abstract/3071.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
Available from: http://www.congress.,Non-OADS,/arxiv_data1/oa_pdf/b4/75/JEHP-5-20.PMC4960764.pdf
c2013‑ Available from:  http://www.unicef.org/media/files/UNICEF_ Key_facts_and_figures_on_Nutrition.docx.,Non-OADS,/arxiv_data1/oa_pdf/d6/d1/JEHP-5-24.PMC4960768.pdf
"In the web‑based group, 1‑h training on how to use  educational website1 that contains educational researcher  1 http://schools.mums.ac.ir/sites/nurse Assessed for eligibility (n = 115) Excluded:  n = 10 - Not meeting    - Inclusion criteria   Register( n = 105) Randomized Allocatio n Follow up: 1wee k after the training Analysi sWeb based grou p Intervention  (n = 35) Received allocate d intervention (n = 35) Leave the study (n = 1)simulation based grou p Intervention  (n = 35) Received allocate d intervention (n = 35) Leave the study (n = 0)conventional grou p Intervention  (n = 35)Received allocate d intervention (n = 35) Leave the study (n = 0) Not eager to continu e (n = 0)Not eager to continu e (n = 0)Not eager to continu e (n = 4) Data Analysis (n = 34) Data Analysis (n = 35) Data Analysis (n = 31) Figure  1: CONSORT flow chart of participants",Non-OADS,/arxiv_data1/oa_pdf/87/bc/JEHP-5-22.PMC4960770.pdf
Available from:http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/87/bc/JEHP-5-22.PMC4960770.pdf
Available  from: https://intraweb.stockton.edu/eyos/energy_studies/content/ docs/effstock09/Session_8_1%20Sustainable_Comfort_Cooling/61.,Non-OADS,/arxiv_data1/oa_pdf/66/47/JEHP-5-15.PMC4960771.pdf
Available from: https://www.tx.ncsu.edu/jtatm/ volume4issue3/articles/Nam/Nam_full_138_05.pdf.,OADS,/arxiv_data1/oa_pdf/66/47/JEHP-5-15.PMC4960771.pdf
Available from: http://behdasht.gov.ir/?siteid=1&pageid=12 961&newsview=3893.,Non-OADS,/arxiv_data1/oa_pdf/56/9f/JEHP-5-11.PMC4960774.pdf
Available from: http://www.justice.ir_Portal_ Home_Default.aspx.,OADS,/arxiv_data1/oa_pdf/56/9f/JEHP-5-11.PMC4960774.pdf
Available from: http://www.aftabir.com/articles/view/health_ therapy/nutrition_health.,Non-OADS,/arxiv_data1/oa_pdf/56/9f/JEHP-5-11.PMC4960774.pdf
Available from: http://www.zuhen.persianblog.ir/post/232.,Non-OADS,/arxiv_data1/oa_pdf/56/9f/JEHP-5-11.PMC4960774.pdf
Available from: http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/21/43/JEHP-5-18.PMC4960775.pdf
Available from: http://www.who.int/reproductivehealth/topics/ adolescence/questionnaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/43/JEHP-5-18.PMC4960775.pdf
Available from: http://www.marketing‑bulletin.,Non-OADS,/arxiv_data1/oa_pdf/21/43/JEHP-5-18.PMC4960775.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/19/kfw088.PMC4960908.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS475Abstract Background:  Mammalian target of rapamycin (mTOR) complex 1 (mTORC1) acts  as a downstream effector of phosphatidyl‑inositol‑3 kinase, which is frequently  hyperactivated in glioblastoma multiforme and links to cell signaling in cellular  proliferation, differentiation, metabolism, and survival.",Non-OADS,/arxiv_data1/oa_pdf/6b/7d/SNI-7-475.PMC4960920.pdf
"http://surgicalneurologyint.com/mTORC1-signaling-in-primary-central-nervous- system-lymphoma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6b/7d/SNI-7-475.PMC4960920.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS492Abstract Background:  Glioblastoma multiforme (GBS) is a highly malignant glioma that  rarely presents as an infratentorial tumor.",Non-OADS,/arxiv_data1/oa_pdf/2c/ab/SNI-7-492.PMC4960921.pdf
"http://surgicalneurologyint.com/Multicentric-spinal-cord-and-brain-glioblastoma- without-previous-craniotomy/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/2c/ab/SNI-7-492.PMC4960921.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull Base, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS449Abstract Background:  Xanthomatous hypophysitis (XH) is an extremely rare form of  primary hypophysitis characterized by infiltration of the pituitary gland by mixed  types of inflammatory cells, including foamy cells, plasma cells, and small mature  lymphocytes.",Non-OADS,/arxiv_data1/oa_pdf/4b/c9/SNI-7-449.PMC4960922.pdf
"http://surgicalneurologyint.com/Xanthomatous-hypophysitis-associated-with- autoimmune-disease-in-an-elderly-patient:-A-rare-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/4b/c9/SNI-7-449.PMC4960922.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS481INTRODUCTION Medulloblastoma is a malignant embryonal tumor  that commonly arises in the cerebellum.",Non-OADS,/arxiv_data1/oa_pdf/cf/21/SNI-7-481.PMC4960923.pdf
"http://surgicalneurologyint.com/Adult-medulloblastoma:-A-rare-case-report-and- literature-review/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/cf/21/SNI-7-481.PMC4960923.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull Base, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS454Abstract Background:  Extradural temporopolar approach (ETA) has been modified as less  invasive manner and named as trans‑superior orbital fissure (SOF) approach with  mini‑peeling technique.",Non-OADS,/arxiv_data1/oa_pdf/bf/ee/SNI-7-454.PMC4960924.pdf
"http://surgicalneurologyint.com/Operative-surgical-nuances-of-modified-extradural- temporopolar-approach-with-mini-peeling-of-dura-propria-based-on-cadaveric- anatomical-study-of-lateral-cavernous-structures/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/bf/ee/SNI-7-454.PMC4960924.pdf
"OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull Base, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USA © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS469Abstract Background:  The association between neurofibromatosis type 1 (NF‑I) and Chiari  I malformation (CMI) is rare, and not many studies are reported in the literature.",Non-OADS,/arxiv_data1/oa_pdf/b2/2b/SNI-7-469.PMC4960925.pdf
"http://surgicalneurologyint.com/Neurofibromatosis-type-1-and-Chiari-type-1- malformation:-A-case-report-and-literature-review-of-a-rare-association/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b2/2b/SNI-7-469.PMC4960925.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull Base, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS463Dural repair using autologous fat: Our experience and review of  the literature Hambra Di Vitantonio, Danilo De Paulis1, Mattia Del Maestro, Alessandro Ricci1,  Soheila Raysi Dechordi, Sara Marzi1, Daniele F .",Non-OADS,/arxiv_data1/oa_pdf/98/51/SNI-7-463.PMC4960926.pdf
"http://surgicalneurologyint.com/Dural-repair-using-autologous-fat:-Our-experience- and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/98/51/SNI-7-463.PMC4960926.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Skull Base, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS459Abstract Background:  It is rare for patients with pituitary apoplexy to exhibit concomitant  subarachnoid hemorrhage (SAH).",Non-OADS,/arxiv_data1/oa_pdf/52/72/SNI-7-459.PMC4960927.pdf
"http://surgicalneurologyint.com/Subarachnoid-hemorrhage-caused-by-an- undifferentiated-sarcoma-of-the-sellar-region/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/52/72/SNI-7-459.PMC4960927.pdf
"For reprints contact:  reprints@medknow.comAccess this article online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.185783  Quick Response Code: Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International",Non-OADS,/arxiv_data1/oa_pdf/14/fb/SNI-7-485.PMC4960928.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS488Abstract Background: Urothelial carcinoma occurs in the bladder, upper urinary tract, and  lower urinary tract, including prostatic urethra.",Non-OADS,/arxiv_data1/oa_pdf/2d/ee/SNI-7-488.PMC4960929.pdf
"http://surgicalneurologyint.com/Metastatic-brain-tumor-from-urothelial-carcinoma- of-the-prostatic-urethra/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/2d/ee/SNI-7-488.PMC4960929.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS473Abstract Background: A rare cause of spinal cord compression is spinal arachnoid cysts.",Non-OADS,/arxiv_data1/oa_pdf/e4/6d/SNI-7-473.PMC4960930.pdf
"http://surgicalneurologyint.com/Intramedullary-cyst-formation-after-removal-of- multiple-intradural-spinal-arachnoid-cysts:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/e4/6d/SNI-7-473.PMC4960930.pdf
"Nemade R, Reiss Staats  N, Dombeck M. Psychology of  Depression‑Psychodynamic Theories, Available 15 Oct, 2011,  Online via: http://www.mentalhelp.",Non-OADS,/arxiv_data1/oa_pdf/c9/9e/NAJMS-8-232.PMC4960931.pdf
"(Accessed December  30, 2015, at: http://www.drugabuse.gov/publications/ drugfacts/ synthetic‑cannabinoids).",Non-OADS,/arxiv_data1/oa_pdf/89/e3/NAJMS-8-256.PMC4960936.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/02/97/JMH-7-56.PMC4960940.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/02/97/JMH-7-56.PMC4960940.pdf
Available from: http://www.iarc.,Non-OADS,/arxiv_data1/oa_pdf/16/e4/JMH-7-61.PMC4960941.pdf
Available  from: http://www.who.int/mediacentre/factsheets/ fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/16/e4/JMH-7-61.PMC4960941.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/03/e8/JMH-7-73.PMC4960944.pdf
Available from: http://www.epc2006.princeton.edu/download.,Non-OADS,/arxiv_data1/oa_pdf/8f/cf/JMH-7-83.PMC4960946.pdf
Trial Registration:  ClinicalTrials.org NCT02517073 https://clinicaltrials.gov/ct2/show/NCT02517073.,Non-OADS,/arxiv_data1/oa_pdf/de/f4/CMJ-129-1643.PMC4960952.pdf
Trial Registration:  ClinicalTrials.gov NCT02196870 (https://clinicaltrials.gov/ct2/show/NCT02196870).,Non-OADS,/arxiv_data1/oa_pdf/24/0b/CMJ-129-1652.PMC4960953.pdf
The study was registered in http://www.ClinicalTrials.gov  (No.,Non-OADS,/arxiv_data1/oa_pdf/24/0b/CMJ-129-1652.PMC4960953.pdf
"Trial Registration:  ClinicalTrials.gov, NCT01920776; https://clinicaltrials.gov/ct2/show/NCT01920776?term=NCT01920776&rank=1.",Non-OADS,/arxiv_data1/oa_pdf/f4/85/CMJ-129-1658.PMC4960954.pdf
Trial Registration:  Clinicaltrials.gov NCT02060773 (https://clinicaltrials.gov/ct2/show/NCT02060773).,Non-OADS,/arxiv_data1/oa_pdf/2b/96/CMJ-129-1666.PMC4960955.pdf
Available  from: http://www.goldcopd.org/uploads/users/files/GOLD_ Report_2013Feb13.pdf.,OADS,/arxiv_data1/oa_pdf/e7/a4/CMJ-129-1696.PMC4960959.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/70/3c/CMJ-129-1752.PMC4960968.pdf
"2, 158 –166 http://dx.doi.org/10.1080/19336950.2015.1120390",Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"J.Neurophysiol 2004; 91:1337-49; PMID:13679409; http://dx.doi.org/10.1152/jn.00414.2003 [2] Goldberg EM, Clark BD, Zagha E, Nahmani M, Erisir A, Rudy B. K Cchannels at the axon initial segment dampen near-threshold excitability of neocortical fast-spiking GABAergic interneurons.",Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Neuron 2008; 58:387-400; PMID:18466749; http://dx.doi.org/10.1016/j.neuron.2008.03.003 [3] Po S, Roberds S, Snyders DJ, Tamkun MM, Bennett PB.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"CircRes 1993; 72:1326-36; PMID:8495559; http://dx.doi.org/10.1161/01.RES.72.6.1326 [4] Sheng M, Liao YJ, Jan YN, Jan LY.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Nature 1993; 365:72-5; PMID:8361540; http://dx.doi.org/10.1038/365072a0 [5] Wang H, Kunkel DD, Martin TM, Schwartzkroin PA, Tempel BL.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Nature 1993;365:75-9; PMID:8361541; http://dx.doi.org/10.1038/ 365075a0 [6] Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W. Heteromultimeric Kv1 channelscontribute to myogenic control of arterial diameter.",Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"CircRes 2005; 96:216-24; PMID:15618540; http://dx.doi.org/10.1161/01.RES.0000154070.06421.25 [7] Rezazadeh S, Kurata HT, Claydon TW, Kehl SJ, Fedida D. An Activation Gating Switch in Kv1.2 Is Localized to a Threonine Residue in the S2-S3 Linker.",Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
J Neurosci 2015; 35:3515-24;PMID:25716850; http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"J Neurophysiol 2007; 98:1501-25; PMID:17634333; http://dx.doi.org/10.1152/jn.00640.2006 [10] Syrbe S, Hedrich UB, Riesch E, Djemie T, Muller S, Mol- ler RS, Maher B, Hernandez-Hernandez L, Synofzik M,Caglayan HS et al.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"J Biol Chem 2010; 285:32160-73; PMID: 20696761; http://dx.doi.org/10.1074/jbc.M110.153676 [12] Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jack- son M, Vincent A. Potassium channel antibodies in twopatients with reversible limbic encephalitis.",Non-OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Ann Neurol2001; 50:73-8; PMID:11456313; http://dx.doi.org/10.1002/ana.1097 [13] Kleopa KA, Elman LB, Lang B, Vincent A, Scherer SS.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Brain 2006;129:1570-84; PMID:16613892; http://dx.doi.org/10.1093/brain/awl084 [14] Baronas VA, McGuinness BR, Brigidi GS, Gomm Kolisko RN, Vilin YY, Kim RY, Lynn FC, Bamji SX, Yang R, Kurata HT.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"J Neurosci 2015; 35:3515-24;PMID:25716850; http://dx.doi.org/10.1523/JNEUROSCI.4518-13.2015 [15] Fujita T, Utsunomiya I, Ren J, Matsushita Y, Kawai M, Sasaki S, Hoshi K, Miyatake T, Taguchi K. Glycosylationand cell surface expression of Kv1.2 potassium channelare regulated by determinants in the pore region.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"Cell 2013; 152:236-47; PMID:23332758; http://dx.doi.org/10.1016/j.cell.2012.12.004 [18] Hyun JH, Eom K, Lee KH, Ho WK, Lee SH.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"JPhysiol 2013; 591:5525-40; PMID:23981714; http://dx.doi.org/10.1113/jphysiol.2013.259002 [19] Tsai W, Morielli AD, Cachero TG, Peralta EG.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"EMBO J 1999; 18:109-18; PMID:9878055;http://dx.doi.org/10.1093/emboj/18.1.109 [20] Accili EA, Kiehn J, Yang Q, Wang Z, Brown AM, Wible BA.",OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
J Biol Chem 1997; 272:25824-31; PMID:9325312; http://dx.doi.org/10.1074/ jbc.272.41.25824166 V. A. BARONAS ET AL.,OADS,/arxiv_data1/oa_pdf/89/69/kchl-10-02-1120390.PMC4960988.pdf
"2, 88 –100 http://dx.doi.org/10.1080/19336950.2015.1106654",Non-OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Nature 2007; 446:749-57;PMID:17429392; http://dx.doi.org/10.1038/nature05630 [2] Fischbach MA, Walsh CT.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Science 2009; 325:1089-93; PMID:19713519; http://dx.doi.org/10.1126/science.1176667 [3] Brown MH, Paulsen IT, Skurray RA.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Mol Microbiol 1999; 31:394-5; PMID:9987140; http://dx.doi.org/10.1046/j.1365-2958.1999.01162.x [4] Omote H, Miasa M, Matsumoto T, Otsuka M, Moroyama Y.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"The MATE proteins as fundamental trans- porters of metabolic and xenobiotic organic cations.Trends Pharmacol Sci 2006; 27:587-93; PMID:16996621; http://dx.doi.org/10.1016/j.tips.2006.09.001 [5] Kuroda T, Tsuchiya T. Multidrug ef ﬂux transporters in the MATE family.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Bacteriol 2000; 182:6694-7; PMID: 11073914; http://dx.doi.org/10.1128/JB.182.23.6694-6697.2000 [7] Chen J, Morita Y, Huda MN, Kuroda T, Mizushima T, Tsuchiya T. VmrA, a member of a novel class of Na(C)-coupled multidrug ef ﬂux pumps from Vibrio para- haemolyticus.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Bacteriol 2002; 184:572-6; PMID:11751837;http://dx.doi.org/10.11 28/JB.184.2.572-576.2002 [8] Long F, Rouquette-Loughlin C, Shafer WM, Yu EW.",Non-OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Antimicrob Agents Chemo-ther 2008; 52:3052-60; PMID:18591276; http://dx.doi.org/10.1128/AAC.00475-08 [9] He GX, Kuroda T, Mima T, Morita Y, Mizushima T, Tsuchiya T. An H C-coupled multidrug ef ﬂux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Bacteriol 2004;186:262-5; PMID:14679249; http://dx.doi.org/10.1128/JB.186.1.262-265.2004 [10] Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T. AbeM, an HC-coupled Acinetobacter baumannii multidrug ef ﬂux pump belonging to the MATE family of transporters.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Antimi-crob Agents Chemother 2005; 49:4362-4; PMID:16189122; http://dx.doi.org/10.1128 /AAC.49.10.4362-4364.2005 [11] Li L, He Z, Pandey, GK, Tsuchiya T, Luan S. Functional cloning and characterization of a plant ef ﬂux carrier for multidrug and heavy metal detoxi ﬁcation.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Biol Chem 2002; 277:5360-8; PMID:11739388; http://dx.doi.org/10.1074/jbc.M108777200 [12] Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Am Sci Nephrol 2006; 17:2127-35; http://dx.doi.org/10.1681/ASN.2006030205 [14] He X, Szewczyk P, Karyakin A, Evin M, Hong WX, Zhang Q, Chang G. Structure of a cation-bound multi-drug and toxic compound extrusion transporter.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Nature2010; 467:991-4; PMID:20861838; http://dx.doi.org/10.1038/nature09408 [15] Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S. Structure and mechanism of the lactose permease of Escherichia coli.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
Science 2003; 301:610-5; PMID:12893935; http://dx.doi.org/10.1126/science.1088196CHANNELS 99,OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Science 2003; 301:616-20;PMID:12893936; http://dx.doi.org/10.1126/science.1087619 [17] Lu M, Symersky J, Radchenko M, Koide A, Guo Y, Nie R, Koide S. Structures of a Na C-coupled, substrate-bound MATE multidrug transporter.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Science 2009; 323: 1718-22; PMID:19325113; http://dx.doi.org/10.1126/science.1168750 [20] Otsuka M, Yasuda M, Morita Y, Otsuka C, Tsuchiya T, Omote H, Moriyama Y. Identi ﬁcation of essential amino acid residues of the NorM Na C/multidrug antiporter in Vibrio parahaemolyticus.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Bacteriol 2005; 187:1552-8;PMID:15716425; http://dx.doi.org/10.1128/JB.187.5.1552-1558.2005 [21] Kha ﬁzov K, Perez C, Koshy C, Quick M, Fendler K, Zie- gler C, Forrest LR.",Non-OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"J Mol Biol 2014; 426:2539-46; PMID:24862284; http://dx.doi.org/10.1016/j.jmb.2014.05.020 [23] Padan E. Functional and structural dynamics of NhaA, a prototype for Na( C) and H( C) antiporters, which are responsible for Na( C) and H( C) homeostasis in cells.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Biochim Biophys Acta 2014; 1837:1047-62; PMID:24361841; http://dx.doi.org/10.1016/j.bbabio.2013.12.007 [24] Tanaka Y, Hipolito CJ, Maturana AD, Ito K, Kuroda T, Higuchi T, Katoh T, Kato HE, Hattori M, Kuma-zaki K, et al.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Structural basis for the drug extrusionm e c h a n i s mb yaM A T Em u l t i d r u gt r a n s p o r t e r .N a t u r e 2013; 496:247-51; PMID:23535598; http://dx.doi.org/10.1038/nature12014 [25] Lu M, Radchenko M, Symersky J, Nie R, Guo Y.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Nat Struct Mol Biol2013; 20:1310-7; PMID:24141706; http://dx.doi.org/ 10.1038/nsmb.2687 [26] Radchenko M, Symersky J, Nie R, Lu M. Structural basis for the blockade of MATE multidrug ef ﬂux pumps.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Nat Commun 2015; 6:7995; PMID:26246409; http://dx.doi.org/10.1038/ncomms8995 [27] Miyamae S, Ueda O, Yoshimura F, Hwang J, Tanaka Y, Nikaido H. A MATE family multidrug ef ﬂux trans- porter pumps out ﬂuoroquinolones in Bacteroides the- taiotaomicron.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Antimicro Agents Chemother 2001; 45:3341-6; http://dx.doi.org/10.1128/AAC.45.12.3341-3346.2001 [28] Jonas BM, Murray BE, Weinstock GM.",Non-OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Antimicro Agents Che-mother 2001; 45:3574-9; http://dx.doi.org/10.1128/AAC.45.12.3574-3579.2001 [29] Spoelstra EC, Westerhoff HV, Pinedo HM, Dekker H, Lankelma J.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
"Eur JBiochem 1994; 221:363-73; PMID:7909520; http://dx.doi.org/10.1111/j.1432-1033.1994.tb18748.x [30] Ohta KY, Inoue K, Yasujima T, Ishimaru M, Yuasa H. Functional characteristics of two human MATE trans- porters: kinetics of cimetidine transport and pro ﬁles of inhibition by various compounds.",OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
Nature 2013; 500:102-6 (2013);PMID:23812586; http://dx.doi.org/10.1038/nature12300100 M. LU,Non-OADS,/arxiv_data1/oa_pdf/af/09/kchl-10-02-1106654.PMC4960993.pdf
The sequences were processed using scripts implement-ed through the workﬂow package Quantitative Insights Into Microbial Ecology (QIIME) (v1.9.0; http://qiime.org/index.,OADS,/arxiv_data1/oa_pdf/d7/d5/i1552-5783-57-8-3747.PMC4960998.pdf
"RetNet 1, https://sph.uth.edu/retnet; available in the public domain).",OADS,/arxiv_data1/oa_pdf/ab/2b/i1552-5783-57-8-3780.PMC4960999.pdf
"Fluorescence was detected by using an Odysseyinfrared imager (LI-COR Biosciences) and quantiﬁed by usingImageJ software (http://imagej.nih.gov/ij/; provided in thepublic domain by the National Institutes of Health, Bethesda,MD, USA).",OADS,/arxiv_data1/oa_pdf/ab/2b/i1552-5783-57-8-3780.PMC4960999.pdf
Sequencing data were trimmed to remove adapter sequences and aligned against human refer- ence database using Bowtie software (http://bowtie-bio.sourceforge.net/index.shtml; in the public domain).,OADS,/arxiv_data1/oa_pdf/f7/8d/i1552-5783-57-8-3731.PMC4961003.pdf
"31The original sequencing data, as well as the normalized data, have been deposited into the NCBI Gene Expression Omnibus and are accessible through GEO Seriesaccession number GSE81254 (http://www.ncbi.nlm.nih.gov/geo/; in the public domain).",OADS,/arxiv_data1/oa_pdf/f7/8d/i1552-5783-57-8-3731.PMC4961003.pdf
"All analysis wasdone using Microsoft Excel 2013 (Microsoft Corp., Seattle, WA, USA) and The R Language and Environment for StatisticalComputing (https://www.r-project.org/; in the public do-main).",OADS,/arxiv_data1/oa_pdf/f7/8d/i1552-5783-57-8-3731.PMC4961003.pdf
"43–55Heat maps were created using The R Language and Environment for Statistical Computing.36The color palette used in the heat maps was made with the Heatplus package (http://bioconductor.org/packages/release/bioc/html/Heatplus.html; in the public domain), and the gplots package(http://ggplot2.org/; in the public domain) was used to create the heat maps.",OADS,/arxiv_data1/oa_pdf/f7/8d/i1552-5783-57-8-3731.PMC4961003.pdf
Available at: https://cran.r-project.org/web/packages/gplots/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/8d/i1552-5783-57-8-3731.PMC4961003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/38/bhw123.PMC4961018.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf Abstract Recent ﬁndings suggest that Alzheimer ’s disease (AD) is a disconnection syndrome characterized by abnormalities in large- scale networks.,Non-OADS,/arxiv_data1/oa_pdf/fa/06/bhw128.PMC4961019.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/06/bhw128.PMC4961019.pdf
We used BrainNet Viewer ( http://www.nitrc.org/projects/ bnv/) for network visualization (Xia et al.,OADS,/arxiv_data1/oa_pdf/fa/06/bhw128.PMC4961019.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/fe/bhw133.PMC4961020.pdf
"Both the SPMs and PPI maps were projected (enclosing voxel projection) onto ﬂattened left and right hemispheres of the human PALS B12 atlas ( Van Essen 2005, http://sumsdb.wustl.",Non-OADS,/arxiv_data1/oa_pdf/c3/fe/bhw133.PMC4961020.pdf
"2001 ,http://brainvis.wustl.edu/caret).",OADS,/arxiv_data1/oa_pdf/c3/fe/bhw133.PMC4961020.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/3f/bhw134.PMC4961021.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/cd/bhw135.PMC4961022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/60/bhw137.PMC4961023.pdf
The remainingimages were preprocessed using DPARSF (Chao-Gan and Yu-Feng2010; http://www.restfmri.net).,OADS,/arxiv_data1/oa_pdf/0c/60/bhw137.PMC4961023.pdf
"2011; http://www.bic.mni.mcgill.ca/ServicesAtlases/NIHPD-obj1) using its asymmetric,T 1v e r s i o na n da4 .",Non-OADS,/arxiv_data1/oa_pdf/0c/60/bhw137.PMC4961023.pdf
"2011; http://www.restfmri.net) and further corrected for multiple com-parisons using Gaussian Random Field (GRF) theory ( Z> 2.3, clus- ter-wise P< 0.05, GRF corrected) with a minimum cluster size of 130 voxels.",Non-OADS,/arxiv_data1/oa_pdf/0c/60/bhw137.PMC4961023.pdf
"2013, http://www.nitrc.org/projects/bnv/).",Non-OADS,/arxiv_data1/oa_pdf/0c/60/bhw137.PMC4961023.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/de/bhw144.PMC4961024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/4d/bhw154.PMC4961026.pdf
For segmen- tation and parcellation of cortical and subcortical structures theFreeSurfer version 5.3 tool was used http://surfer.nmr.mgh.,OADS,/arxiv_data1/oa_pdf/b9/4d/bhw154.PMC4961026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/5c/bhw155.PMC4961027.pdf
"The human Brainnetome Atlas will be made freely availablefor download at http://atlas.brainnetome.org, so that whole brain parcellations, connections, and functional data will be readily available for researchers to use in their investigations into healthy and pathological states.",Non-OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
http://www.brainmap.org/taxonomy ) using forward and reverse inferences ( Eickhoff et al.,OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
The anatomical and functional connectivity maps as well as th e detailed connectogram for each brain subregion are shown on the website (http://atlas.brainnetome.org; Fig.,OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
and paradigm class meta data labels following the BrainMap tax- onomy (http://www.brainmap.org/taxonomy).,OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
"The details of the parcellation results for each subregion are listed in Table 1, and the online version is available at http://atlas.brainnetome.org/bnatlas.",OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
"The atlas together with its related software is avail- able for download to serve as a shared community resource(http://atlas.brainnetome.org, Fig.",OADS,/arxiv_data1/oa_pdf/5d/86/bhw157.PMC4961028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/07/bhw158.PMC4961029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/e6/bhw166.PMC4961030.pdf
Supplementary Material Supplementary material can be found at http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/2d/e6/bhw166.PMC4961030.pdf
"Developmental  Cognitive  Neuroscience  19  (2016)  70–77 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Dysfunctional  error-related processing in  incarcerated  youth  with elevated  psychopathic traits J.  Michael  Maurera,b,∗,  Vaughn  R.  Steelea,b,c,  Lora  M.  Coped,  Gina  M.  Vincente, Julia M.  Stephena,  Vince  D.  Calhouna,f,  Kent  A.  Kiehla,b,∗ aThe  Mind  Research  Network,  an  afﬁliate  of  the  Lovelace  Biomedical  and  Environmental  Research  Institute  (LBERI),  Albuquerque,  NM,  United  States  of America bDepartment  of  Psychology;  University  of  New  Mexico,  Albuquerque,  NM,  United  States  of  America cNeuroimaging  Research  Branch,  National  Institute  on  Drug  Abuse,  Intramural  Research  Program,  National  Institutes  of  Health,  Baltimore,  MD,  United States  of  America dDepartment  of  Psychiatry  and  Addiction  Research  Center;  University  of  Michigan,  Ann  Arbor,  MI,  United  States  of  America eDepartment of Psychiatry; University of Massachusetts  Medical  School,  Worcester,  MA,  United  States  of  America fDepartment  of  Electrical  Engineering;  University  of  New  Mexico,  Albuquerque  NM,  United  States  of  America a  r  t  i  c  l  e  i  n  f  o Article  history: Received  25 September 2015 Received in  revised  form  16  February  2016 Accepted  16  February  2016 Available  online  22  February  2016 Keywords:Juvenile delinquency PsychopathyEvent-related potentials Principal  component  analysis Error-related  processinga  b  s  t  r  a  c  t Adult  psychopathic  offenders  show  an  increased  propensity  towards  violence,  impulsivity,  and  recidi- vism.",Non-OADS,/arxiv_data1/oa_pdf/44/95/main.PMC4961041.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/95/main.PMC4961041.pdf
Reduced  hemodynamic http://dx.doi.org/10.1016/j.dcn.2016.02.006 1878-9293/© 2016  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/44/95/main.PMC4961041.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/95/main.PMC4961041.pdf
"Keywords: ABCA4, GPR143, Stargardt disease, X-linked ocular albinism, heterozygous carrier, co-occurrence Progress in next-generation sequencing (NGS) technologies has vastly improved the ﬁeld of medical genetics and as a result, over 8000 genes and 15,000 phenotypes have been catalogued in the Online Mendelian Inheritance in Man (OMIM)database (in the public domain; http://www.omim.org).",OADS,/arxiv_data1/oa_pdf/4a/a0/i1552-5783-57-7-3409.PMC4961055.pdf
"The variants’ allelefrequency in the population is 0.0052% and 0.03% according to the ExAC (in the public domain, http://exac.broadinstitute.",OADS,/arxiv_data1/oa_pdf/4a/a0/i1552-5783-57-7-3409.PMC4961055.pdf
"org/) and ESP6500 (in the public domain, http://evs.gs.",Non-OADS,/arxiv_data1/oa_pdf/4a/a0/i1552-5783-57-7-3409.PMC4961055.pdf
"The mutational change was predicted to bedeleterious or damaging by all four, sorting Intolerant from Tolerant (score: 0) (SIFT; in the public domain, http://sift.jcvi.",Non-OADS,/arxiv_data1/oa_pdf/4a/a0/i1552-5783-57-7-3409.PMC4961055.pdf
"25The microarray glass chip was returned to RayBiotech for laser scanning (GenePix 4000B; Molecular Devices, Sunnyvale, CA, USA); then ﬂuorescence intensity from the individual spots was determined with S02-AAR-CYT-G2 RayBiotech software (http://www.raybiotech.com; in the public domain).",OADS,/arxiv_data1/oa_pdf/ae/0b/i1552-5783-57-7-3522.PMC4961056.pdf
"Bioinformatic Data Analysis and Protein Network Modeling We used PANTHER (Protein Analysis THrough Evolutionary Relationships, http://pantherdb.org; in the public domain)26to examine the categories of biological process, molecularfunction, cellular components, and protein class for the arrayresults of the 21 signiﬁcantly increased proteins in hypoxiccompared to normoxic conditioned medium.",OADS,/arxiv_data1/oa_pdf/ae/0b/i1552-5783-57-7-3522.PMC4961056.pdf
"Next, the 21proteins were input into DAVID Bioinformatics (http://david.ncifcrf.gov; in the public domain).",OADS,/arxiv_data1/oa_pdf/ae/0b/i1552-5783-57-7-3522.PMC4961056.pdf
"The stained areas in theimaged slides were quantiﬁed using Image J software (http://imagej.nih.gov/ij/; provided in the public domain by the NationalInstitutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/73/49/i1552-5783-57-7-3381.PMC4961058.pdf
"Densitometry was per-formed using ImageJ analysis of scanned ﬁlms (http://imagej.nih.gov/ij/; provided in the public domain by the NationalInstitutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/82/82/i1552-5783-57-7-3496.PMC4961059.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Understanding the Behavior of Systems Pharmacology Bakshi et al.,OADS,/arxiv_data1/oa_pdf/85/06/PSP4-5-339.PMC4961077.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)TGI Metrics to Predict Survival in Gastric Cancer Han et al.,OADS,/arxiv_data1/oa_pdf/57/26/PSP4-5-352.PMC4961078.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Naloxegol Exposure-Response Modeling Al-Huniti et al .,OADS,/arxiv_data1/oa_pdf/24/c7/PSP4-5-359.PMC4961079.pdf
"Instead, inputparameters for CL intwere back-calculated from observed mean CL po(55.87 L/hr; single dose)15,19using fm dataTable 1 Input parameter values used to simulate the kinetics of efavirenz Parameter Value Method/comment MW [g/mol] 315.68 http://www.drugbank.ca/drugs/DB00625 logP 4.02 Mean of measured values (range, 2.07–5.4)12,35–37 pKa 10.2 Monoprotic acid38 fu 0.029 Significant variability in measured values (range, 0.005–0.029), reported highest f uvalue used21 B:P ratio 0.74 Reported37 fa 0.67 Reported33 ka(hr21) 0.14 Estimated from clinical data obtained following a single oral dose of 100 mg efavirenz (unpublished data provided by BMS) Tlag(hr) 0.36 Estimated from clinical data obtained following a single oral dose of 100 mg efavirenz (unpublished data provided by BMS) Fu,gut 0.005 Default value of 1 was used initially, optimized based on sensitivity analysis (see Results) Vss(L/kg) (minimal PBPK) 2.25 Estimated from clinical data due to the uncertainty in efavirenz f upand logP Vsac(L/kg) 1.1 Estimated from clinical data obtained following a single oral dose of 800 mg efavirenz (unpublished data provided by BMS) kin(hr21) 0.29 Estimated from clinical data obtained following a single oral dose of 800 mg efavirenz (unpublished data provided by BMS) kout(hr21) 0.36 Estimated from clinical data obtained following a single oral dose of 800 mg efavirenz (unpublished data provided by BMS) CLR(L/h) 0 Reported Single-dose CL/F (L/h) 5.87 Mean value observed after the administration of a single oral dose to 600 mg to healthy volunteers15,19 Enzyme kinetics – CYP2B6 CL int(ll/min/pmol) 1.36 Retrograde calculation – assign 62% of hepatic CL CYP2A6 CL int(ll/min/pmol) 0.46 Retrograde calculation – assign 26.6% of hepatic CL CYP1A2 CL int(ll/min/pmol) 0.03 Retrograde calculation – assign 4.6% of hepatic CL CYP3A4 CL int(ll/min/pmol) 0.012 Retrograde calculation – assign 4.6% of hepatic CL Additional HLM CL int(ll/min/mg) 0.694 Retrograde calculation – assign 2% of hepatic CL CYP2B6 IndC 50(mM) 1.2 Determined in human hepatocytes based on activity levels and not cali- brated39;fu,incof 0.15 was applied (see below) CYP2B6 Ind max(fold) 6.2 Determined in human hepatocytes based on activity levels39and not calibrated CYP3A4 IndC 50(mM) 3.8 Determined in human hepatocytes based on mRNA levels and calibrated against rifampin data34;fu,incof 0.15 was applied based on sensitivity analysis in the range of 0.1–0.5 (per experiment values) CYP3A4 Ind max(fold) 9.9 Determined in human hepatocytes based on mRNA levels and calibrated against rifampin data34 MW, molecular weight; logP , log octanol/buffer partition coefficient (neutral species); B:P , blood-to-plasma ratio; f a, fraction absorbed; k a, absorption rate con- stant; BMS, Bristol Myers Squibb; V ss, volume of distribution at steady state; PBPK, physiologically based V sac, volume of the single-adjusting compartment; kinand k out, first order rate constants which act on the masses of drug within the systemic compartment and the SAC respectively; CL R, renal clearance; CL/ F , oral clearance; CL int, intrinsic clearance; IndC 50, inducer concentration that support half maximal induction; HLM, human liver microsome; F u,inc, the fraction unbound in an in vitro hepatocyte incubation.Best Practice Approach in Efavirenz PBPK Modeling Ban Ke et al.",Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.who.int/hiv/pub/guidelines/arv2013/download/en/ >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21548_levixa_lbl.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204790lbl.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202258lbl.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000 ClinPharmR.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204760Orig1s000 ClinPharm.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/205552Orig1s000 ClinPharmR.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20972.cfm >.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)Best Practice Approach in Efavirenz PBPK Modeling Ban Ke et al.,Non-OADS,/arxiv_data1/oa_pdf/62/b5/PSP4-5-367.PMC4961080.pdf
<http://www.unaids.org/en/resources/docu- ments/2015/AIDS_by_the_numbers_2015 >.,Non-OADS,/arxiv_data1/oa_pdf/29/d9/PSP4-5-377.PMC4961081.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://www.wileyonlinelibrary.com/psp4)PrEP Efficacy of NRTIs Duwal et al.,Non-OADS,/arxiv_data1/oa_pdf/29/d9/PSP4-5-377.PMC4961081.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.1 LETTER TO THE EDITOR 1Accepted for publication April 21, 2016, Published online May 30, 2016 Correspondence to Yoshiki Yui Formerly affiliated with Department of Cardiology, Kyoto  University Hospital, 54 Kawaharachou, Shogoin, Sakyoku, Kyoto  6068397, JapanTel: +81-75-751-3111 E-mail: yoshikibmw@gmail.com & yoshiki@kuhp.kyoto-u.ac.jp  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Questions Surrounding iPS Cells in Japan Yoshiki Yui   iPS cells represent marked progress in regenerative  medicine.",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ijsc-09-001.PMC4961097.pdf
"7B, right were different from  those of the paper (https://www.cira.kyotou.ac.jp/ j/press-release/other/140428-192654.html).",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ijsc-09-001.PMC4961097.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.3 REVIEW ARTICLE 3Accepted for publication April 7, 2016, Published online May 30, 2016 Correspondence to Jaesang Kim Department of Life Science, Science Bldg C-516, Ewha Womans  University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, KoreaTel: +82-2-3277-3414, Fax: +82-2-3277-7600 E-mail: jkim1964@ewha.ac.kr  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.SoxD Transcription Factors: Multifaceted  Players of Neural Development Eun Hye Ji, Jaesang Kim Department of Life Science, Ewha Womans University, Seoul, Korea SoxD transcription factor subfamily includes three members, Sox5, Sox6, and Sox13.",Non-OADS,/arxiv_data1/oa_pdf/c0/96/ijsc-09-003.PMC4961098.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.9 REVIEW ARTICLE 9Accepted for publication March 24, 2016, Published online May 30, 2016 Correspondence to Behnam Ebrahimi Yazd Cardiovascular Research Center, Afshar Hospital, Jomhouri  Boulevard, Yazd 8917945556, IranTel: +98-3535231421, Fax: +98-3535231421 E-mail: bhnmebrahimi@yahoo.com, ebrahimi.b@ssu.ac.ir   This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Chemicals as the Sole Transformers of Cell Fate Behnam Ebrahimi Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Forced expression of lineage-specific transcription factors in somatic cells can result in the generation of different  cell types in a process named direct reprogramming, bypassing the pluripotent state.",Non-OADS,/arxiv_data1/oa_pdf/b8/45/ijsc-09-009.PMC4961099.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.21 REVIEW ARTICLE 21Accepted for publication March 7, 2016, Published online May 30, 2016 Correspondence to Sheetal Kashinath Medhekar Department of Pharmacology, Satara College of Pharmacy,  Degaon, Satara, Plot No.",Non-OADS,/arxiv_data1/oa_pdf/55/cf/ijsc-09-021.PMC4961100.pdf
"MIDC, Satara (MH)  415004, India Tel: +02162 275164, Fax: +02162 275043 E-mail: smedhekar5@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Recent Stem Cell Advances: Cord Blood and Induced Pluripotent  Stem Cell for Cardiac Regeneration- a Review Sheetal Kashinath Medhekar, Vikas Suresh Shende, Anjali Baburao Chincholkar Department of Pharmacology, Satara College of Pharmacy, Degaon, Satara (MH), India Stem cells are primitive self renewing undifferentiated cell that can be differentiated into various types of specialized  cells like nerve cell, skin cells, muscle cells, intestinal tissue, and blood cells.",Non-OADS,/arxiv_data1/oa_pdf/55/cf/ijsc-09-021.PMC4961100.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.31 REVIEW ARTICLE 31Accepted for publication March 1, 2016, Published online May 30, 2016 Correspondence to Heba Wagih Abdelwahab Department of Chest Medicine, Mansoura University, Mansoura  35516, EgyptTel: +00201011930335, Fax: +002-050-2267016 E-mail: wagihheba84@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Stem Cells and Lung Regeneration Mohammad K. El-Badrawy1, Nesrein M. Shalabi1, Mie A. Mohamed2,  Amany Ragab1, Heba Wagih Abdelwahab1 Departments of 1Chest Medicine, 2Pathology, Mansoura University, Mansoura, Egypt Background: Tissues such as the lung, liver, and pancreas that have a low steady-state cell turnover yet can respond  robustly after injury to replace damaged cells.",Non-OADS,/arxiv_data1/oa_pdf/d3/3e/ijsc-09-031.PMC4961101.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.36 REVIEW ARTICLE 36Accepted for publication December 28, 2015, Published online May 30, 2016 Correspondence to Gangenahalli Gurudutta Division of Stem Cell Gene Therapy Research, Institute of Nuclear  Medicine & Allied Sciences (INMAS), Lucknow Road, Timarpur,  Delhi 110054, IndiaTel: +91-11-23905144, Fax: +91-11-25737049 E-mail: gugdutta@rediffmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Epigenetic Regulation of Hematopoietic Stem Cells Shilpa Sharma, Gangenahalli Gurudutta Division of Stem Cell Gene Therapy Research, Institute of Nuclear Medicine & Allied Sciences (INMAS), Delhi, India Hematopoietic stem cells are endowed with a distinct potential to bolster self-renewal and to generate progeny that  differentiate into mature cells of myeloid and lymphoid lineages.",Non-OADS,/arxiv_data1/oa_pdf/3d/6e/ijsc-09-036.PMC4961102.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.44 ORIGINAL ARTICLE 44Accepted for publication January 23, 2016, Published online May 30, 2016 Correspondence to Dina Sabry Department of Medical Biochemistry and Molecular Biology,  Faculty of Medicine, Cairo University, Cairo 11561, EgyptTel: +2-02-23632297, Fax: +2-02-23632297 E-mail: dinasabry@kasralainy.edu.eg  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Comparative Evaluation for Potential Differentiation of  Endothelial Progenitor Cells and Mesenchymal  Stem Cells into Endothelial-Like Cells Dina Sabry1, Olfat Noh2, Mai Samir1 1Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt  2Obstetrics and Gynecology Department, Faculty of Medicine, Cairo University, Cairo, Egypt Understanding the mechanisms of vascular remodeling could lead to more effective treatments for ischemic conditions.",Non-OADS,/arxiv_data1/oa_pdf/65/01/ijsc-09-044.PMC4961103.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.60 ORIGINAL ARTICLE 60Accepted for publication February 14, 2016, Published online May 30, 2016 Correspondence to Shabari Sarang Reliance Life Sciences Pvt Ltd., Dhirubhai Ambani Life Sciences  Centre, R/282, MIDC area of TTC, Thane Belapur Road, Rabale,  Navi Mumbai 400701, India Tel: +91-22-67678436, Fax: +91-22-67678099 E-mail: shabari.tipnis@relbio.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Umbilical Cord Derived Mesenchymal Stem Cells Useful in  Insulin Production - Another Opportunity in Cell Therapy Shabari Sarang, Chandra Viswanathan Reliance Life Sciences Pvt Ltd., Dhirubhai Ambani Life Sciences Centre, Navi Mumbai, India Background and Objectives: T y p e  1  D i a b e t e s  M e l l i t u s  ( T 1 D M )  i s  a n  a u t o i m m u n e  d i s o r d e r  r e s u l t i n g  o u t  o f  T  c e l l  m e d i - ated destruction of pancreatic beta cells.",Non-OADS,/arxiv_data1/oa_pdf/a2/61/ijsc-09-060.PMC4961105.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.70 ORIGINAL ARTICLE 70Accepted for publication February 11, 2016, Published online May 30, 2016 Correspondence to Rehab H. Ashour Lecturer of Clinical Pharmacology, Faculty of Medicine, Mansoura  University, El-Gomhoria Street, El-Mansoura 35516, EgyptTel: +2-01005409956, Fax: +20-50-2248203 E-mail: zohoor26203@yahoo.com, drrehab40@mans.edu.eg  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Amniotic Fluid-Derived Mesenchymal Stem Cells  Cut Short the Acuteness of Cisplatin-Induced  Nephrotoxicity in Sprague-Dawley Rats Fatma Al-Husseiny1,5, Mohamed Ahmed Sobh2, Rehab H. Ashour4, Samah Foud5, Tarek Medhat3,  Abdel-Hady El-Gilany6, Doaa Elghannam7, Hassan Abdel-Ghaffar7, Mohamed-Ahdy Saad4,5, Mohamed Sobh3,5 1Department of Pathology, 2Zoology Unit-3Urology and Nephrology Center, 4Department of Clinical Pharmacology,  5Medical Experimental Research Center (MERC), 6Department of Public Health,  7Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt Background and objectives:  Cisplatin is a nephrotoxic chemotherapeutic agent.",Non-OADS,/arxiv_data1/oa_pdf/18/d4/ijsc-09-070.PMC4961106.pdf
Supplementary Materials   Supplementary data including three figure can be found  with this article online at http://pdf.medrang.co.kr/paper/  pdf/IJST/IJST-09-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/d4/ijsc-09-070.PMC4961106.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.79 ORIGINAL ARTICLE 79Accepted for publication January 22, 2016, Published online May 30, 2016 Correspondence to Mohamed Abouelkheir Department of Clinical Pharmacology, Faculty of Medicine, Man- soura University, El-Goumhouria Street, El-Mansoura 35516, EgyptTel: +20-50-2315281, +20-50-2478061, Fax: +20-50-2248203 E-mail: aboelkhairmohamed@yahoo.com, mkhair@mans.edu.eg  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Study of the Effect of Route of Administration  of Mesenchymal Stem Cells on Cisplatin-Induced  Acute Kidney Injury in Sprague Dawley Rats Fatma E Moustafa1, Mohamed-A Sobh2, Mohamed Abouelkheir3, Youmna Khater4,  Khalid Mahmoud2, Mohamed-Ahdy Saad3, Mohamed A Sobh2,4 1Department of Pathology, 2Urology and Nephrology Center, 3Department of Clinical Pharmacology,  4Mansoura Medical Experimental Research Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt Background and Objectives: Mesenchymal stem cells (MSCs) have been shown to ameliorate cisplatin-induced acute  kidney injury (AKI).",Non-OADS,/arxiv_data1/oa_pdf/04/2c/ijsc-09-079.PMC4961107.pdf
Supplementary Materials   Supplementary data including one figure can be found with this article online at http://pdf.medrang.co.kr/paper/ pdf/IJST/IJST-09-s002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/2c/ijsc-09-079.PMC4961107.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.90 ORIGINAL ARTICLE 90Accepted for publication January 19, 2016, Published online May 30, 2016 Correspondence to Nassim H. Abi Chahine Neurosurgery, The Lebanese-Canadian Hospital, Sin El Fil, Horch  Tabet, Beirut, LebanonTel: +961-308-2498, Fax: +961-695-1100 E-mail: nassim@wp.eu  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Treatment of Cerebral Palsy with Stem Cells:  A Report of 17 Cases Nassim H. Abi Chahine1, Tarek W. Wehbe2, Ramzi A. Hilal3,  Victoria V. Zoghbi4, Alia E. Melki5, Emil B. Bou Habib6 1Neurosurgery, The Lebanese-Canadian Hospital, Beirut, Lebanon, 2H e a d  o f  t h e  D e p a r t m e n t  o f  H e m a t o l o g y ,   Notre Dame Du Liban University Hospital and The Lebanese-Canadian Hospital, Beirut, Lebanon, 3Neurology, Head of the  Department, The Lebanese-Canadian Hospital, Beirut, 4Anesthesiology and Reanimation, Salam Hospital, Tripoli, Lebanon 5Doctorate of Acupuncture and TCM, The Five Elements Wellness Center, Koura, Lebanon 6Neurosurgery, Head of Department, The Lebanese-Canadian Hospital, Beirut, Lebanon Cerebral Palsy (CP) is a disabling condition that affects a child's life and his/her family irreversibly.",Non-OADS,/arxiv_data1/oa_pdf/ee/db/ijsc-09-090.PMC4961108.pdf
2015 Oct. Availa- ble from: http://cerebralpalsy.org/about-cerebral-palsy/costs/.3.,Non-OADS,/arxiv_data1/oa_pdf/ee/db/ijsc-09-090.PMC4961108.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.96 ORIGINAL ARTICLE 96Accepted for publication December 23, 2015, Published online May 30, 2016 Correspondence to Walaa Baher Department of Histology, Faculty of Medicine, Ain Shams University,  Abasyia, Cairo 11358, EgyptTel: +20-1002050563, Fax: +20-222909854 E-mail: walaabaher78@gmail.com  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Therapeutic Potential of Bone Marrow-Derived  Mesenchymal Stem Cells on Experimental Liver Injury  Induced by Schistosoma mansoni : A Histological Study Heba Fikry, Sara Abdel Gawad, Walaa Baher Department of Histology, Faculty of Medi cine, Ain Shams University, Cairo, Egypt Background and Objectives:  Bone marrow derived mesenchymal stem cells (BM-MSCs) have been proposed as effective  treatment of many diseases owing to their unique ability to differentiate into other cell types in vivo .",Non-OADS,/arxiv_data1/oa_pdf/b4/ff/ijsc-09-096.PMC4961109.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.107 ORIGINAL ARTICLE 107Accepted for publication December 9, 2015, Published online May 30, 2016 Correspondence to Seyed Alireza Mesbah-Namin Department of Clinical Biochemistry, Faculty of Medical Sciences,  Tarbiat Modares University, Tehran 14115-111, IranTel: +98-2182883570, Fax: +98-2182884555 E-mail: mesbahna@modares.ac.ir  This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.L-carnitine Effectively Induces hTERT  Gene Expression of  Human Adipose Tissue-derived Mesenchymal Stem Cells  Obtained from the Aged Subjects Raheleh Farahzadi1, Seyed Alireza Mesbah-Namin1, Nosratollah Zarghami2,3, Ezzatollah Fathi4 1Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University,  2Department of Biochemistry and Clinical Laboratories, Faculty of Medicine,  3Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences,  4Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran Background and Objectives:  Human mesenchymal stem cells (hMSCs) are attractive candidates for cell therapy and  regenerative medicine due to their multipotency and ready availability, but their application can be complicated by  the factors such as age of the donors and senescence-associated growth arrest during culture conditions.",Non-OADS,/arxiv_data1/oa_pdf/ae/fa/ijsc-09-107.PMC4961110.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.124 ORIGINAL ARTICLE 124Accepted for publication November 6, 2015, Published online May 30, 2016 Correspondence to Diana Legzdina Latvian Biomedical Research and Study Centre, Ratsupites Str.1  k-1, Riga, LV-1067, Latvia Tel: +371 67808200, Fax: +371 67442407E-mail: dianal@biomed.lu.lv *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d9/cc/ijsc-09-124.PMC4961112.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Characterization of Senescence of Culture-expanded Human  Adipose-derived Mesenchymal Stem Cells Diana Legzdina1,*, Anete Romanauska1,*, Sergey Nikulshin2, Tatjana Kozlovska1, Uldis Berzins1 1Latvian Biomedical Research and Study Centre, Riga, Latvia,  2Children’s Clinical University Hospital, Clinical Laboratory, Riga, Latvia Background and Objectives:  Adipose-derived mesenchymal stem cells (ADSCs) are promising candidates in regenerative  medicine.",Non-OADS,/arxiv_data1/oa_pdf/d9/cc/ijsc-09-124.PMC4961112.pdf
Supplementary Materials   Supplementary data including four figure can be found  with this article online at http://pdf.medrang.co.kr/paper/  pdf/IJST/IJST-09-s003.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/cc/ijsc-09-124.PMC4961112.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.137 ORIGINAL ARTICLE 137Accepted for publication October 21, 2015, Published online May 30, 2016 Correspondence to Maria Rosaria De Pascale Division of Immunohematology, Transfusion Medicine and Transplant Immunology, Department of Internal Medicine and Specialistics , AOU  Second University of Naples, Piazza L. Miraglia 2, Naples 80138, ItalyTel: +39-0815665070, Fax: +39-0815665092 E-mail: maria.depascale@policliniconapoli.it *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b3/07/ijsc-09-137.PMC4961113.pdf
"1, 2016 http://dx.doi.org/10.15283/ijsc.2016.9.1.152 ORIGINAL ARTICLE 152Accepted for publication October 21, 2015, Published online May 30, 2016 Correspondence to U. Deniz Dincer Department of Pharmacology, School of Pharmacy, Department of  Clinical Pharmacy  School of Pharmacy, Department of Pharmacology, School of Medicine, Girne American University,  University Drive, 99428 Karmi Campus, Karaoglanoglu, Girne,  North Cyprus via Mersin 10, TurkeyTel: +90-392-6502000, Fax: +90-392-6502062 E-mail: denizdincer@gau.edu.tr   This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.Moderate Hypoxia Exhibits Increased Endothelial Progenitor  Vessel-forming Ability However Gestational Diabetes Caused  to Impede Compensatory Defense Reaction  U. Deniz Dincer1,2,3 1Department of Pharmacology, School of Pharmacy, 2Department of Clinical Pharmacy, School of Pharmacy, 3Department of Pharmacology, School of Medicine, Girne American University, Girne, North Cyprus via Mersin 10, Turkey Endothelium represents a defense barrier and responds and integrates neuro humoral stimulus which describes as a  compensatory mechanism.",Non-OADS,/arxiv_data1/oa_pdf/0b/b0/ijsc-09-152.PMC4961115.pdf
Primers  were designed using Genomatix and (http://www.genoma- tix.de/cgi-in/dialign/dialign.pl) the National Center for Biotechnology Information database (http://www3.ncbi.,OADS,/arxiv_data1/oa_pdf/0b/b0/ijsc-09-152.PMC4961115.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Methicillin-susceptible Staphylococcus aureus Panton-Valentibe LeukocidinST1-MSSA PVL positive Malaysia isolates Speciﬁcations Organism/cell line/tissue Methicillin-susceptible Staphylococcus aureus Strain KT/314250 Sequencer or array typeIllumina GA IIx Data format Assembled Experimental factorsBacterial strain Experimental featuresAssembled and annotated draft genome of a strain of methicillin susceptible Staphylococcus aureus PVL+from east coast Malaysia Consent Not applicable Sample source locationPus 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.002 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
16 (6) (2010) 575 –582 ( http://doi.org/ 10.1111/j.1469-0691.2009.02891.x ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
50 (3) (2006) 1001 –1012 ( http://doi.org/10.1128/AAC.50.3.1001-1012.2006 ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
29 (5) (1999) 1128 –1132 (http://doi.org/10.1086/313461 ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
"Shahbazkia, DNAGear – a free software for spa type identi ﬁcation in Staphylococcus aureus .B M CR e s .N o t e s5 (2012) 642 ( http://doi.org/10.1186/1756-0500-5-642 ).",Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
"2005, http://dx.doi.org/10.1093/bioinformatics/bti610 .",OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
BMC Genomics 9 (2008) 75 ( http://doi.org/10.1186/1471-2164-9-75 ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
"33 (Web Server issue) (2005) W455 –W459, http://dx.doi.org/10.1093/ nar/gki593 .",Non-OADS,/arxiv_data1/oa_pdf/1f/9c/main.PMC4961218.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.06.014 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
"91 (May  (5)) (2013)  e25,  http://dx.doi.org/10.1016/j.ciresp.2012.05.012  (Epub  2012  Oct 26).",OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
"1) (2014)  UCTN:E666,  http://dx.doi.org/10.1055/s- 0034-1390867 (Eub  2014  Dec  19).",Non-OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
"75  (April  (4))  (2012)  918–919,  http://dx.doi.org/10.1016/j.gie.2011.",OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
"25  (January  (1))  (2009) 45–48, http://dx.doi.org/10.1016/s1607-551x(09)70040-3 .",Non-OADS,/arxiv_data1/oa_pdf/38/3f/main.PMC4961227.pdf
"2016 Fe b 15; 143 (4):582-8. http://dx.doi.org/10.1242/dev.126573 #Present address: Max-Delbru €ck-Zentrum fu €r Molekulare Medizin, Berlin, Germany © 2016 Jean-Loup Duband, Sophie Escot, and Claire Fournier-Thibault.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"1, e1195050 (8 pages)http://dx.doi.org/10.1080/21675511.2016.1195050",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
Curr OpinPediatr 2005; 17:725-30; PMID:16282778; http://dx.doi.org/10.1097/01.mop.0000184465.73833.0b [2] Scambler PJ.,OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Pediatr Cardiol 2010; 31:378-90; PMID:20054531; http://dx.doi.org/10.1007/s00246-009-9613-0 [3] Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah YC, Rosenblatt HM, Bradley A, Baldini A. Congenitalheart disease in mice de ﬁcient for the DiGeorge syn- drome region.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
NatGenet 2001; 27:286-91; PMID:11242110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Cell 2001; 104:619-29;PMID:11239417; http://dx.doi.org/10.1016/S0092-8674 (01)00247-1 [6] Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF,Scambler PJ, et al.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Nature 2001; 410:97-101; PMID:11242049; http://dx.doi.org/10.1038/35065105 [7] Zhang Z, Baldini A.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Hum Mol Genet 2008; 17:150-7; PMID:17916582; http://dx.doi.org/10.1093/hmg/ddm291 [8] Zhang Z, Cerrato F, Xu H, Vitelli F, Morishima M, Vin- centz J, Furuta Y, Ma L, Martin JF, Baldini A, et al.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Development 2005;132:5307-15; PMID:16284121; http://dx.doi.org/10.1242/ dev.02086 [9] Zhang Z, Huynh T, Baldini A. Mesodermal expression of Tbx1 is necessary and suf ﬁcient for pharyngeal arch and cardiac out ﬂow tract development.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Development 2006; 133:3587-95; PMID:16914493; http://dx.doi.org/10.1242/dev.02539 [10] Arnold JS, Werling U, Braunstein EM, Liao J, Nowot- schin S, Edelmann W, Hebert JM, Morrow BE.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Development 2006; 133:977-87;PMID:16452092; http://dx.doi.org/10.1242/dev.02264 [11] Yamagishi H, Srivastava D. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome.Trends Mol Med 2003; 9:383-9; PMID:13129704; http://dx.doi.org/10.1016/S1471-4914(03)00141-2 [12] Epstein JA.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Semin Cell Dev Biol 2007;18:101-10; PMID:17224285; http://dx.doi.org/10.1016/j.semcdb.2006.12.004 [14] Garg V, Yamagishi C, Hu T, Kathiriya IS, Yamagishi H, Srivastava D. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngealarch development.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Dev Biol 2001; 235:62-73;PMID:11412027; http://dx.doi.org/10.1006/dbio.2001.0283 [15] Kochilas L, Merscher-Gomez S, Lu MM, Potluri V, Liao J, Kucherlapati R, Morrow B, Epstein JA.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
Develop Biol 2002; 251:157-66; PMID:12413905; http://dx.doi.org/10.1006/ dbio.2002.0819e1195050-6 J.-L. DUBAND ET AL.,OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Development 2009; 136:3173-83;PMID:19700621; http://dx.doi.org/10.1242/dev.028902 [17] Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A. Tbx1 mutation causes multiple cardiovascular defectsand disrupts neural crest and cranial nerve migratorypathways.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Hum Mol Genet 2002; 11:915-22;PMID:11971873; http://dx.doi.org/10.1093/hmg/11.8.915 [18] Vitelli F, Taddei I, Morishima M, Meyers EN, Lindsay EA, Baldini A.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Dev Biol 2011;354:18-30; PMID:21419761; http://dx.doi.org/10.1016/j.ydbio.2011.03.010 [22] McLennan R, Teddy JM, Kasemeier-Kulesa JC, Romine MH, Kulesa PM.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Dev Biol 2010; 339:114-25; PMID:20036652; http://dx.doi.org/10.1016/j.ydbio.2009.12.022 [23] Kulesa PM, Bailey CM, Kasemeier-Kulesa JC, McLennan R. Cranial neural crest migration: New rules for an oldroad.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"J Neurosci 2010; 30:13078-88; PMID:20881125; http://dx.do i.org/10.1523/JNEUROSCI.0892- 10.2010 [25] Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Nature 1998;393:595-9; PMID:9634238; http://dx.doi.org/10.1038/31269 [27] Meechan DW, Tucker ES, Maynard TM, LaMantia AS.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Proc Natl Acad Sci U S A 2012; 109:18601-6; PMID:23091025; http://dx.doi.org/ 10.1073/pnas.1211507109[28] Toritsuka M, Kimoto S, Muraki K, Landek-Salgado MA, Yoshida A, Yamamoto N, Horiuchi Y, Hiyama H,Tajinda K, Keni N, et al.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"PLoSOne 2014; 9:e95151; PMID:24797903; http://dx.doi.org/10.1371/journal.pone.0095151 [30] Escot S, Blavet C, Hartle S, Duband JL, Fournier-Thibault C. Misregulation of SDF1-CXCR4 signaling impairs earlycardiac neural crest cell migration leading to conotruncal defects.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Circ Res 2013; 113:505-16; PMID:23838132; http://dx.doi.org/10.1161/CIRCRESAHA.113.301333 [31] Escot S, Blavet C, Faure E, Zaffran S, Duband JL, Four- nier-Thibault C. Disruption of CXCR4 signaling in pha-ryngeal neural crest cells causes DiGeorge syndrome-likemalformations.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Development 2016; 143:582-8;PMID:26755698; http://dx.doi.org/10.1242/dev.126573 [32] van Bueren KL, Papangeli I, Rochais F, Pearce K, Roberts C, Calmont A, Szumska D, Kelly RG, Bhattacharya S, Scambler PJ.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Dev Biol 2010;340:369-80; PMID:20122914; http://dx.doi.org/10.1016/j.ydbio.2010.01.020 [33] Yamagishi H, Maeda J, Hu T, McAnally J, Conway SJ, Kume T, Meyers EN, Yamagishi C, Srivastava D. Tbx1 is regulated by tissue-speci ﬁc forkhead proteins through a common Sonic hedgehog-responsive enhancer.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"GenesDev 2003; 17:269-81; PMID:12533514; http://dx.doi.org/10.1101/gad.1048903 [34] Katoh M, Katoh M. Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based onTGFbeta, Nodal, Activin signaling and POU5F1, FOXA2,FOXC2, FOXH1, SOX17, and GFI1 transcription factors.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Devel- opment 2006; 133:2419-33; PMID:16720879; http://dx.doi.org/10.1242/dev.02367 [36] Vitelli F, Zhang Z, Huynh T, Sobotka A, Mupo A, Baldini A. Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modi ﬁes the aortic arch but not the outﬂow tract phenotype of Tbx1 mutants.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Dev Biol 2006; 295:559-70; PMID:16696966; http://dx.doi.org/10.1016/j.ydbio.2006.03.044 [37] Karpinski BA, Maynard TM, Fralish MS, Nuwayhid S, Zohn IE, Moody SA, LaMantia AS.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
Dis Model Mech 2014; 7:245-57; PMID:24357327; http://dx.doi.org/ 10.1242/dmm.012484RARE DISEASES e1195050-7,Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Circ Res 1999; 84:127-35; PMID:9933243;http://dx.doi.org/10.1161/01.RES.84.2.127 [39] Yamagishi C, Hierck BP, Gittenberger-De Groot AC, Yamagishi H, Srivastava D. Functional attenuation of UFD1l, a 22q11.2 deletion syndrome candidate gene,leads to cardiac out ﬂow septation defects in chicken embryos.",Non-OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Pediatr Res 2003; 53:546-53; PMID:12612215;http://dx.doi.org/10.1203/01.PDR.0000055765.11310.E3 [40] Hierck BP, Molin DG, Boot MJ, Poelmann RE, Gitten- berger-de Groot AC.",OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
Pediatr Res 2004; 56:440-8; PMID:15333760; http://dx.doi.org/ 10.1203/01.PDR.0000136151.50127.1Ce1195050-8 J.-L. DUBAND ET AL.,OADS,/arxiv_data1/oa_pdf/58/f2/krad-04-01-1195050.PMC4961262.pdf
"Molecular Psychiatry,5 January 2016; http://dx.doi.org/10.1038/mp.2015.192.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"1, e1198458 (11 pages)http://dx.doi.org/10.1080/21675511.2016.1198458",Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"An expanded list of myelin-related genes was gen- erated by more extensive literature searching andapplication of an augmented suite of bioinformaticstools including DAVID ( http://david.abcc.ncifcrf.gov/ home.jsp ), KEGG ( http://www.genome.jp/kegg/ ), NCBI Biosystems ( http://www.ncbi.nlm.nih.gov/bio systems/ ) and AmiGO2 ( http://amigo.geneontology.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Hepatology2012; 56:585-93; PMID:22383097; http://dx.doi.org/ 10.1002/hep.25689 [4] Heidari M, Johnstone DM , Bassett B, Graham RM, Chua ACG, House MJ, Collingwood JF, BettencourtC, Houlden H, Ryten M, et al.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Neurochem Int 2010; 56:856-63; PMID:20350576;http://dx.doi.org/10.1016 /j.neuint.2010.03.015 [6] Acikyol B, Graham RM, Trinder D, House MJ, Olynyk JK, Scott RJ, Milward EA, Johnstone DM.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Neuroscience2013; 235:119-28; PMID:23333676; http://dx.doi.org/10.1016/j.neuroscience.2013.01.014 [7] Johnstone D, Graham RM, Trinder D, Delima RD, Riveros C, Olynyk JK, Scott RJ, Moscato P, Milward EA.Brain transcriptome perturbations in the Hfe( ¡/¡) mouse model of genetic iron loading.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Brain Res 2012; 1448:144-52; PMID:22370144; http://dx.doi.org/10.1016/j.brainres.2012.02.006 [8] Johnstone D, Riveros C, Heidari M, Graham R, Trinder D, Berretta R, Olynyk J, Scott R, Moscato P, Milward E.Evaluation of Different Normalization and Analysis Pro-cedures for Illumina Gene Expression Microarray DataInvolving Small Changes.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"2013; 2:131-52; http://www.mdpi.com/2076-3905/2/2/131 [9] Bettencourt C, Forabosco P, Wiethoff S, Heidari M, Johnstone DM, Botia JA, Collingwood JF, Hardy J, Mil-ward EA, Ryten M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Neu-robiol Dis 2016; 87:59-68; PMID:26707700; http://dx.doi.org/10.1016/j.nbd.2015.12.004 [10] Bhatia KP, Schneider S. Metal Related Neurodegenera- tive Disease.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"J Neurosci 2011; 31:13301-11; PMID:21917813;http://dx.doi.org/10.152 3/JNEUROSCI.2838-11.2011 [14] Alazami AM, Schneider SA, Bonneau D, Pasquier L, Carecchio M, Kojovic M, Steindl K, de Kerdanet M,Nezarati MM, Bhatia KP, et al.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"ClinGenet 2010; 78:585-90; PMID:20507343; http://dx.doi.org/10.1111/j.1399-0004.2010.01441.x [15] Ben-Omran T, Ali R, Almureikhi M, Alameer S, Al-Saffar M, Walsh CA, Felie JM, Teebi A. Phenotypic heterogene- ity in Woodhouse-Sakati syndrome: two new families with a mutation in the C2orf37 gene.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Am J Med Genet A2011; 155A:2647-53; PMID:21964978; http://dx.doi.org/10.1002/ajmg.a.34219 [16] Okamoto N, Ikeda T, Hasegawa T, Yamamoto Y, Kawato K, Komoto T, Imoto I.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Am J Med Genet A 2014; 164:3095-9;http://dx.doi.org/10.1002/ajmg.a.36779 [17] Rathore GS, Schaaf CP, Stocco AJ.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Mov Disord 2014; 29:574-5;PMID:24610255; http://dx.doi.org/10.1002/mds.25868 [18] Drecourt A, Boddaert N, Desguerre I, Chretien D, Munnich A, Rotig A. REPS1 is a novel gene of Neu-rodegeneration with Brain I ron Accumulation.",Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"J Neurol 2010; 257:1465-72; PMID:20358215; http://dx.doi.org/10.1007/s00415-010-5548-x [20] Shen MR, Chou CY, Hsu KF, Liu HS, Dunham PB, H o l t z m a nE J ,E l l o r yJ C .T h eK C lc o t r a n s p o r t e ri s o f o r m KCC3 can play an important role in cell growth regulation.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Aging 2010; 2:567-81;PMID:20844315; http://dx.doi.org/10.18632/aging.100195 [23] Brobey RK, German D, Sonsalla PK, Gurnani P, Pastor J, Hsieh CC, Papaconstantinou J, Foster PP, Kuro-o M, Rosenblatt KP.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"PloS one 2015; 10: e0139914; PMID:26452228; http://dx.doi.org/10.1371/journal.pone.0139914 [24] Zeldich E, Chen CD, Colvin TA, Bove-Fenderson EA, Liang J, Tucker Zhou TB, Harris DA, Abraham CR.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"J Biol Chem 2014; 289:24700-15; PMID:25037225; http://dx.doi.org/10.1074/ jbc.M114.567321 [25] Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T,Kume E, et al.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Nature 1997; 390:45-51; PMID:9363890; http://dx.doi.org/10.1038/36285 [26] Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"Sci Rep 2015; 5:14235; PMID:26383267; http://dx.doi.org/10.1038/srep14235 [28] Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA.",OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
Trends Genet 1999; 15:125-8; PMID:10203813;http://dx.doi.org/10.1016/S0168-9525(99)01716-3RARE DISEASES e1198458-11,Non-OADS,/arxiv_data1/oa_pdf/e7/97/krad-04-01-1198458.PMC4961263.pdf
"1, e1195043 (9 pages)http://dx.doi.org/10.1080/21675511.2016.1195043",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"ORCID Ola Abdelhadi http://orcid.org/0000-0002-6341-6885 Robert Kleta http://orcid.org/0000-0002-0228-8656 Detlef Bockenhauer http://orcid.org/0000-0001-5878-941X References [1] Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, Reichold M, Tobin J, Lieberer E, Sterner C,Landoure G, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
2009; 360(19):p. 1960-70; PMID:19420365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Am J Med Genet 1993; 46(5):p.592-6; PMID:8322826; http://dx.doi.org/10.1002/ajmg.1320460526 [4] Cross JH, Arora R, Heckemann RA, Gunny R, Chong K, Carr L, Baldeweg T, Differ AM, Lench N, Varadkar S, et al.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Dev Med ChildNeurol 2013; 55(9):p. 846-56; PMID:23924083; http://dx.doi.org/10.1111/dmcn.12171 [5] Freudenthal B, Kulaveerasingam D, Lingappa L, Shah MA, Brueton L, Wassmer E, Ognjanovic M, Dorison N,Reichold M, Bockenhauer D, et al.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Neph- ron Physiol 2011; 119(3):p. p40-8; PMID:21849804;http://dx.doi.org/10.1159/000330250 [6] Parrock S, Hussain S, Issler N, Differ AM, Lench N, Guarino S, Oosterveld MJ, Keijzer-Veen M, Brilstra E,van Wieringen H, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Pediatr Nephrol 2012; 27(11):p. 2081-90;PMID:22907601; http://dx.doi.org/10.1007/s00467-012-2219-4 [8] Reichold M, Zdebik AA, Lieberer E, Rapedius M, Schmidt K, Bandulik S, Sterner C, Tegtmeier I, Pen- t o nD ,B a u k r o w i t zT ,e ta l .K C N J 1 0g e n em u t a t i o n scausing EAST syndrome (epilepsy, ataxia, sensorineu-ral deafness, and tubulopathy) disrupt channel func-tion.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Nat Genet1996; 12(1):p. 24-30; PMID:8528245; http://dx.doi.org/10.1038/ng0196-24 [10] Kleta R, Bockenhauer D. Bartter syndromes and other salt-losing tubulopathies.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Nephron Physiol 2006; 104(2): p. p73-80; PMID:16785747; http://dx.doi.org/10.1159/ 000094001[11] Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Nat Genet 1996; 13(2):p. 183-8; PMID:8640224; http://dx.doi.org/10.1038/ng0696-183 [12] Scheinman SJ, Guay-Woodford LM, Thakker RV, War- nock DG.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"N Engl J Med 1999; 340(15):p. 1177-87; PMID:10202170; http://dx.doi.org/10.1056/NEJM199904153401507 [13] Tanemoto M, Abe T, Uchida S, Kawahara K. Mislocaliza- tion of K Cchannels causes the renal salt wasting in EAST/SeSAME syndrome.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"FEBS Lett 2014; 588(6):p.899-905; PMID:24561201; http://dx.doi.org/10.1016/j.febslet.2014.02.024 [14] Shi M, Zhao G. The EAST syndrome and KCNJ10 mutations.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
N Engl J Med 2009; 361(6):p. 630; author reply 630-1; PMID:19657131; http://dx.doi.org/10.1056/NEJMc091202 [15] Stivaros S. How the imaging investigation of EAST syn- drome points towards the future of radiological multi-parametric phenotyping of a genetic disease.,Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Neuro- science 2014; 265:p. 137-46; PMID:24480364; http://dx.doi.org/10.1016/j.neuroscience.2014.01.036 [17] Olsen ML, Sontheimer H. Functional implications for Kir4.1 channels in glial biology: from K Cbuffering to cell differentiation.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"J Neurochem 2008; 107(3):p. 589-601; PMID:18691387; http://dx.doi.org/10.1111/j.1471-4159.2008.05615.x [18] Kuf ﬂer SW, Nicholls JG.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Ergeb Physiol 1966; 57:p. 1-90; PMID:5330861;http://dx.doi.org/10.1007/BF02259903 [19] Orkand RK, Nicholls JG, Kuf ﬂer SW. Effect of nerve impulses on the membrane potential of glial cells in thecentral nervous system of amphibia.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Neuroscience 2004; 129(4):p. 1045-56; PMID:15561419; http://dx.doi.org/10.1016/j.neuroscience.2004.06.008 [21] Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P. Kir4.1 potassium channel subunit is crucial for oligoden-drocyte development and in vivo myelination.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Am J Physiol Cell Physiol 2002; 282(2):p.C403-7; PMID:11788352; http://dx.doi.org/10.1152/ajpcell.00312.2001 [25] Zdebik AA, Wangemann P, Jentsch TJ.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
Physiology (Bethesda) 2009; 24:p. 307-16;PMID:19815857;http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"org/10.1152/physiol.00018.2009 [26] Rozengurt N, Lopez I, Chiu CS, Kofuji P, Lester HA, Neusch C. Time course of inner ear degeneration and deaf-ness in mice lacking the Kir4.1 potassium channel subunit.Hear Res 2003; 177(1-2):p. 71-80; PMID:12618319; http:// dx.doi.org/10.1016/S0378-5955(02)00799-2 [27] Ito M, Inanobe A, Horio Y, Hibino H, Isomoto S, Ito H, Mori K, Tonosaki A, Tomoike H, Kurachi Y. Immunolocalizationof an inwardly rectifying K Cchannel, K(AB)-2 (Kir4.1), in the basolateral membrane of renal distal tubular epithelia.FEBS Lett 1996; 388(1):p. 11-5; PMID:8654579; http://dx.doi.org/10.1016/0014-5793(96)00502-9 [28] Tanemoto M, Abe T, Onogawa T, Ito S. PDZ binding motif-dependent localization of K Cchannel on the baso- lateral side in distal tubules.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
Am J Physiol Renal Physiol2004; 287(6):p. F1148-53; PMID:15292049; http://dx.doi.org/10.1152/ajprenal.00203.2004 [29] Bindels RJ.,Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"JAm Soc Nephrol 2010; 21(8):p. 1263-9; PMID:20595678;http://dx.doi.org/10.1681/ASN.2010010001 [30] Reilly RF, Ellison DH.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Acta Physiol Scand 1958; 42(3 –4):p. 298- 308; PMID:13544986; http://dx.doi.org/10.1111/j.1748- 1716.1958.tb01563.x [34] Lachheb S, Cluzeaud F, Bens M, Genete M, Hibino H, Lourdel S, Kurachi Y, Vandewalle A, Teulon J, PaulaisM.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Am J Physiol Renal Physiol 2008; 294(6):p. F1398-407; PMID:18367659; http://dx.doi.org/10.1152/ajprenal.00288.2007 [35] Schultheis PJ, Lorenz JN, Meneton P, Nieman ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, ShullGE.",Non-OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"J Biol Chem 1998; 273(44):p. 29150-5;PMID:9786924; http://dx.doi.org/10.1074/jbc.273.44.29150 [36] Nijenhuis T, Vallon V, van der Kemp AW, Lof ﬁng J, Hoenderop JG, Bindels RJ.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"J Clin Invest 2005; 115(6):p. 1651-8; PMID:15902302;http://dx.doi.org/10.1172/JCI24134 [37] Takumi T, Ishii T, Horio Y, Morishige K, Takahashi N, Yamada M, Yamashita T, Kiyama H, Sohmiya K, Naka-nishi S. A novel ATP-dependent inward recti ﬁer potas- sium channel expressed predominantly in glial cells.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"JBiol Chem 1995; 270(27):p. 16339-46; PMID:7608203; http://dx.doi.org/10.1074/jbc.270.27.16339 [38] Sala-Rabanal M, Kucheryavykh LY, Skatchkov SN, Eaton MJ, Nichols CG.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"J BiolChem 2010; 285(46):p. 36040-8; PMID:20807765; http://dx.doi.org/10.1074/jbc.M110.163170 [39] Williams DM, Lopes CM, Rosenhouse-Dantsker A, Con- nelly HL, Matavel A, O-Uchi J, McBeath E, Gray DA.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"J Am Soc Nephrol 2010; 21(12):p.2117-29; PMID:21088294; http://dx.doi.org/10.1681/ASN.2009121227 [40] Lourdel S, Paulais M, Cluzeaud F, Bens M, Tanemoto M, Kurachi Y, Vandewalle A, Teulon J.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"The Journal of Physiology 2002; 538(2):p. 391-404; PMID:11790808; http://dx.doi.org/10.1113/jphysiol.2001.012961 [41] Tanemoto M, Kittaka N, Inanobe A, Kurachi Y.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"The Journal of Physi-ology 2000; 525(3):p. 587-592; PMID:10856114; http://dx.doi.org/10.1111/j.1469-7793.2000.00587.x [42] Zhang C, Wang L, Su XT, Lin DH, Wang WH.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"Am J Physiol Renal Physiol2015; 308(11):p. F1288-96; PMID:25834074; http://dx.doi.org/10.1152/ajprenal.00687.2014 [43] Tang X, Hang D, Sand A, Kofuji P. Variable loss of Kir4.1 channel function in SeSAME syndrome muta-tions.",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"bbrc.2010.07.105 [44] Hibino H, Higashi-Shingai K, Fujita A, Iwai K, Ishii M ,K u r a c h iY .E x p r e s s i o no fa ni n w a r d l yr e c t i f y i n gKCchannel, Kir5.1, in speci ﬁc types of ﬁbrocytes in the cochlear lateral wall suggests its functional impor-tance in the establishment of endocochlear potential.European Journal of Neuroscience 2004; 19(1):p. 76- 84; PMID:14750965; http://dx.doi.org/10.1111/j.1460- 9568.2004.03092.xRARE DISEASES e1195043-9",OADS,/arxiv_data1/oa_pdf/3e/b9/krad-04-01-1195043.PMC4961265.pdf
"COLUMN EDITOR: Brad Schoenfeld, PhD, CSCS, CSPS, NSCA-CPT Application of the Repetitions in Reserve- Based Rating of Perceived Exertion Scale for Resistance Training Eric R. Helms, MS, CSCS,1John Cronin, PhD, CSCS,1,2Adam Storey, PhD,1and Michael C. Zourdos, PhD, CSCS3 1Sport Performance Research Institute New Zealand (SPRINZ), AUT University, Auckland, New Zealand;2School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth, Australia; and3Department of Exercise Science and Health Promotion, Muscle Physiology Laboratory, Florida Atlantic University, Boca Raton, Florida Supplemental digital content is available for this article (Video 1, http://links.lww.com/SCJ/A185).",Non-OADS,/arxiv_data1/oa_pdf/f3/fe/scj-38-42.PMC4961270.pdf
Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (http://journals.lww.com/nsca-scj).,Non-OADS,/arxiv_data1/oa_pdf/f3/fe/scj-38-42.PMC4961270.pdf
11 This patient category was more sensitive  to losartan treatment when compared with most patients with a  Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.116.307841Objective—Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the fibrillin-1 gene.,Non-OADS,/arxiv_data1/oa_pdf/b3/e7/atv-36-1618.PMC4961273.pdf
"The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.116.307841/-/DC1.Correspondence to Vivian de Waard, PhD, Academic Medical Center, Amsterdam, Department of Medical Biochemistry, K1-114, Meibergdreef 15, 1105  AZ Amsterdam, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/b3/e7/atv-36-1618.PMC4961273.pdf
"4 Cathepsins are a family of cysteine proteases localized  in lysosomes.5–7 Over the past decade, emerging data revealed  Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.115.307110Objective—Cathepsin S (CatS) participates in atherogenesis through several putative mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/ff/77/atv-36-1549.PMC4961274.pdf
"*These authors contributed equally to this article.The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.115.307110/-/DC1.Correspondence to Xian Wu Cheng, MD, PhD, Institute of Innovation for Future Society, Nagoya University Graduate School of Medicine, 65 Tsuruma- cho, Showa-ku, Nagoya 466–8550, Japan.",Non-OADS,/arxiv_data1/oa_pdf/ff/77/atv-36-1549.PMC4961274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pompe disease Angiotensin-converting enzyme Gene polymorphismEnzyme replacement therapyAlglucosidase alfa 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/d8/main.PMC4961277.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.07.0052214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/d8/main.PMC4961277.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/d8/main.PMC4961277.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/1e/main.PMC4961297.pdf
"Furthermore, MAL is also topically available (being well absorbed into the skin when applied as a cream formulation) making it a convenientContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.07.002 2213-2317/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/58/1e/main.PMC4961297.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: A431, Human squamous carcinoma cells; ALA, Aminolaevulinic acid; CP94, 1,2-diethyl-3-hydroxypyridin-4-one; DEPMPO, 5-(diethoxypho- sphoryl)-5-methyl-1-pyrroline-N-oxide; DTPA, Diethylenetriaminepentaaceticacid; EPR, Electron paramagnetic resonance; FCS, Fetal calf serum; MAL, Methyl-aminolevulinate; MnTBAP, [5,10,15,20-tetrakis(4-carboxyphenyl)-porphyrinato]manganese(III) chloride; 1O2, Singlet oxygen; O 2, Superoxide; OH, Hydroxyl radical; PpIX, Protoporphyrin IX; PMA, Phorbol myristate acetate; ROS, Reactive oxygenspecies; SOD, Superoxide dismutase; TEMPOL, 4-hydroxy-2,2,6,6-tetra-methylpiperidine-1-oxyl; TMP, 4-hydroxy-2,2,6,6-tetramethylpiperidine nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/58/1e/main.PMC4961297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/63/main.PMC4961303.pdf
"Therefore, the Keap1/Nrf2 pathway is considered as one of the primary regulatory nodal points for the cellular oxidative/electrophilic stress response.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.06.004 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/e8/63/main.PMC4961303.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/63/main.PMC4961303.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/e7/main.PMC4961307.pdf
"For example, ROS mediate endothelial dysfunction induced by obesity and body fatContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.06.006 2213-2317/ &2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/60/e7/main.PMC4961307.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AP-1, activator protein 1; DCFH-DA, 2 ′,7′-dichloro ﬂuorescin dia- cetate; E-selectin, endothelial-leukocyte adhesion molecule-1; EGCG, epigalloca-techin gallate; FBS, fetal bovine serum; GCL, glutamate-cysteine ligase; GCLC, glu-tamate-cysteine ligase catalytic subunit; GCLM, glutamate-cysteine ligase modi ﬁer subunit; HAEC, human aortic endothelial cells; HO-1, heme oxygenase-1; ICAM-1,intercellular adhesion molecule-1; LPS, lipopolysaccharide; NF- κB, nuclear factor- kappaB; NQO1, NAD(P)H dehydrogenase, quinone 1; Nrf2, erythroid 2-relatedfactor 2; p38, p38 mitogen-activated protein kinase; PBS, phosphate-buffered sal- ine; qPCR, real-time quantitative polymerase chain reaction; ROS, reactive oxygen species; TNF α, tumor necrosis factor alpha nCorrespondence to: Linus Pauling Institute, Oregon State University, 307 Linus Pauling Science Center, Corvallis, OR 97331, USA.",Non-OADS,/arxiv_data1/oa_pdf/60/e7/main.PMC4961307.pdf
"In addition, Müller glial cells (MGCs), whose  processes extend through most of the retinal layers, provide Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> Received 27 March 2016 | Accepted 21 July 2016 | Published 23 July 2016© 2016 Molecular Vision 847The cellular and compartmental profile of mouse retinal  glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and  ~P transferring kinases Elda M. Rueda,1 Jerry E. Johnson Jr.,2,3 Anand Giddabasappa,3 Anand Swaroop,4 Matthew J. Brooks,4 Irena  Sigel,1 Shawnta Y. Chaney,3 Donald A. Fox1,3,5 1College of Optometry, University of Houston, Houston TX; 2Department of Natural Sciences, University of Houston-Downtown,  Houston TX; 3Department of Biology and Biochemistry, University of Houston, Houston TX; 4National Eye Institute, Bethesda,  MD; 5Department of Pharmacology and Pharmaceutical Sciences, University of Houston, Houston TX Purpose:  The homeostatic regulation of cellular ATP is achieved by the coordinated activity of ATP utilization, synthe - sis, and buffering.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  848structural, functional, and metabolic support for retinal  neurons.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  849Gck gene) [ 39-41].,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  850multifunctional ubiquitous enzyme localized in the cytosol,  mitochondria, and nucleus and is associated with protein and  nucleic acid synthesis, as well as GTP-dependent mechanisms  [66,67].",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  851Affymetrix of bioenergetic metabolism enzymes from the  mouse genome array:  Gene expression profiling experiments  and data analysis were performed at the Microarray Core  Facility at Kellogg Eye Center, University of Michigan (Ann  Arbor, MI) essentially as previously described [ 87].",OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  852Table  1.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  853Cell and organelle specific markers     Middle wavelength-sensitive  cone arrestinM-Car AA 369-381 of C-terminus Rabbit Cheryl Craft gift 1:500 99 Pan-plasma membrane calcium  ATPasepan-PMCA Human erythrocyte calcium  ATPaseMouse Affinity  Bioreagents1:400 9 Sarcoplasmic-endoplasmic  reticulum calcium ATPase 3SERCA3 Synthetic Peptide: V(29) T  D A R E R Y G P N(39)Rabbit Affinity  Bioreagents1:500 9 CHX10 CHX10 Human CHX10 AA 1 to 131  of N terminusSheep Exalpha 1:500 102 Protein kinase C-α PKCα Rat PKCα AA 659-672 Mouse Serotec 1:1000 9 Calbindin Calb Chicken gut D28-K Mouse Swant 1:1000   Choline acetyltransferase ChAT Porcine CHAT N-terminus Sheep Chemicon 1:500   Disabled-1 DAB1 Mouse DAB1 AA 400-555 Rabbit Chemicon 1:500 101 GABA GABA GABA Glutaraldehyde-BSA Rabbit Chemicon 1:1000 100 Vesicular glutamate transporter  1VGLUT1 Synthetic peptide from rat  VGLUT1Guinea pig Chemicon 1:1000 9 Glutamate/Aspartate transporter GLAST Synthetic peptide from Rat  GLAST C-terminusGuinea pig Chemicon 1:1000   Glutamine synthetase GS Sheep brain GS Mouse Sigma 1:1000,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  854IHC and confocal microscopy:  Frozen sections of retinas  from four to seven mice from different litters were immuno - labeled in parallel to ensure identical processing as described  [9,103].",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  855layer and concentration-dependent differences.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  856 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  857To determine the association of HK-2 with mitochondria,  we double-labeled retinas with HK-2 and COX IV (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  858PK-M1 and PK-M2 have differential compartmental and  laminar expression:  Pkm is expressed approximately three - fold higher than Pklr (Figure 1A).,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  859 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  860 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  861and the IPL (Figure 6I).,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  862The mitochondrial enzymes GDH1, GABA-T, OGDH, and  STK are differentially and highly expressed in photoreceptor  mitochondria and the inner retina:  Our previous work  [9] characterized the distribution of retinal mitochondria  using an antibody to COX IV, the well-accepted marker of  mitochondria [ 8-10].",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  863 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  864are not present there.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  865 Figure 10.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  866 Figure 11.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  867was highest among the NDPK isoforms (Figure 1B).,OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  868terminals) and the GCL and moderate to strong expression  in the BCs (dendrites, somas, and synaptic terminals) as  seen in Figure 15E–J.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  869DISCUSSION Our combined results indicate the following: 1) Outer retinal  glycolytic metabolism is significantly different from inner  retinal glycolytic metabolism.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  870 Figure 14.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  871 Figure 16.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  872OXPHOS, and ~P transferring kinases (see Figure 16 for an  integrative spatial and quantitative summary).",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  873needed for membrane biosynthesis for the newly formed OSs.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  874glutamate is abundant to support OXPHOS.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  875and MCT4 (Appendix 3) and have high levels of COX activity  (Figure 9).,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  876MCT2 in the MGC end-feet, suggests that MGCs are able to  uptake lactate.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  877used cell- and compartment-specific IHC techniques and  enzyme histochemistry to explore, characterize, and integrate  uncharacterized aspects of retinal bioenergetics.",Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  878APPENDIX 5.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  87922.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  88050.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  881regulation of cellular respiration–a synthesis.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  88298.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  883127.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  884156.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
Molecular Vision  2016; 22:847-885 <http://www.molvis.org/molvis/v 22/847> © 2016 Molecular Vision  885184.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/mv-v22-847.PMC4961465.pdf
"We also found that Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> Received 24 January 2016 | Accepted 22 July 2016 | Published 25 July 2016© 2016 Molecular Vision 886Tissue factor induces VEGF expression via activation of the Wnt/ β-catenin signaling pathway in ARPE-19 cells Ying Wang, Aimin Sang, Manhui Zhu, Guowei Zhang, Huaijin Guan, Min Ji, Hui Chen (The first three authors contributed to this work equally.)",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  887suppression of TF by intravitreal injection of anti-TF mono - clonal antibody significantly ameliorated CNV and decreased  the expression of VEGF in the mouse CNV model.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  888VEGF concentrations were determined using a quantitative  enzyme-linked immunosorbent assay (ELISA; Cusabio  Biotech Co, Wuhan, China).",OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  889increased under hypoxia at 200  μM (Figure 1), and this dose  was used for the following experiments.",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  890 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  891we observed that IWR-1-endo changed the levels of phos - phorylated GSK3β little but evidently reduced the levels of  β-catenin (Figure 4C,D).",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  892cells while TF siRNA showed the contrary results (Figure  6).,OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  893Wnt signaling was blocked by IWR-1-endo in the ARPE-19  cells, invasiveness and tube formation were reduced signifi - cantly compared to overexpression plasmid transfected cells  (Figures 5 and 6).",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  894activation of the Wnt/β-catenin signaling pathway, but the  detailed mechanism requires further exploration.",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
"Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  895overexpression of TF in the RPE cells resulted in increased  VEGF expression, suggesting VEGF was positively regu - lated by TF in vitro.",Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  89622.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
Molecular Vision  2016; 22:886-897 <http://www.molvis.org/molvis/v 22/886> © 2016 Molecular Vision  89746.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/mv-v22-886.PMC4961466.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/95/main.PMC4961494.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.014 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/95/main.PMC4961494.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: U2OSRKOHEK 293THeLaMRC5K562 DNA replication timing 1.,Non-OADS,/arxiv_data1/oa_pdf/63/f9/main.PMC4961496.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80029 .2.,OADS,/arxiv_data1/oa_pdf/63/f9/main.PMC4961496.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.003 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/f9/main.PMC4961496.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/f9/main.PMC4961496.pdf
"The intersection was performed with the Intersection GALAXY tools (Operate on genomic intervals, https://main.g2.bx.psu.edu/ ).",OADS,/arxiv_data1/oa_pdf/63/f9/main.PMC4961496.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4961498.pdf
"Laboratory  tests  showed  an  increased  white  blood  cell  count  of 90  ×  109/L  with  65.75  ×  109/L  neutrophils,  7  ×  109/L  lymphocytes http://dx.doi.org/10.1016/j.ijscr.2016.07.010 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4961498.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/b0/main.PMC4961499.pdf
The  tumour  with  15  ×  13  cm  diameter  was http://dx.doi.org/10.1016/j.ijscr.2016.06.045 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/f6/b0/main.PMC4961499.pdf
"[2] GLOBOCAN, 2012. http://globocan.iarc.fr/Default.aspx  (24  November  2014, date last  accessed).",Non-OADS,/arxiv_data1/oa_pdf/f6/b0/main.PMC4961499.pdf
Bronchoscopy was applied as a routine method in all forms of tuberculosis in Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com Annals of Medicine and Surgery 10 (2016) 8 e10 http://dx.doi.org/10.1016/j.amsu.2016.07.014 2049-0801/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b1/30/main.PMC4961676.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.017,Non-OADS,/arxiv_data1/oa_pdf/f2/3b/main.PMC4961677.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 1–74 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/3b/main.PMC4961677.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 1–74 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/3b/main.PMC4961677.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 1–74 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/3b/main.PMC4961677.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/b8/main.PMC4961678.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.008 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1b/b8/main.PMC4961678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4961679.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.007 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4961679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/09/main.PMC4961680.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.006 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/09/main.PMC4961680.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 54 e57,Non-OADS,/arxiv_data1/oa_pdf/69/09/main.PMC4961680.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
She  was  noted  to  a  large  ventral  incisional http://dx.doi.org/10.1016/j.ijscr.2016.07.015 2210-2612/© 2016  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
"[2]  G.  Dapri,  J.  Bruyns,  M.  Paesmans,  et  al.,  Single-access  laparoscopic  primary and incisional  prosthetic  hernia  repair:  ﬁrst  50  patient,  Hernia  17  (October (5))  (2013)  619–626,  http://dx.doi.org/10.1007/s10029-012-1025-z  (Epub 2013  Jan  6).",Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
"25 (June  (6))  (2011)  1921–1925,  http://dx.doi.org/10.1007/s00464-010-1488-x (Epub  2010  Dec  7).",Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
"38  (September  (9))  (2014)  2233–2240,  http://dx.doi.org/10.1007/s00268- 014-2578-z .",Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
[12] http://www.appliedmedical.com/Products/GelPoint  Overview.aspx .,Non-OADS,/arxiv_data1/oa_pdf/05/f8/main.PMC4961682.pdf
http://www.e-cancer.fr/publications/69-epidemiologie/ 824-les-cancers-en-france-edition-2014 (2014).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.invs.sante.fr/beh/2011/22/beh_ 22_2011.pdf (2011).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
https://lesdonnees.e-cancer.fr/les- fiches-de-synthese/29-incidenc e-mortalite/38-ensemble-des- cancers/22-incidence-mortalite-france.html (2015).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.allodocteurs.fr/actualite-sante-cancer-pour- une-reevaluation-des-prix-des-traitements-11720.asp?1=1 (2013).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.slate.fr/france/79671/le-prix-immoral-des- nouveaux-medicaments-anti-cancer (2013).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://sante.lefig aro.fr/actua lite/2012/07/05/18603- cancer-pourquoi-prix-medica ments-ont-ils-augmente (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.lemonde.fr/sante/article/2012/ 07/10/pour-l-igas-les-prix-des-anticancereux-sont-trop-favorables-aux-laboratoires_1731608_1651302.html (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.lemonde.fr/science s/article/2014/ 06/03/cancer-l- epineuse-question-du-prix -des-traitements_4430785_1650684.,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
Avis n°17 du 30 septembre 2011. http://www.ethique-cancer.fr/phoenixws/detailavis/topic-1/ article-81/avis-n-17-du-30-septembre-2011.html (2011).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.annuaire-secu.com/pdf/rapportIGAS-evaluation- dispositif-medicament-en-sus.pdf (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.fondation-arc.org/Information-du-public/les- revolutions-de-la-recherche-sur-le-cancer-15-annees-de-progres-12 -defis-pour-l-avenir.html (2014).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.la-croix.,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
Plan cancer 2014-2019. http://www.e-cancer.fr/toutes-les- actualites/2755-plan-cancer/8644-lancement-du-plan-cancer- 2014-2019 (2014).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.irdes.fr/EspaceDoc/DossiersBiblios/ LoisFinancementSecu.pdf (2013).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
Legifrance: Loi n° 2011-1906 du 21 décembre 2011 de financement de la sécurité sociale pour 2012. http://www.legifrance.gouv.fr/ affichTexte.do?cidTexte=JORFTEXT000025005833&categorieLien=id (2011).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.legifrance.gouv.fr/affichTexte.do?cidTexte= JORFTEXT000025053440&ca tegorieLien= id#JORFARTI000025053734 (2011).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.sante.gouv.fr/IMG/pdf/ Rapport_T2A_au_Parlement_2011_transmis_1509_11.pdf (2010).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
Inspection générale des finances et inspection générale des affaires sociales: Propositions pour la maîtrise de l'ONDAM 2013-2017. http://www.sante.gouv.fr/IMG/pdf/Rapport_ONDAM-IGAS-IGF_juin2012.pdf (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://fichiers.fhf.fr/documents/Rapport-finances-04juin.,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.igas.,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
Legifrance: Décret n° 2012-1116 du 2 octobre 2012 relatif aux missions médico-économiques de la Haute Autorité de santé.http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000026453514&categorieLien=id (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://ec.europa.eu/research/health/ pdf/event06/13052011/fabien-calvo_en.pdf (2011).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://www.e-cancer.fr/presse/7141-resultats-de- safir-01-premiers-resultats-dune-etude-clinique-de-medecine- personnalisee-a-large-echelle (2012).,Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
http://ansm.sante.fr/ var/ansm_site/storage/original/application/1c7c13b95daa7804f72df7e589867a86.pdf (2014).,OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
"Delcroix Lopes S, Marty C, Berdai D.: PHIS Pharma Profile France 2011. http://whocc.goeg.at/Literaturliste/Dokumente/ CountryInformationReports/P HIS_Pharma%20Profile%20FR_ 2011_final.pdf (2011).",Non-OADS,/arxiv_data1/oa_pdf/26/ce/11523_2015_Article_411.PMC4961733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/96/main.PMC4961741.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.002 2213-0071/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/74/96/main.PMC4961741.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 53,Non-OADS,/arxiv_data1/oa_pdf/74/96/main.PMC4961741.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/9b/main.PMC4961796.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.004 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/9b/main.PMC4961796.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 49 e52,Non-OADS,/arxiv_data1/oa_pdf/60/9b/main.PMC4961796.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/c7/main.PMC4961798.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.007 2213-0071/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/86/c7/main.PMC4961798.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 46 e48,Non-OADS,/arxiv_data1/oa_pdf/86/c7/main.PMC4961798.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.003 2213-0071/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 43 e45,Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"3 (2008), http://dx.doi.org/10.1186/1750-1172-3-34 ,3 4e1172-3-34.",Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"Inc 34 (6) (2014) 1692 e1706, http://dx.doi.org/10.1148/rg.346130089 .",Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
http://wwwn.cdc.gov/eworld/ Grouping/Malignant_mesothelioma/100 .,Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"Case Rep. 3 (1) (2015) 9 e12,http://dx.doi.org/10.1002/rcr2.84 .",Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"Woodcock, J. Grayez, Simultaneous bilateral spontaneous hydropneumothorax: a rare presentation of bilateral malignant pleural me- sothelioma, BMJ Case Rep. 2013 (2013) 10, http://dx.doi.org/10.1136/bcr- 2013-009350 .",Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"Port.De.Pneu- mol.18(2)(2012)93 e95,http://dx.doi.org/10.1016/j.rppneu.2011.04.001 .",OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"19 (1) (2008)63e64,http://dx.doi.org/10.1016/j.ejim.2007.03.010 .",OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
"9 (4) (2012) 209 e211, http://dx.doi.org/10.5812/iranjradiol.8764 .",Non-OADS,/arxiv_data1/oa_pdf/fa/c3/main.PMC4961801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/e7/main.PMC4961824.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.07.005 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/e7/main.PMC4961824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 58 e60,Non-OADS,/arxiv_data1/oa_pdf/a2/e7/main.PMC4961824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/43/main.PMC4961825.pdf
E-mail address: mcdadee@neuro.wustl.edu http://dx.doi.org/10.1016/j.dadm.2016.03.008 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/43/main.PMC4961825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/43/main.PMC4961825.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.03.008 .,OADS,/arxiv_data1/oa_pdf/a7/43/main.PMC4961825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/d5/main.PMC4961826.pdf
E-mail address: durantj@ccf.org http://dx.doi.org/10.1016/j.dadm.2016.06.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/d5/main.PMC4961826.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/d5/main.PMC4961826.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Plasmodium falciparumMicroarrayUncomplicated malariaComplicated malariaPfEMP1RIFIN 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.006 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
"Upon release of subsequent updates of P. falciparum genome database annotation, many new versions of microarrays were evolved and uti- lized various platforms (To see the comprehensive list of P. falciparum microarrays designed till date, please refer to NCBI's Gene Expression Omnibus website http://www.ncbi.nlm.nih.gov/geo/ .",OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
"Additionally, probes were included for transcripts unique to the PlasmoDB v5.3, HB3 and IT4 strains using Agilent eArray tool (http://earray.chem.agilent.com ).",OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
"Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.gdata.2016.07.006 .",OADS,/arxiv_data1/oa_pdf/b1/98/main.PMC4961827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC4961828.pdf
A complete listing of ADNI inves-tigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/ how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC4961828.pdf
http://dx.doi.org/10.1016/j.dadm.2016.05.003 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC4961828.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.05.003 .,OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC4961828.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/a3/kjfm-37-203.PMC4961851.pdf
"Vitamin D Studies: Mistaking Correlation  for Causation Seung-Won Oh Department of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Koreahttp://dx.doi.org/10.4082/kjfm.2016.37.4.203  • Korean J Fam Med 2016;37:203-204 Editorial eISSN: 2092-6715 There has been a growing interest in the study of vitamin D.  Numerous conference presentations on vitamin D and related  articles can be easily found through media outlets or on the  internet.",Non-OADS,/arxiv_data1/oa_pdf/b7/a3/kjfm-37-203.PMC4961851.pdf
Seung-Won Oh • Vitamin D Studies: Mistaking Correlation for Causation 204  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.203 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/a3/kjfm-37-203.PMC4961851.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"Keywords:  Bile Acids and Salts; Gallstones; Obesity; Primary Prevention; Risk Factors Received: April 1, 2016, Revised: April 22, 2016, Accepted: April 25, 2016 *Corresponding Author:  Piero Portincasa  Tel: +39-080-5478227, Fax: +39-080-5478232, E-mail: piero.portincasa@uniba.ithttp://dx.doi.org/10.4082/kjfm.2016.37.4.205  • Korean J Fam Med 2016;37:205-213 Review Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"• Gallstones Disease Prevention 206  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.205 INTRODUCTION Gallstone disease (GSD) is one of the most frequent gastro-intestinal  disorders in westernized countries,1-3) including Europe.4) There are 3  types of gallstones that develop in the gallbladder and bile ducts, and  they are distinguished by their chemical composition: pure cholester - ol, pure pigment, or mixed (containing small amounts of bilirubin salts  and calcium).",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
SEARCH METHODOLOGY We assessed all literature published from 1974–2015 by searching  PubMed (http://www.ncbi.nlm.nih.gov/pubmed).,OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"• Gallstones Disease Prevention http://dx.doi.org/10.4082/kjfm.2016.37.4.205www.kjfm.or.kr   207 tance, and reduced high density lipoprotein (HDL)-cholesterol.16) Ap- propriate lifestyle interventions may influence the pathogenesis of cho - lesterol gallstones, and should focus on maintaining an ideal weight in  people with normal weight and weight loss in overweight and obese in -dividuals.15) The key mechanisms regulating this pathogenic process  seem to involve gene-environment interactions through epigenetic  mechanisms that also occur during the fetal stage and involve factors  such as lifestyle, toxic agents, and environmental pollutants.18)Table 1.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"• Gallstones Disease Prevention 208  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.205 2) Physical activity People should be aware of the importance of performing regular phys - ical activity whenever possible.19) The overall beneficial effect of exer - cise goes beyond simple protection against gallstone formation.20) In  the Epic-Norfolk prospective cohort study, energy expenditure and  cardio-respiratory fitness21) were investigated via questionnaires in  25,639 volunteers (range, 40 to 74 years old).",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"• Gallstones Disease Prevention http://dx.doi.org/10.4082/kjfm.2016.37.4.205www.kjfm.or.kr   209 coming symptomatic,58) following rapid weight loss.58,59) A meta-analy - sis of 5 randomized controlled trials including 521 patients (322 taking  UDCA and 199 taking a placebo) concluded that UDCA 300–1,200  mg/d effectively prevents gallstone formation after bariatric surgery,59)  reducing the incidence from 32% to 2%,60) with no severe side effects.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
• Gallstones Disease Prevention 210  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.205 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
• Gallstones Disease Prevention http://dx.doi.org/10.4082/kjfm.2016.37.4.205www.kjfm.or.kr   211 2) Recurrent bile duct stones There are no evidence-based prophylactic measures able to prevent  the recurrence of bile duct stones.,Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"• Gallstones Disease Prevention 212  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.205 Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-meth - ylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic  AMP and hydrocortisone.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
• Gallstones Disease Prevention http://dx.doi.org/10.4082/kjfm.2016.37.4.205www.kjfm.or.kr   213 58.,Non-OADS,/arxiv_data1/oa_pdf/e6/43/kjfm-37-205.PMC4961852.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"Keywords:  Alcohol; Alcoholism; Binge Drinking; Sensitivity and Specificity Received: February 16, 2016, Revised: March 22, 2016, Accepted: April 7, 2016 *Corresponding Author:  Jong Sung Kim  Tel: +82-42-280-8172, Fax: +82-42-280-7879, E-mail: jskim@cnuh.co.kr *Corresponding Author:  Han Ju Pack  Tel: +82-42-589-2050, Fax: +82-42-589-2029, E-mail: vivianpak@daum.nethttp://dx.doi.org/10.4082/kjfm.2016.37.4.214  • Korean J Fam Med 2016;37:214-220 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"• Heavy and Binge Drinking for Alcohol Use Disorder Screening http://dx.doi.org/10.4082/kjfm.2016.37.4.214www.kjfm.or.kr   215 INTRODUCTION Excessive alcohol drinking causes many problems both socially and  economically.1,2) Therefore, it is important to address alcohol-related  problems using appropriate diagnostic standards.",Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"• Heavy and Binge Drinking for Alcohol Use Disorder Screening 216  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.214 gal problems (e.g., arrests for alcohol-related disorderly conduct).",Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"• Heavy and Binge Drinking for Alcohol Use Disorder Screening http://dx.doi.org/10.4082/kjfm.2016.37.4.214www.kjfm.or.kr   217  In males, drinking frequency per week, drinks per drinking day, and  drinks per week in the binge- and non-binge-drinking groups were  2.25±1.16, 6.86±1.95, and 15.73±10.27, and 1.35±1.30, 2.22±1.52, and  4.09±4.77, respectively.",OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"• Heavy and Binge Drinking for Alcohol Use Disorder Screening 218  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.214 44.4%, 97.0%, 64.9%, 93.3%, and 0.707, respectively.",Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
• Heavy and Binge Drinking for Alcohol Use Disorder Screening http://dx.doi.org/10.4082/kjfm.2016.37.4.214www.kjfm.or.kr   219 nostic criteria without using an alcohol-screening tool in clinical situa - tions.,Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
• Heavy and Binge Drinking for Alcohol Use Disorder Screening 220  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.214 study.,Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
Avail - able from: http://pubs.niaaa.nih.gov/publications/dsmfactsheet/ dsmfact.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
Available from: http://www.dsm5.org/ documents/changes%20from%20dsm-iv-tr%20to%20dsm-5.pdf.,OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
Available from: http://cdc.go.kr/ CDC/contents/CdcKrContentView.jsp?cid=60949&menuIds=HOME001- MNU1130-MNU1639-MNU1749-MNU1761.,Non-OADS,/arxiv_data1/oa_pdf/9f/fc/kjfm-37-214.PMC4961853.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
"Keywords:  Vitamin D; Quality of Life; Depression; Anxiety Received: February 27, 2015, Revised: August 24, 2015, Accepted: September 23, 2015 *Corresponding Author:  Young Eun Choi  Tel: +82-31-900-0231, Fax: +82-31-900-0343, E-mail: yechoimd@gmail.comhttp://dx.doi.org/10.4082/kjfm.2016.37.4.221  • Korean J Fam Med 2016;37:221-227 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
"• Vitamin D and Health-Related Quality of Life 222  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.221 INTRODUCTION Vitamin D is involved in the absorption and distribution of calcium,  and the correlation between vitamin D and bone health has been  proven through numerous studies.1) In 2006, vitamin D deficiency was  found in 92.1% of Korean women, which is the highest prevalence rate  worldwide.2) According to the Korea National Health and Nutrition Ex - amination Survey (KNHANES) in 2008, the average blood vitamin D  levels was 21.2 ng/mL for males and 18.2 ng/mL for females, which  were below the normal vitamin D level of 30 ng/mL.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
• Vitamin D and Health-Related Quality of Life http://dx.doi.org/10.4082/kjfm.2016.37.4.221www.kjfm.or.kr   223 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
"• Vitamin D and Health-Related Quality of Life 224  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.221 current smoker, past smoker, and nonsmoker; and alcohol consump - tion consisted of frequency of less than once a month, 1–4 times a  month, and more than 5 times a month.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
• Vitamin D and Health-Related Quality of Life http://dx.doi.org/10.4082/kjfm.2016.37.4.221www.kjfm.or.kr   225 5.,Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
"• Vitamin D and Health-Related Quality of Life 226  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.221 DISCUSSION Numerous studies have shown that groups with increased vitamin D  levels or consumption had increased muscular strength and a de - crease in fall risk compared with the group without vitamin D supple - mentation.5,14-19) In other words, decreased vitamin D level may be re - lated to increased prevalence of mobility, self-care, and usual activity  deficits related to muscular strength.",Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
• Vitamin D and Health-Related Quality of Life http://dx.doi.org/10.4082/kjfm.2016.37.4.221www.kjfm.or.kr   227 uation study using time trade-off method.,Non-OADS,/arxiv_data1/oa_pdf/5d/d5/kjfm-37-221.PMC4961854.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
"Keywords:  Survivors; Depression; Fatigue; Koreans Received: February 27, 2015, Revised: August 17, 2015, Accepted: October 1, 2015 *Corresponding Author:  Yun-Mi Song  Tel: +82-2-3410-2449, Fax: +82-2-3410-0388, E-mail: yunmisong@skku.eduhttp://dx.doi.org/10.4082/kjfm.2016.37.4.228  • Korean J Fam Med 2016;37:228-234 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
• Depression in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.228www.kjfm.or.kr   229 INTRODUCTION Cancer is a critical and severe disease.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
"• Depression in Cancer Survivors 230  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.228 RESULTS Among the participants, the number of non-depressive group and de - pressive group were 519 people (73.9%) and 183 people (26.1%), re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
• Depression in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.228www.kjfm.or.kr   231 in one organ of the body.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
• Depression in Cancer Survivors 232  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.228 3.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
"• Depression in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.228www.kjfm.or.kr   233 pression decreased annually and was 15% on last fifth year, which is  not significantly different compared to other people.",Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
• Depression in Cancer Survivors 234  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.228 because our research was performed on hospital visitors including  people with more desirable health behavior.,Non-OADS,/arxiv_data1/oa_pdf/8f/ed/kjfm-37-228.PMC4961855.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"Keywords:  Cardiovascular Diseases; Risk Factors; Neoplasms; Survivors Received: February 27, 2015, Revised: September 7, 2015, Accepted: September 27, 2015 *Corresponding Author:  Jung-Kwon Lee  Tel: +82-2-3410-2449, Fax: +82-2-3410-0388, E-mail: jklee@skku.eduhttp://dx.doi.org/10.4082/kjfm.2016.37.4.235  • Korean J Fam Med 2016;37:235-241 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"• Cardiovascular Disease Risk in Cancer Survivors 236  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.235 INTRODUCTION With improvements in cancer screening and treatment, there are cur - rently over 13 million cancer survivors in the Unites States.1) In Korea,  the estimated number of cancer survivors was more than 1 million,2)  and the 5-year relative survival rate was almost 68% in 2012.3)  Cancer survivors have more co-morbidities and an elevated risk of  non-cancer mortality compared to the general population.4,5) Cardio - vascular disease (CVD) is the most frequent cause of morbidity and  mortality in cancer survivors, following second primary cancer.6,7) and  the most common cause of non-cancer mortality in cancer survivors,  accounting for 31% of these deaths in Korea.8)  There are several factors that increase the risk of CVD among cancer  survivors.",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"• Cardiovascular Disease Risk in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.235www.kjfm.or.kr   237 ≥3,000 USD).",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
• Cardiovascular Disease Risk in Cancer Survivors 238  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.235 if they answered “yes” to the following question: “Have you ever been  told by a doctor that you have any kind of cancer?” The type of cancer  and the age at diagnosis were also noted.,Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"• Cardiovascular Disease Risk in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.235www.kjfm.or.kr   239  Of the 1225 cancer survivors, 63.3% reported having one of the fol - lowing four types of cancer: stomach (22.5%), cervical (14.6%), breast,  (14.4%), or colon (11.8%), and 44.2% of the cancer survivors were diag - nosed as having had the disease for less than 5 years.",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"• Cardiovascular Disease Risk in Cancer Survivors 240  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.235 nificant number of studies have reported similar rate of smoking in  cancer survivors compared with the general population.9,13,18,19) In con - trast, our study showed that current smoking rates were significantly  lower in cancer survivors, which is consistent with prior studies report - ing a lower rate of current smoking among cancer survivors.7,20) These  contradictory results might be explained by two possibilities.",Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
• Cardiovascular Disease Risk in Cancer Survivors http://dx.doi.org/10.4082/kjfm.2016.37.4.235www.kjfm.or.kr   241 CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/8b/28/kjfm-37-235.PMC4961856.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
"Keywords:  Non-Alcoholic Fatty Liver Disease; Homocysteine; Sex Characteristics; Men; Fatty Liver Received: March 2, 2016, Revised: April 11, 2016, Accepted: April 18, 2016 *Corresponding Author:  Kyung-Chae Park  Tel: +82-31-780-5360, Fax: +82-31-780-5944, E-mail: kc829@cha.ac.krhttp://dx.doi.org/10.4082/kjfm.2016.37.4.242  • Korean J Fam Med 2016;37:242-247 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
"• The Association between Homocysteine and NAFLD http://dx.doi.org/10.4082/kjfm.2016.37.4.242www.kjfm.or.kr   243 INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) refers to the presence of he - patic steatosis when no other causes for secondary hepatic fat accu - mulation, such as signiﬁcant alcohol consumption, use of steatogenic  medication, or hereditary disorders, are present.1) The term NAFLD  refers of to a wide spectrum of liver diseases, including simple steato - sis, nonalcoholic steatohepatitis (NASH), liver cirrhosis, and hepato - cellular carcinoma.2) NAFLD is the most common cause of chronic liv - er disease in the industrialized world, and the prevalence of NAFLD  has become a substantial burden to public health.3)  Many studies have reported that NAFLD is associated with meta - bolic disorders caused by insulin resistance, such as obesity, dyslipid - emia, type 2 diabetes, and metabolic syndrome.4,5) Moreover, cardio - vascular disease risk factors, such as a high Framingham risk score, ca - rotid intima-media thickness, and coronary artery calcification, are  considerably elevated in NAFLD patients.6,7)  Homocysteine, a sulfur-containing amino acid, is an intermediate  product in the normal biosynthesis of the amino acids methionine  and cysteine.8,9) Homocysteine is known to be an independent risk fac - tor for atherosclerosis and cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
• The Association between Homocysteine and NAFLD 244  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.242 homocysteine.,OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
• The Association between Homocysteine and NAFLD http://dx.doi.org/10.4082/kjfm.2016.37.4.242www.kjfm.or.kr   245 except for total cholesterol.,Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
• The Association between Homocysteine and NAFLD 246  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.242 development of NAFLD.,Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
• The Association between Homocysteine and NAFLD http://dx.doi.org/10.4082/kjfm.2016.37.4.242www.kjfm.or.kr   247 21.,Non-OADS,/arxiv_data1/oa_pdf/af/07/kjfm-37-242.PMC4961857.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
"Keywords:  Mycobacterium avium  Complex; Multiple Cavitary Pulmonary Nodule; Percutaneous Transthoracic  Needle Aspiration Received: October 26, 2015, Revised: November 27, 2015, Accepted: December 14, 2015 *Corresponding Author:  Myoung Sook Kim  Tel: +82-42-220-9100, Fax: +82-42-220-9037, E-mail: kims@catholic.ac.kr †These authors contributed equally to this work.http://dx.doi.org/10.4082/kjfm.2016.37.4.248  • Korean J Fam Med 2016;37:248-252 Case Report eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
• Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare http://dx.doi.org/10.4082/kjfm.2016.37.4.248www.kjfm.or.kr   249 INTRODUCTION Nontuberculous mycobacteria (NTM) have emerged as an increasing - ly important pathogen in the last two decades.,Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
• Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare 250  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.248 tected in the bronchial washing fluid culture.,Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
• Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare http://dx.doi.org/10.4082/kjfm.2016.37.4.248www.kjfm.or.kr   251 culture.,Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
• Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare 252  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.248 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/67/kjfm-37-248.PMC4961858.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
"Keywords:  Domestic Violence; Emotional Violence; Physical Abuse; Risk Factors of Violence; Sexual Offenses Received: March 3, 2016, Revised: May 31, 2016, Accepted: June 27, 2016 *Corresponding Author:  Ashraf Direkvand-Moghadam  Tel: +98-8432240404, Fax: +98-8432227123, E-mail: direkvand-a@medilam.ac.ir †This study is associated with Ilam University of Medical Sciences, Ilam, Iran.http://dx.doi.org/10.4082/kjfm.2016.37.4.253  • Korean J Fam Med 2016;37:253-258 Brief Communication  eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
• Prevalence and Risk Factors of Domestic Violence against Women 254  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.253 INTRODUCTION Anger is an emotion that all individuals experience and it is considered  a natural aspect of married life.,Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
• Prevalence and Risk Factors of Domestic Violence against Women http://dx.doi.org/10.4082/kjfm.2016.37.4.253www.kjfm.or.kr   255 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
"• Prevalence and Risk Factors of Domestic Violence against Women 256  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.253 mensions of violence against women physical, emotional, and sexual  from our 46 items questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
• Prevalence and Risk Factors of Domestic Violence against Women http://dx.doi.org/10.4082/kjfm.2016.37.4.253www.kjfm.or.kr   257 study population.,Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
• Prevalence and Risk Factors of Domestic Violence against Women 258  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.4.253 ductive health of Egyptian women.,Non-OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
Available from: http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=  4536.,OADS,/arxiv_data1/oa_pdf/be/41/kjfm-37-253.PMC4961859.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/kjfm-37-259.PMC4961860.pdf
"Hyperamylasemia Related to Sertraline Mehmet Emin Ceylan, Alper Evrensel*, Barı ş Önen Ünsalver Department of Psychiatry, Uskudar University, İstanbul, Turkey Received: February 4, 2016, Revised: February 4, 2016, Accepted: February 29, 2016 *Corresponding Author:  Alper Evrensel  Tel: +90-2122701292, Fax: +90-2122701719, E-mail: alperevrensel@gmail.comhttp://dx.doi.org/10.4082/kjfm.2016.37.4.259  • Korean J Fam Med 2016;37:259 Letter eISSN: 2092-6715 To the Editor Elevation of serum amylase level is usually associated with  pancreatitis,1) but 2% of cases are associated with medica - tion.2) Only 1 case of pancreatitis caused by sertraline has been  reported.1) Although it has been reported that selective sero - tonin reuptake inhibitors may rarely cause pancreatitis,2) Ele- vated serum amylase levels associated with sertraline use in  cases without pancreatitis has not been reported in the litera - ture.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/kjfm-37-259.PMC4961860.pdf
" Annals of Surgical Treatment and Research 59pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.59 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Two-port laparoscopic appendectomy assisted with  needle grasper comparison with conventional  laparoscopic appendectomy Turgut Donmez, Adnan Hut1, Huseyin Avaroglu, Sinan Uzman2, Dogan Yildirim1, Sina Ferahman3, Erdinc Cekic4 Department of General Surgery, Lutfiye Nuri Burat State Hospital, Istanbul, 1Department of General Surgery, Haseki Training and  Research Hospital, Istanbul, 2Department of Anesteziologist, Haseki Training and Research Hospital, Istanbul, 3Department of  General Surgery, Istanbul University, Cerrahpasa Medical Faculty Hospital, Istanbul, 4Department of Otolaryngology, Lutfiye Nuri  Burat State Hospital, Istanbul,Turkey INTRODUCTION Laparoscopic appendectomy (LA) has been accepted as the  gold standard procedure for complicated or uncomplicated acute  appendicitis [1].",Non-OADS,/arxiv_data1/oa_pdf/da/64/astr-91-59.PMC4961887.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/64/astr-91-59.PMC4961887.pdf
66pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.66 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Does Korea’s current diagnosis-related group-based  reimbursement system appropriately classify  appendectomy patients?,Non-OADS,/arxiv_data1/oa_pdf/dd/e8/astr-91-66.PMC4961888.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/e8/astr-91-66.PMC4961888.pdf
"74pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.74 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Feasibility of single-incision laparoscopic appendectomy  in a small hospital Byung Hee Kang, Kyung Chul Yoon, Sung Woo Jung, Gyeo Ra Lee, Hyung Soon Lee1 Department of Surgery, Armed Forces Ildong Hospital, Pocheon, 1Department of Surgery, National Health Insurance Corporation  Ilsan Hospital, Goyang, Korea INTRODUCTION Conventional laparoscopic appendectomy (CLA) using three  port incisions is accepted as the standard technique for pa­ tients with acute appendicitis [1].",Non-OADS,/arxiv_data1/oa_pdf/34/48/astr-91-74.PMC4961889.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/48/astr-91-74.PMC4961889.pdf
"80pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.80 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Transumbilical laparoscopic-assisted appendectomy is a  useful surgical option for pediatric uncomplicated  appendicitis: a comparison with conventional 3-port  laparoscopic appendectomy Doo Yeon Go, Yoon Jung Boo, Ji Sung Lee1, Cheol Woong Jung2 Division of Pediatric Surgery, Department of Surgery, Korea University College of Medicine, Seoul, 1Department of Medical  Statistics, Seoul Asan Medical Center, Seoul, 2Department of Surgery, Korea University College of Medicine, Seoul, Korea INTRODUCTION Laparoscopic appendectomy (LA) has been widely accepted  as a treatment of choice for acute appendicitis for pediatric  surgeons because of its advantages of lower complication rate, shorter length of hospital stay, reduced pain, and improved cosmetic outcomes compared to open appendectomy [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fa/16/astr-91-80.PMC4961890.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/16/astr-91-80.PMC4961890.pdf
" Annals of Surgical Treatment and Research 85pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.85 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effect of surgical timing and outcomes for appendicitis  severity Maru Kim, Sung Jeep Kim, Hang Joo Cho Department of Trauma Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea INTRODUCTION Appendicitis has been known to require emergency manage­ ment [1].",Non-OADS,/arxiv_data1/oa_pdf/0b/b1/astr-91-85.PMC4961891.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/b1/astr-91-85.PMC4961891.pdf
http://dx.doi.org/10.1111/ans.13373.,Non-OADS,/arxiv_data1/oa_pdf/0b/b1/astr-91-85.PMC4961891.pdf
"90pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.91.2.90 Annals of Surgical Treatment and ResearchCASE REPORT Meckel diverticulum in exomphalos minor Hee Ju Sohn, Kwi-Won Park, Na Mi Lee1, Mi-Kyoung Kim2, Seung Eun Lee Departments of Surgery, 1Pediatrics, and 2Pathology, Chung-Ang University College of Medicine, Seoul, Korea INTRODUCTION A congenital hernia into the base of the umbilical cord is  known as an exomphalos and it is classified as major and  minor according to size of the defect [1].",Non-OADS,/arxiv_data1/oa_pdf/85/cc/astr-91-90.PMC4961892.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/astr-91-90.PMC4961892.pdf
This anatomical approach is especially pertinent as the biological mechanisms underlying RLS are poorly understood.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"18,19Activation of brainstem arousal systems in the dorsal midbrain and pons would result in alertness andKoo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"33 Indeed, there is a well-known association between RLS and depression.47Lifetime prevalence of depression ranges between 19% and 35% in persons with RLS, representing a greater than twofold increased odds of depression compared with those without RLS.48–50 Another potential clinical correlate of altered limbic and behavioral neuroanatomy is the increased impulsivity shown in persons with RLS, who are more likely than controls without RLS to make risky choices in studies using validated gambling task testing.10Table 1.Brain Regions Implicated in Restless Legs Syndrome Brain Region Abnormality Prefrontal cortex qactivity (fMRI),18Qgray matter density (voxel morphometry MRI)27 Medial frontal qgray matter density28;«gray matter density (voxel morphometry MRI)29 Precentral gyrus qactivity (fMRI),18Qintra-cortical inhibition (TMS)30;qgray matter (voxel morphometry MRI)31 Postcentral gyrus qactivity (fMRI)18;qgray matter (voxel morphometry MRI)31 Anterior cingulate cortexqactivity (fMRI),18«gray matter density (Voxel morphometry MRI),32Qwhite matter volume (voxel morphometry MRI)33 Posterior cingulatecortexqactivity (fMRI) 18 Whole brain «gray matter (voxel morphometry MRI)18,34 Putamen Qiron staining (pathology),15,16,35Qiron (MRI),12Qdopamine-2 binding (PET),36Qdopamine-2 receptor levels (pathology)37 Substantia nigra Qiron (pathology),15,16,35Qiron (MRI),12,13Qiron (phase imaging),22qtyrosine hydroxylase levels (pathology)37 Caudate Qiron staining (pathology), Qiron (MRI)14 Pons, medulla «Serotonin transporter38 Thalamus qactivity (fMRI),17,18qgray matter density pulvinar (Voxel morphometry MRI),39«NAA,40 qglutamate (MRS),40Qb-endorphin positive cells (pathology),41Qiron (MRI)14 Cerebellum qactivity (fMRI),17,18Qgray matter density (voxel morphometry MRI)27 Abbreviations: q, Increased; Q, Decreased; «, Unchanged; fMRI, Functional Magnetic Resonance Imaging; MRS, Magnetic Resonance Spectroscopy; NAA, N-acetylaspartate; PET, Positron Emission Tomography; TMS, Transcranial Magnetic Stimulation.RLS Pathophysiology Koo BB, Bagai K, Walters AS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Also noticeable in this schematic are activat ions of electroencephalography, in the form of synchronous cortical firing (K-complexes) and acceleration of heart rate as evidenced by shortening of the R-R interval on electrocard iography.Koo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Glutamatergic activity was increased in the thalamus of RLS patients compared with controls, and intriguingly totalRLS Pathophysiology Koo BB, Bagai K, Walters AS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Genes that are likely associated with the presence of RLS include BTBD9 ,MEIS1 ,PTPRD ,MAP2K5 , SKOR1 , and TOX3 .102–106Within these genes, several common singleKoo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Through sensorimotor discomfort and sleep loss, additional neuroanatomic structures, such as the cingulate and otherTable 2.Genes Implicated in RLS and PLMS: Cohort, Location, and Function Gene Chromosome Function SNP Cohort BTBD9 6p21.2 Synaptic plasticity, learningrs3923809, rs9296249, rs9357271Iceland,103United States,106 Germany,104Austria,114 Canada,104Czech Republic,114Finland,114 Korea115 MEIS1 2p14 Homeobox gene, limb formation, motor neuronconnectivityRs2300478 Germany, 104Austria,114 Czech Republic,114 Canada,104United States106 PTPRD 9p23-24 Protein tyrosine phosphatase regulates cellgrowth, mitosisrs4626664, rs1975197 Korea, 115United States116 MAP2K5 15q23 Protein kinase involved in cell proliferationRs12593813, rs11635424,rs4489954, rs3784709,rs1026732, rs6494696Germany, 104Austria,114 Czech Republic,114 Canada,104United States106 TOX3 16q12.1 Transcription factor Rs3104767, rs3104788 Germany117 Abbreviations: PLMS, Periodic Limb Movements during Sleep; RLS, Restless Legs Syndrome; SNP, Single Nucleotide Polymorphism.RLS Pathophysiology Koo BB, Bagai K, Walters AS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"doi: 10.1002/gps.2754.Koo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"doi: 10.1212/WNL.0b013e318294b3f6.RLS Pathophysiology Koo BB, Bagai K, Walters AS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation:Koo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 withRLS Pathophysiology Koo BB, Bagai K, Walters AS Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
"doi: 10.1182/blood- 2009-05-189985.Koo BB, Bagai K, Walters AS RLS Pathophysiology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/tre-06-401-7522-1.PMC4961894.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/54/main.PMC4961897.pdf
E-mail address: victorlv@unimelb.edu.au http://dx.doi.org/10.1016/j.dadm.2016.05.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/54/main.PMC4961897.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/54/main.PMC4961897.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.05.001 .,OADS,/arxiv_data1/oa_pdf/db/54/main.PMC4961897.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)PALB2 mutation induces error-prone DSB repair K Obermeier et al 3806 Oncogene (2016) 3796 –3806 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/33/10/onc2015448a.PMC4962030.pdf
Theoretical design of p28-NRC chimeric peptide   189   Homology modeling   Three dimentional structures of the chimeric  proteins with different linkers were created by             I-TASSER (http://zhang.bi oinformatics.ku.edu/I- TASSER ) web server (19).,OADS,/arxiv_data1/oa_pdf/09/6d/RPS-11-187.PMC4962299.pdf
Available in April   2015 from  http://www.globalhealingcenter.com/  natural-health/lung-cleansing-benefits-orange-peel.,Non-OADS,/arxiv_data1/oa_pdf/da/c3/RPS-11-219.PMC4962302.pdf
"MATERIALS AND METHODS    Virtual screening and docking   Firstly, the 3D structure of SD8 was taken  from PDB accession code 4CKL and used              as a primary backbone for structural              similarity search in ZINC database  (http://zinc.docking.org/ ).",OADS,/arxiv_data1/oa_pdf/6f/16/RPS-11-250.PMC4962306.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c0/80/10.1177_2325967116657535.PMC4962339.pdf
http://thesportjournal.org/article/ description-of-phases-and-discrete-events-of-the-lacrosse-shot/.,Non-OADS,/arxiv_data1/oa_pdf/c0/80/10.1177_2325967116657535.PMC4962339.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/51/a1/10.1177_2325967116658419.PMC4962340.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0e/cc/10.1177_2325967116656829.PMC4962341.pdf
"[http://dx.doi.org/10.1212/01.wnl.0000266639.50620.d1 ] [PMID: 17664408 ] [2] Pankratz N, Foroud T. Genetics of parkinson disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1097/GIM.0b013e31815bf97c ] [PMID: 18091429 ] [3] Van Den Eeden SK, Tanner CM, Bernstein AL, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/aje/kwg068 ] [PMID: 12777365 ] [4] Xia R, Mao Z-H.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1007/s12264-012-1050-z ] [PMID: 22233888 ] [5] Lesage S, Brice A. Parkinson’s disease: from monogenic forms to genetic susceptibility factors.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/hmg/ddp012 ] [PMID: 19297401 ] [6] Baba M, Nakajo S, Tu PH, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1001/jama.283.20.2674 ] [PMID: 10819950 ] [9] Seidl SE, Potashkin JA.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.3389/fneur.2011.00068 ] [PMID: 22125548 ] [10] Hsu CW, Wang CS, Chiu TH.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1186/1423-0127-17-4 ] [PMID: 20074377 ] [11] Alves J, Petrosyan A, Magalhães R. Olfactory dysfunction in dementia.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.12998/wjcc.v2.i11.661 ] [PMID: 25405189 ] [12] Baba T, Kikuchi A, Hirayama K, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1093/brain/awr321 ] [PMID: 22287381 ] [13] Wood H. Parkinson disease: Severe olfactory dysfunction may herald cognitive decline in Parkinson disease.,Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/nrneurol.2012.80 ] [PMID: 22584158 ] [15] Gillies GE, Pienaar IS, Vohra S, Qamhawi Z.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.yfrne.2014.02.002 ] [PMID: 24607323 ] [16] Lu H, Liu X, Deng Y, Qing H. DNA methylation, a hand behind neurodegenerative diseases.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.3389/fnagi.2013.00085 ] [PMID: 24367332 ] [17] Haaxma CA, Bloem BR, Borm GF, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1136/jnnp.2006.103788 ] [PMID: 17098842 ] [18] Sawada H, Ibi M, Kihara T, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1016/S0028-3908(02)00049-7 ] [PMID: 12128007 ] [19] Puschmann A. Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations.,OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1016/j.parkreldis.2013.01.020 ] [PMID: 23462481 ],OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2009.07.008 ] [PMID: 19580781 ] [21] Kotzbauer PT, Giasson BI, Kravitz AV, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2004.01.007 ] [PMID: 15144854 ] [22] Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1212/WNL.50.5.1346 ] [PMID: 9595985 ] [23] Semchuk KM, Love EJ, Lee RG.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1212/WNL.42.7.1328 ] [PMID: 1620342 ] [24] Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1212/WNL.0000000000000083 ] [PMID: 24491970 ] [25] Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/ana.20882 ] [PMID: 16718702 ] [26] Jafari S, Etminan M, Aminzadeh F, Samii A.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/mds.25458 ] [PMID: 23609436 ] [27] Maia PD, Kutz JN.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1007/s10827-014-0504-x ] [PMID: 24916135 ] [28] Rappold PM, Tieu K. Astrocytes and therapeutics for Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1016/j.nurt.2010.07.001 ] [PMID: 20880505 ] [29] Miller JW.,OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1301/002966402320964089 ] [PMID: 12521146 ] [30] Chen H, Zhang SM, Schwarzschild MA, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/aje/kwh213 ] [PMID: 15286022 ] [31] Wichmann T, DeLong MR. Functional neuroanatomy of the basal ganglia in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.2003.tb07477.x ] [PMID: 12846988 ] [34] Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S. Adenosine A2A receptors and basal ganglia physiology.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.pneurobio.2007.05.001 ] [PMID: 17646043 ] [35] Chung KK, Zhang Y, Lim KL, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/nm1001-1144 ] [PMID: 11590439 ] [36] Kawamata H, McLean PJ, Sharma N, Hyman BT.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1046/j.1471-4159.2001.00301.x ] [PMID: 11331421 ] [37] Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1371/journal.pone.0049750 ] [PMID: 23505409 ] [39] Li J, Uversky VN, Fink AL.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1021/bi010616g ] [PMID: 11560511 ],Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/mds.25373 ] [PMID: 23390095 ] [41] Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.2003.tb07541.x ] [PMID: 12853325 ] [45] Caruana  M,  Högen  T,  Levin  J,  Hillmer  A,  Giese  A,  Vassallo  N.  Inhibition  and  disaggregation  of  α-synuclein  oligomers  by  natural polyphenolic compounds.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.febslet.2011.03.046 ] [PMID: 21443877 ] [46] Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/mds.25028 ] [PMID: 22693036 ] [47] Huang LZ, Grady SR, Quik M. Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1124/jpet.111.182949 ] [PMID: 21665941 ] [48] Ahsan N, Mishra S, Jain MK, Surolia A, Gupta S. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/srep09862 ] [PMID: 25985292 ] [49] Ahmad B, Lapidus LJ.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1074/jbc.M111.325548 ] [PMID: 22267729 ] [50] Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1007/s00401-007-0332-4 ] [PMID: 18189141 ] [51] Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/0165-0173(92)90012-B ] [PMID: 1356551 ] [52] Frary CD, Johnson RK, Wang MQ.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.jada.2004.10.027 ] [PMID: 15635355 ] [53] Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1111/ggi.12123 ] [PMID: 23879665 ] [54] Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/mds.21706 ] [PMID: 17712848 ] [55] Zahniser NR, Simosky JK, Mayfield RD, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1007/s11302-008-9100-8 ] [PMID: 18438720 ] [57] Yu L, Schwarzschild MA, Chen J-F. Cross-sensitization between caffeine and L-dopa-induced behaviors in hemiparkinsonian mice.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.neulet.2005.09.036 ] [PMID: 16236444 ] [58] Shen  H-Y,  Chen  J-F.  Adenosine  A(2A)  receptors  in  psychopharmacology:  modulators  of  behavior,  mood  and  cognition.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.2174/157015909789152191 ] [PMID: 20190961 ] [59] Schwarzschild MA, Agnati L, Fuxe K, Chen J-F, Morelli M. Targeting adenosine A2A receptors in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.tins.2006.09.004 ] [PMID: 17030429 ] [60] Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.2174/138161208784480108 ] [PMID: 18537670 ] [62] Ascherio A, Zhang SM, Hernán MA, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/ana.1052 ] [PMID: 11456310 ] [63] Bode AM, Dong Z.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.canlet.2006.03.032 ] [PMID: 16709440 ] [64] Lopez-Garcia E, van Dam RM, Willett WC, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.598664 ] [PMID: 16636169 ] [65] Chen  X,  Ghribi  O,  Geiger  JD.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/0091-3057(94)90115-5 ] [PMID: 7906891 ] [69] Garrett BE, Holtzman SG.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/0014-2999(94)90029-9 ] [PMID: 7813580 ] [70] Popoli  P,  Reggio  R,  Pèzzola  A.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/S0893-133X(99)00144-X ] [PMID: 10731627 ] [71] Ikeda K, Kurokawa M, Aoyama S, Kuwana Y. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1046/j.0022-3042.2001.00694.x ] [PMID: 11902116 ] [72] Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1096/fj.99-0508com ] [PMID: 11023991 ] [75] Ricardo C, Marco FA, Daniel T. Astrocytes Role in Parkinson: A Double-Edged Sword.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.5772/54305 ] [76] Lin C-C, Deneen B. Astrocytes The missing link in neurological disease?",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/nrn1824 ] [PMID: 16371949 ] [78] Barreto GE, Gonzalez J, Torres Y, Morales L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.neures.2011.06.004 ] [PMID: 21693140 ] [79] Maragakis NJ, Rothstein JD.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/ncpneuro0355 ] [PMID: 17117171 ] [80] Sian J, Youdim MB, Riederer P, Gerlach M. MPTP-Induced Parkinsonian Syndrome.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1515/BC.2002.045 ] [PMID: 12033432 ],Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1096/fj.02-0126com ] [PMID: 12374784 ] [83] Varçin M, Bentea E, Michotte Y, Sarre S. Oxidative stress in genetic mouse models of Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1186/2047-9158-2-20 ] [PMID: 24093918 ] [85] Martin HL, Teismann P. Glutathione-a review on its role and significance in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1096/fj.08-125443 ] [PMID: 19542204 ] [86] Mytilineou C, Kramer BC, Yabut JA.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/S1353-8020(02)00018-4 ] [PMID: 12217624 ] [87] Liu Y, Qiang M, Wei Y, He R. A novel molecular mechanism for nitrated alpha-synuclein-induced cell death.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/jmcb/mjr011 ] [PMID: 21733982 ] [88] Przedborski  S,  Chen  Q,  Vila  M,  et  al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1046/j.1471-4159.2001.00174.x ] [PMID: 11208927 ] [89] Lull ME, Block ML.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.nurt.2010.05.014 ] [PMID: 20880500 ] [90] Chen JF, Xu K, Petzer JP, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.biocel.2010.06.021 ] [PMID: 20599520 ] [92] Chrovian CC, Rech JC, Bhattacharya A, Letavic MA.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/B978-0-444-63380-4.00002-0 ] [PMID: 24418608 ] [93] Marret S, Delpech B, Girard N, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1203/00006450-199312000-00004 ] [PMID: 8108181 ] [94] Horrigan LA, Kelly JP, Connor TJ.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.intimp.2004.06.005 ] [PMID: 15313438 ] [95] Matos M, Augusto E, Santos-Rodrigues AD, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/glia.22290 ] [PMID: 22298379 ] [96] Orr AG, Orr AL, Li X-J, Gross RE, Traynelis SF.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/nn.2341 ] [PMID: 19525944 ] [97] Addicott MA, Yang LL, Peiffer AM, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/hbm.20732 ] [PMID: 19219847 ] [98] Field  AS,  Laurienti  PJ,  Yen  Y-F,  Burdette  JH,  Moody  DM.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1148/radiol.2271012173 ] [PMID: 12616005 ] [99] Berger SM, Bartsch D. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1007/s00441-014-1936-3 ] [PMID: 24996399 ] [100] Kang S, Cooper G, Dunne SF, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1038/ncomms2149 ] [PMID: 23093183 ] [101] Putzier I, Kullmann PH, Horn JP, Levitan ES.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.4742-09.2009 ] [PMID: 20007466 ],Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/brain/awt180 ] [PMID: 23788521 ] [103] Pasternak B, Svanström H, Nielsen NM, Fugger L, Melbye M, Hviid A.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/aje/kwr362 ] [PMID: 22387374 ] [104] Sei Y, Gallagher KL, Daly JW.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1054/ceca.2000.0175 ] [PMID: 11162852 ] [105] Klegeris A, Choi HB, McLarnon JG, McGeer PL.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/jnr.21361 ] [PMID: 17526017 ] [106] Baroudi G, Qu Y, Ramadan O, Chahine M, Boutjdir M. Protein kinase C activation inhibits Cav1.3 calcium channel at NH2-terminal serine 81 phosphorylation site.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1152/ajpheart.00095.2006 ] [PMID: 16973824 ] [107] Postuma RB, Lang AE, Munhoz RP, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1212/WNL.0b013e318263570d ] [PMID: 22855866 ] [108] Tan  E-K,  Chua  E,  Fook-Chong  SM,  et  al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1097/FPC.0b013e3282f09265 ] [PMID: 18075470 ] [109] Qiu C, Hu G, Kivipelto M, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.171249 ] [PMID: 21536985 ] [110] Sibon I, Tison F. Vascular parkinsonism.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1097/00019052-200402000-00009 ] [PMID: 15090877 ] [111] Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1136/jnnp.2003.020982 ] [PMID: 15026515 ] [112] Palacios N, Gao X, McCullough ML, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1002/mds.25076 ] [PMID: 22927157 ] [113] Palacios N, Fitzgerald KC, Hart JE, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1186/1476-069X-13-80 ] [PMID: 25294559 ] [114] Ascherio A, Weisskopf MG, O’Reilly EJ, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1093/aje/kwh312 ] [PMID: 15522854 ] [115] Xu  K,  Xu  Y,  Brown-Jermyn  D,  et  al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.3008-05.2006 ] [PMID: 16407551 ] [116] Moo-Puc RE, Villanueva-Toledo J, Arankowsky-Sandoval G, Alvarez-Cervera F, Góngora-Alfaro JL.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.neulet.2004.06.022 ] [PMID: 15337259 ] [117] Gevaerd MS, Miyoshi E, Silveira R, Canteras NS, Takahashi RN, Da Cunha C. L-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1017/S1461145701002619 ] [PMID: 11806861 ] [118] Fredduzzi S, Moratalla R, Monopoli A, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.pbb.2006.12.009 ] [PMID: 17250882 ] [120] Casas M, Prat G, Robledo P, Barbanoj M, Kulisevsky J, Jané F. Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/S0924-977X(99)00037-1 ] [PMID: 10625120 ] [121] Holloway RG, Shoulson I, Fahn S, et al.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/S1474-4422(07)70108-4 ] [PMID: 17509486 ] [123] Nakaso K, Ito S, Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1016/j.neulet.2007.12.034 ] [PMID: 18201823 ] [124] Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"[http://dx.doi.org/10.1212/01.WNL.0000046523.05125.87 ] [PMID: 12629235 ] [125] Kaasinen V, Aalto S, Någren K, Rinne JO.",OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
[http://dx.doi.org/10.1097/00001756-200402090-00014 ] [PMID: 15076753 ] © Roshan et al.,Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/c1/TONEUJ-10-42.PMC4962431.pdf
Published  with  permission  from:  http://www.fightmalnutrition.eu/fight-malnutrition/ screening-tools/ Monitoring Nutrition  issues  are  responsibility  of  rehabilitation’s  healthcare  professionals  with  relevant  skills  and  training.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"More information is included in NICE Clinical Guideline 32 Feb.2006 Nutrition Support in Adults: Oral Nutrition Support, Enteral  Tube  Feeding  and  Parenteral  Nutrition  [ 49]  and  the  whole  guideline  can  be  downloaded  from: http://www.nice.org.uk/nicemedia/live/10978/29979/29979.pdf) PHYSIOPATHOLOGY OF MALNUTRITION Pathophysiological mechanisms of malnutrition in neurological and neurosurgical disabilities are multifactorial [ 50 - 57].",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1177/0148607192016005464 ] [PMID: 1433782 ] [2] Ghanbari C. Protocols for nutrition support of neuro intensive care unit patients: a guide for residents.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1007/BF02412640 ] [PMID: 2123428 ] [8] Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1378/chest.111.3.769 ] [PMID: 9118718 ] [11] Faisy C, Guerot E, Diehl JL, Labrousse J, Fagon JY.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1097/00004630-199205000-00005 ] [PMID: 1618877 ] [13] Ireton-Jones CS, Turner WW Jr. Actual or ideal body weight: which should be used to predict energy expenditure?",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/0148607108322399 ] [PMID: 19011147 ] [15] Frankenfield D. Validation of an equation for resting metabolic rate in older obese, critically ill patients.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/0148607110377903 ] [PMID: 21378256 ] [16] Frankenfield DC, Ashcraft CM, Galvan DA.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1177/0148607112446702 ] [PMID: 22577122 ] [17] Hamwi GJ.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/j.jada.2007.06.010 ] [PMID: 17761232 ] [19] Campbell CG, Zander E, Thorland W. Predicted vs. measured energy expenditure in critically ill, underweight patients.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/0115426505020002276 ] [PMID: 16207663 ] [20] Alberda C, Snowden L, McCargar L, Gramlich L. Energy requirements in critically ill patients: how close are our estimates?",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/011542650201700138 ] [PMID: 16214965 ] [21] Ahmad A, Duerksen DR, Munroe S, Bistrian BR.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/S0899-9007(99)00068-4 ] [PMID: 10355852 ],OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/0115426595010006229 ] [PMID: 8700053 ] [23] Dionyssiotis Y, Petropoulou K, Rapidi CA, et al.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/j.jocd.2008.04.006 ] [PMID: 18534884 ] [24] Gupta N, White KT, Sandford PR.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1038/sj.sc.3101790 ] [PMID: 16030513 ] [25] Jones LM, Legge M, Goulding A.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/S0003-9993(03)00045-5 ] [PMID: 12881836 ] [26] Buchholz AC, Bugaresti JM.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1038/sj.sc.3101744 ] [PMID: 15824757 ] [27] Laughton GE, Buchholz AC, Martin Ginis KA, Goy RE.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1038/sc.2009.33 ] [PMID: 19350042 ] [28] Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1007/s002239900309 ] [PMID: 9236259 ] [29] Stevenson RD, Roberts CD, Vogtle L. The effects of non-nutritional factors on growth in cerebral palsy.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1111/j.1469-8749.1995.tb11981.x ] [PMID: 7851668 ] [30] Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1002/ddrr.14 ] [PMID: 18646022 ] [34] Dionyssiotis Y. Malnutrition in spinal cord injury: more than nutritional deficiency.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1155/2011/818979 ] [36] Matsuo K, Palmer JB.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/j.pmr.2008.06.001 ] [PMID: 18940636 ] [37] Logemann J.,OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/j.gerinurse.2007.10.015 ] [PMID: 18694703 ] [39] National Collaborating Centre for Chronic Conditions.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/000348949110000815 ] [PMID: 1872520 ] [42] Périé S, Laccourreye L, Flahault A, Hazebroucq V, Chaussade S, St Guily JL.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1097/00005537-199811000-00022 ] [PMID: 9818831 ] [43] Kelly  AM,  Leslie  P,  Beale  T,  Payten  C,  Drinnan  MJ.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1111/j.1749-4486.2006.01292.x ] [PMID: 17014453 ] [44] Kelly AM, Drinnan MJ, Leslie P. Assessing penetration and aspiration: how do videofluoroscopy and fiberoptic endoscopic evaluation of swallowing compare?",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1097/MLG.0b013e318123ee6a ] [PMID: 17906496 ] [45] Rao N, Brady SL, Chaudhuri G, Donzelli JJ, Wesling MW.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.2340/16501977-0993 ] [PMID: 22729799 ] [47] [Set Performance Indicator rehabilitation centers.],Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/j.clnu.2004.07.015 ] [PMID: 15681104 ] [49] National Collaborating Centre for Acute Care (UK).,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/0148607189013003277 ] [PMID: 2761068 ] [51] Claus-Walker J, Halstead LS.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1056/NEJM199109053251005 ] [PMID: 1908058 ] [53] Burnham EL, Moss M, Ziegler TR.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1097/01.CCM.0000279193.23737.06 ] [PMID: 17713407 ] [55] Cree MG, Wolfe RR.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1089/neu.2009.1155 ] [PMID: 20373845 ] [57] Robertson CS, Grossman RG.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.3171/jns.1987.67.5.0739 ] [PMID: 3312514 ] [58] Bauman WA, Zhong YG, Schwartz E. Vitamin D deficiency in veterans with chronic spinal cord injury.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/0026-0495(95)90083-7 ] [PMID: 8786732 ] [59] Dionyssiotis Y.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.2147/IJGM.S22255 ] [PMID: 21845056 ] [60] Peruzzi WT, Shapiro BA, Meyer PR Jr, Krumlovsky F, Seo BW.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1097/00003246-199402000-00016 ] [PMID: 8306684 ] [61] Endersbe LA.,OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1177/088453369901400105 ] [64] Rello J, Quintana E, Ausina V, et al.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1378/chest.100.2.439 ] [PMID: 1864118 ] [65] Volkert D, Berner YN, Berry E, et al.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/j.clnu.2006.01.012 ] [PMID: 16735082 ] [66] Milne AC, Potter J, Avenell A.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"Cochrane Database Syst Rev 2005; (1): [http://dx.doi.org/10.1002/14651858.CD003288.pub2 ] [67] Simpson F, Doig GS.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1007/s00134-004-2511-2 ] [PMID: 15592814 ],Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1097/00003246-200112000-00005 ] [PMID: 11801821 ] [69] Leite HP, Fantozzi G. Metabolic assessment and enteral tube feeding usage in children with acute neurological diseases.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1590/S1516-31801998000600006 ] [PMID: 10349194 ] [70] O’Keefe SJ.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1038/nrgastro.2009.20 ] [PMID: 19347012 ] [71] DeLegge MH, McClave SA, DiSario JA, et al.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/j.gie.2005.08.024 ] [PMID: 16301043 ] [72] Fay DE, Poplausky M, Gruber M, Lance P. Long-term enteral feeding: a retrospective comparison of delivery via percutaneous endoscopic gastrostomy and nasoenteric tubes.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1300/J052v14n04_03 ] [PMID: 8708978 ] [75] ter Riet G, Kessels AG, Knipschild PG.",OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
[http://dx.doi.org/10.1016/0895-4356(95)00053-4 ] [PMID: 8543959 ] © Dionyssiotis  et al.,Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/1c/TONEUJ-10-32.PMC4962432.pdf
"[http://dx.doi.org/10.1016/j.ijnurstu.2006.03.015 ] [PMID: 16696978 ] [2] Hebling E, Pereira AC.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1111/j.1741-2358.2007.00178.x ] [PMID: 17696892 ] [3] Skaret ST, Ãstrøm AN, Haugejorden O.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
[http://dx.doi.org/10.1111/j.1600-0722.2008.00564.x ] [PMID: 18821987 ] [7] Farquhar M. Definitions of quality of life: a taxonomy.,Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
[http://dx.doi.org/10.1046/j.1365-2648.1995.22030502.x ] [PMID: 7499618 ] [8] van Wijk AJ.,Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.5177/ntvt.2011.03.10204 ] [PMID: 21491761 ] [9] Amsterdam JV, Pennings E, Brunt T, van den Brink W. Physical damage due to drug dependence (ZonMW study).",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1016/0740-5472(92)90009-D ] [PMID: 1317465 ] [11] ter Horst G, Molendijk G, Tjong EJ.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1111/j.1600-0528.1996.tb00826.x ] [PMID: 8654031 ] [14] Molendijk B, ter Horst G, Kasbergen MB, Truin GJ, Mulder J.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1016/0003-9969(81)90031-5 ] [PMID: 6947736 ] [16] Lee CY, Mohammadi H, Dixon RA.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1016/0278-2391(91)90223-9 ] [PMID: 1995818 ] [17] Friedlander AH, Gorelick DA.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1016/0030-4220(88)90190-9 ] [PMID: 2963248 ] [18] Winocur E, Gavish A, Volfin G, Halachmi M, Gazit E. Oral motor parafunctions among heavy drug addicts and their effects on signs and symptoms of temporomandibular disorders.",Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1111/j.1600-0528.1996.tb00827.x ] [PMID: 8654032 ] [20] van der Meulen MJ, John MT, Naeije M, Lobbezoo F. The Dutch version of the Oral Health Impact Profile (OHIP-NL): Translation, reliability and construct validity.",Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1186/1472-6831-8-11 ] [PMID: 18405359 ] [21] van Wijk A, Kieffer JM, Lindeboom JH.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
[http://dx.doi.org/10.1016/j.joms.2008.12.041 ] [PMID: 19375013 ],OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1016/j.joms.2008.01.006 ] [PMID: 18486784 ] [23] Ng SK, Leung WK.",OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1111/j.1600-0528.2006.00267.x ] [PMID: 16515675 ] [24] Cicciù M, Matacena G, Signorino F, Brugaletta A, Cicciù A, Bramanti E. Relationship between oral health and its impact on the quality life of Alzheimer’s disease patients: a supportive care trial.",Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/7b/TODENTJ-10-338.PMC4962433.pdf
"[http://dx.doi.org/10.1097/AAP.0b013e318234007e ] [PMID: 22030722 ] [3] Lind L, Eriksson M. Influence of nervous blockade on insulin-mediated glucose uptake in the human forearm.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1053/meta.2003.50069 ] [PMID: 12701051 ] [4] Kus A, Gurkan Y, Gormus SK, Solak M, Toker K. Usefulness of perfusion index to detect the effect of brachial plexus block.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1007/s10877-013-9439-4 ] [PMID: 23397432 ] [5] Taillefer MC, Denault AY.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1007/BF03018586 ] [PMID: 15625262 ] [6] Repez A, Oroszy D, Arnez ZM.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1016/j.bjps.2007.04.003 ] [PMID: 17532278 ] [7] Mancini DM, Bolinger L, Li H, Kendrick K, Chance B, Wilson JR. Validation of near-infrared spectroscopy in humans.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
[http://dx.doi.org/10.1111/j.1399-6576.2011.02533.x ] [PMID: 22092129 ],Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1093/bja/aep299 ] [PMID: 20007987 ] [10] Ghosh A, Elwell C, Smith M. Review article: cerebral near-infrared spectroscopy in adults: a work in progress.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1213/ANE.0b013e31826dd6a6 ] [PMID: 23144435 ] [11] Wahr JA, Tremper KK, Samra S, Delpy DT.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1016/S1053-0770(96)80107-8 ] [PMID: 8725427 ] [12] Werdehausen R, Braun S, Hermanns H, Freynhagen R, Lipfert P, Stevens MF.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1097/00115550-200701000-00013 ] [PMID: 17196496 ] [13] Chen Y, Shen Z, Shao Z, Yu P, Wu J.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1097/SAP.0000000000000430 ] [PMID: 25664408 ] [14] Goldman JM, Petterson MT, Kopotic RJ, Barker SJ.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1023/A:1011493521730 ] [PMID: 12580205 ] [15] Galvin EM, Niehof S, Verbrugge SJ, et al.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1213/01.ane.0000220947.02689.9f ] [PMID: 16790660 ] [16] Hamilton PD, Pearce CJ, Pinney SJ, Calder JD.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.3113/FAI.2009.1196 ] [PMID: 20003879 ] [17] Murray JM, Derbyshire S, Shields MO.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1111/j.1365-2044.2010.06240.x ] [PMID: 20377547 ] [18] Creech C, Meyr AJ.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1053/j.jfas.2013.03.021 ] [PMID: 23770190 ] [19] Bellingham GA, Smith RS, Morley-Forster P, Murkin JM.",OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"[http://dx.doi.org/10.1007/s12630-014-0140-y ] [PMID: 24668314 ] [20] Bussa M, Guttilla D, Lucia M, Mascaro A, Rinaldi S. Complex regional pain syndrome type I: a comprehensive review.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
[http://dx.doi.org/10.1111/aas.12489 ] [PMID: 25903457 ] © Van de Velde et al.,OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/48/TOORTHJ-10-258.PMC4962434.pdf
"Bologna: Bononia University Press SpA, 2011, http://www.buponline.com/ita/catalogo-noscript.asp?nscod ice=978-88-7395-685-3  61.",Non-OADS,/arxiv_data1/oa_pdf/51/56/10.1177_2050312116660115.PMC4962520.pdf
"Statistical analysis This analysis uses data collected and made public by Project Tycho ®, which has the goal of encoding all weekly US pub- lic health records of reportable diseases.23 (Data are available  at no cost from http://www.tycho.pitt.edu).",Non-OADS,/arxiv_data1/oa_pdf/34/32/10.1177_2050312116658909.PMC4962521.pdf
"8, p. 9, https://www.gov.uk/government/publica- tions/health-protection-report-volume-8-2014 (accessed 15 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/34/32/10.1177_2050312116658909.PMC4962521.pdf
"Eurosurveillance  2014; 19(12), http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20749 (accessed 15 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/34/32/10.1177_2050312116658909.PMC4962521.pdf
"BSc Thesis, Universite d’Ottawa, http://aix2.uottawa.ca/~sbail043/sfposter2.pdf (accessed 11 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/34/32/10.1177_2050312116658909.PMC4962521.pdf
"FEMS  Microbiol Lett 2015; 362, http://dx.doi.org/10.1093/femsle/fnv062  36.",Non-OADS,/arxiv_data1/oa_pdf/34/32/10.1177_2050312116658909.PMC4962521.pdf
http://www.ninds.nih.gov/about_ninds/groups/stroke_prg/sprg_ overview.pdf].,OADS,/arxiv_data1/oa_pdf/45/65/NRR-11-914.PMC4962584.pdf
The VBM8  toolbox in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/ spm8/) was used to process the T-1 weighted structural images.,OADS,/arxiv_data1/oa_pdf/8c/2f/NRR-11-920.PMC4962587.pdf
"© Xiumin Ma, Hui Zhao, Fengbo Zhang, Yuejie Zhu, Shanshan Peng, Haimei Ma, Chunbao Cao, Yan Xin, Delixiati Yimiti, Hao Wen, and Jianbing Ding *Correspondence to: Hao Wen; Email: dr.wenhao@163.com, Jianbing Ding; Email: maxiumin1210@sohu.comSubmitted: 09/25/2014; Revised: 06/03/2015; Accepted: 06/16/2015 http://dx.doi.org/10.1080/21645515.2015.1064564 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Vet Res Commun 2009; 33:47-52; PMID:19575305; http://dx.doi.org/ 10.1007/s11259-009-9247-y2.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Zoo-noses Public Health 2008; 55:156-65; PMID:18331519; http://dx.doi.org/10.1111/j.1863- 2378.2007.01100.x3.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Parasite Immunol 1996; 18:457-62; PMID:9226681; http://dx.doi.org/10.1111/j.1365- 3024.1996.tb01029.x Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Inter J Parasitol 1999; 29:531-4; http://dx.doi.org/10.1016/S0020-7519(99)00003-X 6.,OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Para- site Immunol 2012; 34:40-4; PMID:22043983; http://dx.doi.org/10.1111/j.1365- 3024.2011.01341.x 7.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:1516-22; PMID:19349218; http://dx.doi.org/10.1016/j.jchromb.2009.03.036 13.,OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
The Journal of Infectious Diseases2011; 204:1573-84; PMID:21933877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Infect Immun 2002; 70:3969-72; PMID:12065546; http://dx.doi.org/ 10.1128/IAI.70.7.3969-3972.2002 16.,Non-OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
Parasitol Res 2010; 106:847-51; PMID:20143095; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/a5/khvi-12-01-1064564.PMC4962714.pdf
"9Here we are presenting ourKeyword: conducting vaccine trials, lessons from interventional studies, ran-domized control trial, trials and tribula-tions, urban slums © Tanmay Mahapatra, Sanchita Mahapatra, Debot- tam Pal, Jayanta Saha, AnnaLena Lopez, Moham- mad Ali, Barnali Bannerjee, Byomkesh Manna, Dipika Sur, Sujit Bhattacharya, and Suman Kanungo *Correspondence to: Suman Kanungo; Email: sumankanungo@gmail.com Submitted: 06/04/2015Accepted: 06/21/2015 http://dx.doi.org/10.1080/21645515.2015.1066052 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
PLoS Med 2007; 4:e295; ; http://dx.doi.org/10.1371/journal.pmed.00402953.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Trials 2008; 9:PMID:18261242; http://dx.doi.org/10.1186/1745- 6215-9-7 4.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Am J Public Health 2010; 100:S40-46; PMID:20147663; http://dx.doi.org/10.2105/AJPH.2009.184036 5.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Annu Rev Public Health 1998; 19:173-202; PMID:9611617; http://dx.doi.org/10.1146/annurev.publhealth.19.1.173 6.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Soc Sci Med 2005; 61:1854- 65; PMID:15913858; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Am J Public Health 2003; 93:557-74; PMID:12660197; http://dx.doi.org/10.2105/ AJPH.93.4.557 8.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
J Urban Health 2007; 84:65-74; ; http://dx.doi.org/10.1007/s11524- 007-9183-5 9.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
J Health Popul Nutr 2010; 28:450-7; PMID:20941896;http://dx.doi.org/10.3329/jhpn.v28i5.6153 10.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Nature 2005; 436:484; PMID:16049470; http://dx.doi.org/10.1038/436484a 11.,OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
BMC Public Health 2011; 11:94; PMID:21310081; http://dx.doi.org/10.1186/1471-2458-11-94 13.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Arch Dis Child 2005; 90:1175-81; PMID:15964861; http://dx.doi.org/10.1136/ adc.2004.071316 14.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Lancet 374:1694-702; ; http://dx.doi.org/10.1016/S0140-6736(09)61297-6 15.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
N Engl J Med 361:335-44 ; http://dx.doi.org/10.1056/NEJMoa0807521 16.,OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
PLoS Negl Trop Dis 2011; 5:e1289; PMID:22028938; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Health Promot Pract 2006; 7:312-23;PMID:16760238; http://dx.doi.org/10.1177/ 1524839906289376 18.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Epidemiol Rev 2002; 24:72-9; PMID:12119859; http://dx.doi.org/10.1093/epirev/24.1.72 19.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
J Clin Epidemiol 1999; 52:1143-56; PMID:10580777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Health Educ Res 1998; 13:87-108; PMID:10178339; http://dx.doi.org/10.1093/her/13.1.87 22.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Annu Rev Public Health 2009; 30:175- 201; PMID:19296775; http://dx.doi.org/10.1146/ annurev.publhealth.031308.100134 24.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
Bull World Health Organ 2010; 88:185-91; PMID:20428385; http://dx.doi.org/ 10.2471/BLT.09.073460 25.,Non-OADS,/arxiv_data1/oa_pdf/97/13/khvi-12-01-1066052.PMC4962717.pdf
"Pulsed high-dose dexamethasone (HD-DXM), which has been used to treat multiple myeloma,sub-acute onset myositis, chronic inﬂammatory demyelinating © Xinhong Guo, Halida Yasen, Fang Zhao, Lei Wang, Mingling Sun, Nannan Pang, Xiujuan Wang, Ying Zhang, Jianbing Ding, and Xiumin Ma *Correspondence to: Jianbing Ding; Email: 331044524@sohu.com; Xiumin Ma; Email: maxiumin1210@sohu.comSubmitted: 10/23/2014; Revised: 05/19/2015; Accepted: 06/03/2015 http://dx.doi.org/10.1080/21645515.2015.1059975 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
New Eng J Med 1994; 331(18); PMID:7935660; http://dx.doi.org/10.1056/nejm199411033311807 2.,OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Clin Pediat 2004; 43(8):691-702; PMID:15494875; http://dx.doi.org/10.1177/000992280404300802 3.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
2012; 2012:444-9; PMID:23233617; http://dx.doi.org/10.1182/ asheducation-2012.1.444 4.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Intern Med 2012; 51: 859-863; http://dx.doi.org/10.2169/internalmedicine.51.7005 7.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Neuromus- cul Disord 2010; 20(6):382-9; PMID: 20423755; http://dx.doi.org/10.1016/j.nmd.2010.03.011.,OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
LancetNeurol 2010; 9(3):245-53; PMID:20133204; http://dx.doi.org/10.1016/S1474-4422(10)70021-1.,OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Crit Rev Oncol Hema-tol 2005; 54(2):107-16; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Blood 2003; 101(7):2721-6; PMID:12446456;http://dx.doi.org/10.1182/blood-2002-06-1666 21.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
"Reproduction 2008; 135(3):385-95;http://dx.doi.org/10.1530/rep-07-0063 22. van Wijk F, Nierkens S, de Jong W, Wehrens EJM, Boon L, van Kooten P, Knippels LM, Pieters R. TheCD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.",Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
2006; 61(1):15-26; http://dx.doi.org/ 10.1111/j.1398-9995.2006.01008.x 25.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
N Engl J Med 2003; 349(9):831-6;PMID:12944568; http://dx.doi.org/10.1056/ NEJMoa030254 28.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
2007; 109(4):1401-7; http://dx.doi.org/10.1182/blood-2005-12- 015222 29.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
1994; 55 (14):1147-53; PMID:8090056; http://dx.doi.org/ 10.1016/0024-3205(94)00243-6 30.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
J Interf Cytok Res 2000; 20(11); PMID:11096449; http://dx.doi.org/10.1089/ 10799900050198363 32.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
2011; 117 (6):2061-9; http://dx.doi.org/10.1182/blood-2010-07-295477 33.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Haematologica-theHematol J 2009; 94(11):1603-7; http://dx.doi.org/ 10.3324/haematol.2009.007708 34.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Blood 2010; 115(14):2755-62; http://dx.doi.org/10.1182/blood- 2009-07-229815 35.,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
Blood 2009; 113(11):2386-93; PMID:19005182; http://dx.doi.org/ 10.1182/blood-2008-07-162503 www.tandfonline.com 103 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/dc/9b/khvi-12-01-1059975.PMC4962720.pdf
"This phenomenon affects about 2–10% of vaccinatedhealthy individuals 1-4but the immunological background, the clinical consequences, or the question of whether vaccine failure isantigen-speciﬁc or a general phenomenon are largely unknown.© Ursula Wiedermann, Erika Garner-Spitzer, and Angelika Wagner *Correspondence to: Ursula Wiedermann; Email: ursula.wiedermann@ meduniwien.ac.at Submitted: 08/27/2015; Accepted: 09/06/2015http://dx.doi.org/10.1080/21645515.2015.1093263 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2007; 25:927- 31; PMID:17005304; http://dx.doi.org/10.1016/j.vaccine.2006.08.044 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
J Med Virol 2012; 84(8):1274-8; PMID:22711356;http://dx.doi.org/10.1002/jmv.23313 4.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2010; 28(20):3511-5; PMID:20332047; http://dx.doi.org/10.1016/j.vaccine.2010.03.024 5.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Arch Intern Med 1996; 156:2226-31; PMID:8885822; http://dx.doi.org/10.1001/archinte.1996.00440180088011 6.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Klin Wochenschr 1986; 64:688-94; PMID:2945040;http://dx.doi.org/10.1007/BF01712053 7.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
J Viral Hepat 1998; 5(Suppl 2):9-11; PMID:9857354; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
J Infect Dis 2002; 185:114-17; PMID:11756990; http://dx.doi.org/10.1086/338014 9.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Int J Med Micro- biol 2006; 296 Suppl 40:202-7; PMID:16524776; http://dx.doi.org/10.1016/j.ijmm.2006.01.030 1 0 .,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2013; 31:1293-97; PMID:23306371; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
"Ruggiero A, Battista A, Coccia P, Attina G, Riccardi R. How to manage vaccinations in children with cancer.Pediatr Blood Cancer 2011; 57:1104-08; PMID:21953691; http://dx.doi.org/10.1002/pbc.23333 13.",Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2013; 31:6177-84; PMID:24176495; http://dx.doi.org/10.1016/j.vaccine.2013.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2005; 23:4158-66; PMID:15964484; http://dx.doi.org/10.1016/j.vaccine.2005.03.017 16.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Clin Infect Dis 2011; 53:68- 75; PMID:21653306; http://dx.doi.org/10.1093/cid/ cir270 17.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2013;31:584-90; PMID:23142301; http://dx.doi.org/ 10.1016/j.vaccine.2012.10.101 18.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2009; 27:197-204; PMID:18996424; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
J Immunol 2013;191:2426-36; PMID:23872054; http://dx.doi.org/ 10.4049/jimmunol.1300293 20.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Nat Rev Immunol 2009; 9:185- 94; PMID:19240757; http://dx.doi.org/10.1038/nri2508 22.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Nat Immu- nol 2013; 14:428-36; PMID:23598398; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Immunol Lett 2014; 162:346-53; PMID:24960535; http://dx.doi.org/10.1016/j.imlet.2014.06.006 25.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
PLoSOne 2012; 7:e34145; PMID:22461903; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Vaccine 2006; 24:6808-11; PMID:16872725; http://dx.doi.org/10.1016/j.vaccine.2006.06.037 29.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Exp Gerontol 2012; 47:654-57; PMID:22564865; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Exp Gerontol 2014; 54:94-100; PMID:24370373; http://dx.doi.org/10.1016/j.exger.,OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Chest 2014;146:1347-57; PMID:25367471; http://dx.doi.org/10.1378/chest.14-0049 33.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Pediatr Allergy Immunol 2005; 16:637-40;PMID:16343084; http://dx.doi.org/10.1111/j.1399- 3038.2005.00331.x 34.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Lancet 1999; 353:196-200; PMID:9923875; http://dx.doi.org/10.1016/S0140-6736(98)05104-6 35.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Diabetes Res Clin Pract 2005; 69:29-35; PMID:15955385; http://dx.doi.org/ 10.1016/j.diabres.2004.11.007 37.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
PLoS One 2013; 8: e82779; PMID:24349359; http://dx.doi.org/10.1371/ journal.pone.0082779 38.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
Exp Biol Med (Maywood) 2010;235:1412-24; PMID:21127339; http://dx.doi.org/ 10.1258/ebm.2010.010227 39.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/khvi-12-01-1093263.PMC4962729.pdf
